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CHAPTER 1 
 
FUNDAMENTALS OF ION MOBILITY-MASS SPECTROMETRY FOR THE ANALYSIS 
OF BIOMOLECULES 
 
1.1 Statement of Thesis 
Ion mobility (IM) is an important electrophoretic technique where gas-phase ions are 
separated by their collision cross section (CCS). Often, it is integrated with mass spectrometry 
(MS), allowing separation of both ion size and mass on millisecond timescales to create a high 
sensitivity, high throughput analytical technique. Reproducible properties such as CCS can be 
utilized as metrics for identification and characterization. Molecular size and mass scale 
predictably in these gas-phase measurements, creating class distinctions that aid in identification 
of unknowns. Databases have been curated to allow improved identification of unknowns using 
descriptors such as mass and size and mapping IM class trends. Large databases of canonical CCS 
values demonstrate current trends in IM as well as new areas of exploration that will generate a 
significant impact. One area that has been relatively unexplored is the effect of drift gas on CCS. 
It has been noted that adjusting the ion mobility drift gas can affect these class distinctions. 
However, large scale studies had not been performed to investigate this effect across a wide mass 
and mobility range. This work demonstrates the value of IM as a molecular descriptor in addition 
to MS, establishes signposts for under-explored areas of study through a large review housing 
thousands of canonical CCS values, and further investigates one of these areas, exploring the effect 
of drift gas selection on CCS. This work seeks to demonstrate the importance of IM and its 
applications. A large review of the literature spanning forty years of publications will be shown to 
1
demonstrate the trends in the IM community. It will identify new areas of study and demonstrate 
the need for high quality databases for characterization of unknowns. Such a database will be 
given, detailing the importance of IM inclusion with MS to aid in rapid identification of isomers 
that can be challenging to identify with MS alone. Trends in IM that can be used for 
characterization of unknowns will be shown along with the effect of drift gas on class separation. 
A study spanning a wide range of drift gases, masses, classes, mobilities, and charge states will be 
presented to explore the drift gas effect on CCS separation. Instrument parameters will be 
established to obtain reproducible CCS values and recommendations on drift gas selection will be 
developed. This will give future researchers the tools to investigate drift gas effect and improve 
fundamental IM theory. 
 
1.2 Origins of Biomolecular Analysis by Ion Mobility-Mass Spectrometry 
Ion mobility-mass spectrometry (IM-MS) is an integrated chemical separation technique 
which combines complementary size- and mass-selective separations into a single analytical 
platform. IM-MS is capable of separating individual chemical compounds on the millisecond time 
scale and as such is considered a high-throughput, high-sensitivity techniques which has been 
applied in numerous chemical analysis applications including compounds of a biological origin. 
Historically, IM-MS traces its roots back to experiments by Rutherford and Thomson in the late 
1890s,1 and was further improved by Tyndall in the 1920s using pure drift gases,2-3 before being 
paired with mass spectrometry in the 1960s4 (Figure 1.1).5 Electrospray ionization (ESI) and laser 
ionization were coupled to IM in 19686-7and 1982,8 respectively, with Bowers coupling matrix 
assisted laser desorption/ionization (MALDI) with IM-MS in the mid-1990s.9 From the 1990s, 
MALDI and ESI coupled with IM-MS saw more widespread use as they were developed and 
2
  
 
 
 
 
 
 
 
 
Figure 1.1 (Left) Histogram of the number of publications published per year in ion 
mobility and ion mobility-mass spectrometry. Note that the scale is truncated at 300 
to highlight the number of publications specifically utilizing IM-MS. Further distinction 
is made to discriminate the frequency of publication for both time and space-
dispersive IM-MS publications. (Right) Historical milestones in the development of ion 
mobility and IM-MS instrumentation. (Figure and legend from May, et. al.5) 
3
refined for use with IM.10 These soft ionization techniques paired with IM-MS allowed for 
biomolecular analysis of large molecules11 and the growth in the application of this technology to 
biomolecules is illustrated in the timeline in Figure 1.2.12 In 2006, a commercially available ion 
mobility-mass spectrometer well suited for biomolecular analysis was developed by Waters 
Corporation, named the Synapt HDMS (traveling wave IM), which combined the soft ionization 
of electrospray with the rapid separation of IM and time-of-flight mass spectrometry, and 
supported other optional analytical capabilities including MALDI and MS imaging, as well as 
integration with liquid chromatography.13-15 This first commercial offering enabled a larger 
scientific community access to IM-MS which otherwise was only available to researchers with the 
capability to build their own. Other MS vendors entered the market with their own commercial 
IM-MS offerings, including Agilent Technologies in 2014 (drift tube IM) and Bruker Corporation 
in 2016 (trapped IM). With such versatile commercial instrumentation available, biomolecular 
analysis using IM-MS flourished and continues to be a rapidly growing field, with advances in 
fundamental separation techniques and broad technological application changing the analytical 
landscape. 
 
1.3 Biomolecular Separation and Analytical Utility of IM-MS 
IM-MS has found great utility for biomolecular separation due to its broad sample 
compatibility, resolution, and sensitivity. It has been used to separate and analyze a wide range of 
masses, from small molecules to large protein complexes.16-23 The analytical importance of IM is 
summarized in Table 1.1.12 Whether increasing peak capacity, reducing interference from 
chemical noise, or allowing for structural characterization, IM provides a broad range of 
analytically valuable enhancements. For example, it has been observed that biomolecular classes 
4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Bubble plot projecting the number of CCS values reported over time for the 
top 7 chemical classes represented. The size of each bubble encodes the relative 
number of CCS values for each respective year. (Figure and legend from May, et. al.12) 
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Table 1.1 from May, et. al.12  
6
maintain different molecular packing efficiencies in the gas phase, which results in class-specific 
trend lines to develop in 2-dimensional IM-MS spectra (Figure 1.324).25-26 Notably, the canonical 
biochemical classes: lipids, peptides, carbohydrates, and nucleotides, align themselves into unique 
regions of IM-MS analytical space which reflect their conformational preferences. Within each 
class trend, subclass trends may also exist. Lipids have a characteristic behavior in IM-MS 
indicative of headgroup identity.27 Lipid packing efficiency is affected by its headgroup and 
unsaturation within its acyl tail(s), forming differing trendlines in maps of gas phase collision cross 
section (CCS) versus mass. Current research is considering the effects of degree of unsaturation, 
double bond location, and carbon chain length on lipid packing efficiency and trendline behavior 
in IM.28 This has made IM-MS an applicable tool for the growing field of lipidomics, where the 
high sensitivity and separation speeds are well suited to high throughput analyses of complex 
samples.29-30 Novel approaches such as ozonolysis paired with IM-MS are now being applied to 
lipidomics to allow for determination of double bond location in lipids.31-32  For broad scale 
identification of unknowns, empirically-derived databases of mass and CCS are being assembled 
for a variety of biomolecular compounds.12, 18, 23, 33-41 The IM dimension also adds valuable 
information beyond biomolecular class. Isobaric compounds that are unresolvable by conventional 
MS can be distinguished in the IM dimension due to the different conformations they adopt, 
whether peptides, carbohydrates, or lipids.42-47 Collectively, the capability to rapidly resolve 
biochemical based on both structure and mass differences has made IM-MS an invaluable 
analytical tool for biomolecular analysis.  
 
 
 
7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 A cartoon depiction of where singly charged analytes (e.g., produced by 
MALDI) of different molecular classes are observed in IM–MS conformation space. 
(Figure and legend from Fenn, et. al.24) 
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1.4 Instrumentation Considerations 
 
1.4.1 Chromatography 
Including a front end chromatographic separation prior to IM-MS provides added peak 
capacity while enhancing the analytical sensitivity by reducing ion suppression resulting from the 
simultaneous infusion of multiple analytes. Liquid chromatography (LC) is commonly 
implemented with IM-MS due to its ability to use a wide variety of flow rates, column choices, 
and solvents that pair well with ESI ion generation. Since the IM separation occurs post-ionization, 
all of the LC conditions which work in LC-MS are also compatible with IM-MS, including both 
normal and reversed phase LC columns and numerous solvent systems. Autosampler systems are 
also commonly added to facilitate automated, high throughput LC-IM-MS workflows. Other 
chromatographic separation techniques such gas chromatography (GC) and supercritical fluid 
chromatography (SFC) have also been demonstrated with IM-MS,48-50 although these are less 
common due to the more limited analytical space that these techniques encompass (e.g., volatile 
and nonpolar analytes, respectively). Figure 1.45 demonstrates the compatibility of timescales for 
chromatography with IM-MS. While chromatography operates on a timescale of minutes, the 
downstream analytical strategies such as IM operate on the order of milliseconds to microseconds, 
allowing further separation of the components of the chromatogram in two dimensions. Due to the 
capability of IM-MS to temporally nest these different separation methods, the resulting platform 
is versatile and selective, allowing high throughput for complex biological analyses.  
 
 
 
9
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Nesting of analytical time scales based on speed of separation is shown for 
the analytical strategies on the left combined with the total number of potential 
spectra obtained through nesting the subsequent analytical separation dimensions 
shown to the right. (Figure and legend from May, et. al.5) 
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 1.4.2 Ion Sources 
Two of the most common methods for ionization of biomolecules are MALDI and ESI. 
These two ion sources, unlike many others, do not add significant energy to the molecule during 
ionization. This “soft” ionization helps to maintain the analyte’s structural integrity, which is 
crucial for the analysis of fragile biomolecules.9 MALDI typically generates low charge states in 
a narrow distribution, which simplifies the mass spectra. MALDI is performed on solid samples 
using a laser to ablate and generate ions which allows spatially-resolved mass information to be 
obtained. This has allowed MALDI-MS to be operated in an imaging mode for determining analyte 
location in tissue samples, and more recently, MALDI imaging has been coupled with IM-MS 
which provides a highly-dimensional separation technique that can simultaneously separate 
analytes based on spatial location, size, and mass.51 MALDI, however, is not conducive to direct 
analysis of liquid samples such as the effluent stream originating from LC. Liquid sample analysis 
is facilitated by ESI, which generates a continuous flow of ions from liquid-phase samples. ESI 
has enabled high-throughput LC-MS experiments and more recently has been used to combine LC 
with IM-MS.  In contrast to the low charge states observed in MALDI, ESI typically generates 
multiply charged ions. Since mass spectrometers measure ions as a mass-to-charge ratio, higher 
charge states effectively increase the practical mass range accessible to a mass spectrometer, 
facilitating analysis of proteins and other high mass analytes alongside small molecules in a 
complex biological sample. For IM analysis, the various charge states generated from ESI are 
readily resolved into separate trendlines in mobility versus mass space, which facilitates 
identification of multiply charged species.  
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1.4.3 Time-Dispersive Ion Mobility Techniques 
Two ion mobility techniques that are used in commercially available instruments are drift 
tube ion mobility spectrometry (DTIMS) and traveling wave ion mobility spectrometry (TWIMS) 
(Figure 1.5).5 TWIMS was the first IM technique to be used in a commercially available platform. 
In TWIMS, ion separations result from a series of dynamically-pulsed voltages (an electrodynamic 
field) which creates a traveling wave potential that transfers ions through the drift region in a 
mobility-selective mode. TWIMS separations are typically faster than DTIMS while accessing 
similar resolving powers, and because the traveling wave does not require high voltage operation, 
TWIMS is easier to implement on existing MS platforms. Although DTIMS combined with MS 
was implemented commercially several years after TWIMS, it is an older technique and considered 
the gold standard for CCS determination. Unlike TWIMS, DTIMS separates ions using a constant 
voltage gradient (a uniform electric field) which allows the measured ion drift times to be related 
directly to CCS via the fundamental ion mobility equation, commonly referred to as the Mason-
Schamp relationship.52-53 In TWIMS, CCS values are determined via an empirical calibration 
relationship between TWIMS measured drift times and known CCS values obtained from DTIMS.  
Due to the fact that TWIMS does not require high voltages to operate, it is readily scalable to 
longer path lengths, which fundamentally improves instrument resolution.  In contrast, high 
operational voltages must be utilized in order to increase the path length in DTIMS. Next 
generation TWIMS instruments are taking advantage of this scalability, producing high resolving 
power platforms based on cyclic designs.42,54 
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Figure 1.5 Two representative schematic diagrams for contemporary time-dispersive 
IM-MS instrumentation. (A) An electrostatic drift tube (DTIMS) arrangement similar to 
that described by Smith and co-workers. (B) An electrodynamic drift tube (TWIMS) 
arrangement similar to that described by Giles and co-workers. In both arrangements, 
hypothetical time courses are shown to illustrate the temporal separation of smaller 
and larger collision cross section ions. (Figure and legend from May, et. al.5) 
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1.4.4 Mass Spectrometry Considerations 
When combined with IM, mass spectrometry is almost exclusively used following IM 
separations to provide mass measurement on mobility separated ions. In this IM-MS configuration, 
most of the chemical separation occurs in the mass dimension due to the high resolving power 
(>10,000) accessible by modern mass spectrometers, however, the added IM dimension provides 
improved peak capacity and the capability for resolving isomeric compounds based on structural 
differences.55 IM is commonly coupled with time-of-flight (TOF) mass spectrometry due to its 
ability to rapidly analyze a wide mass range simultaneously and with high resolution. The 
timescale of the TOF is on the order of microseconds, pairing well with an upstream IM which is 
on the order of milliseconds per analysis. Quadrupole MS is also commonly used with IM-MS as 
an added mass filtering stage for tandem MS/MS experiments, which can aid in analyte 
identification and characterization.  
Fragmentation methods have been utilized with great success in tandem mass spectrometry 
and continue to be used in IM-MS, where it can be initiated between the IM and MS stages 
(IM/MS) or prior to IM-MS either with a front-end mass filter (MS/IM-MS) or without, as is the 
case with in-source ion activation (/IM-MS). Collision induced dissociation (CID) is commonly 
used to fragment ions as it is readily implemented with existing ion optics. CID is implemented by 
inducing high-energy ion collisions with an inert background gas (such as nitrogen or argon) and 
is considered an ergodic process whereby energy is distributed across the entire analyte, causing 
the lowest energy bonds break first. This leads to reproducible fragmentation of ions and the 
analysis of CID fragmentation spectra has been used with IM-MS to identify isobaric species 
which exhibit different bond energies. The CID method is commonly used in proteomics to 
determine the amino acid sequence of peptides. While highly predictable, CID does not preserve 
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weak bonds such as noncovalent complexes and post-translational modifications, and is less 
effective at fragmenting large molecules, such as intact proteins. To address these deficiencies, 
electron transfer dissociation (ETD) has been used, which fragments the ion in a non-ergodic 
process, breaking bonds CID would not, and thus creating different but informative fragments 
compared to CID. ETD and CID have been used simultaneously with IM-MS for 
glycoproteomics.56-58 This allows a variety of fragments to be determined for a given precursor 
ion, with CID fragmenting the glycan portion and ETD fragmenting the peptide portion. 
Combining the ion drift time, precursor mass, and fragment mass information allows for confident 
identification of the precursor. 
IM-MS holds an important role in biomolecular analysis. The ability of IM-MS to integrate 
with a wide variety of chromatographic techniques, ion generation methods, fragmentation 
methods, and mass determination ensures it will remain valuable for biomolecular analysis as it is 
applied to proteomics, lipidomics, metabolomics, and other biological problems requiring high 
sensitivity and high confidence identifications. Additionally, IM improves peak capacity compared 
to standalone mass spectrometers while providing separation on the order of milliseconds 
compared to minutes in an LC system. It can be used to identify isobaric species or as an added 
descriptor for the identification of unknowns. The next few sections discuss some of the 
applications of IM-MS to biomolecular analysis in more detail. 
 
1.5 Introduction to Current Trends 
The confident identification of small molecules continues to be one of the most difficult 
challenges in omic studies. While advancements in proteomics have streamlined MS-based 
identification efforts for peptides, metabolomic and lipidomic identification capabilities have 
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generally lagged behind.33,59-62 One reason for this is that while the structure of peptides consist of 
rationally-assembled amino acid building blocks which can be elucidated through ion 
fragmentation strategies, metabolites and lipids are not biopolymers with predicable sub-structural 
units. Additionally, the prevalence of isobaric species in lipidomics complicates feature 
identification, and metabolomics studies often encounter features of redundant mass that lack 
unique fragmentation patterns, further confounding attempts at identification by MS. Therefore, a 
combination of analytical techniques are required for high-confidence lipidomics and 
metabolomics. As shown in Figure 1.6, gas chromatography, liquid chromatography, or another 
front end separation can be readily combined with ion mobility and mass spectrometry analysis to 
provide highly-dimensional datasets which can be partitioned into specific omic workflows.62 The 
ion mobility provides a chemical class-specific separations based on differences in intrinsic gas-
phase packing, as well as quantitative size information via the CCS measurement which can be 
used as a reproducible measurement for identification purposes.62  
 
1.6 Integrating Ion Mobility for Omic Analysis 
IM-MS provides a fast separation of chemically unique biological groups with the added 
benefit of measuring collision cross section concurrently with mass-to-charge ratio.25,60,63 This 
capability is important for omics studies utilizing complex biological samples which routinely 
require extensive sample purification strategies to isolate molecules of interest from undesirable 
compounds that would otherwise make MS analysis difficult (e.g., salts, detergents, and other 
types of chemical noise).59,64 Sample preparation strategies have the potential to chemically alter 
molecules of interest, for example, by oxidation, reduction, conversion to a secondary metabolite, 
or loss of a post-translational modification in peptides. Integrating ion mobility with mass 
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Figure 1.6  Schematic of IMMS analysis workflow with different types of front-end separation 
techniques. Abbreviations: SPE, solid phase extraction; SFC, super critical fluidic chromatography; 
LC, liquid chromatography; CE, capillary electrophoresis; GC, gas chromatography. (Figure and 
Caption from Zhang et al.62) 
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spectrometry can help offset some of the burden of chemical separation and alleviate the need for 
extensive sample handling. In certain cases where fragmentation occurs post-mobility, either 
intrinsically or intentionally, IM-MS also allows the alignment of precursor and product ions 
which can further aid in identification.61 The following sections provide examples of how ion 
mobility has been integrated in proteomic, lipidomic, and metabolomic analyses. Although each 
analysis is discussed separately, it should be noted that ion mobility allows for simultaneous 
analysis of these individual omic fields via chemical class separation, providing a truly integrated 
multi-omic experiment.  
 
1.6.1 Proteomics 
Proteomics, the large-scale study of proteins, has been a driving force in systems biology 
and has increased our understanding of diseases such as lung cancer and Alzheimer’s. Proteins 
serve as the machines for all cellular processes, thus proteomic studies are one of the most crucial 
tasks in systems biology. MS-based proteomics is a major component to the advancements in the 
field.65,66 Proteins encompass a large dynamic range of concentrations, necessitating separation 
techniques to enhance lower abundance species prior to mass analysis. Common separation 
methods for proteomics include gel electrophoresis, liquid chromatography, and, in a growing 
number of instances, ion mobility.67-69 
Ion mobility has been utilized extensively in structural proteomics.60,70 Proteins of similar 
or exact mass, such as protein conformers, can be separated by ion mobility due to differences in 
their gas-phase size. Figure 1.7 illustrates an ion mobility separation for protein ions of different 
sizes but similar mass to charge ratio.70 The majority of multiprotein complexes have been 
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Figure 1.7  Ion mobility-mass spectrometry data acquisition and basic principles. Ions are 
generated at the ion source (lower left) and are allowed to drift in an ion guide filled with 
neutral gas molecules under the influence of an electric field. The ions migrate through 
this region according to their size-to-charge ratio. They are then injected into a ToF mass 
analyzers under vacuum for m/z analysis. The resulting data are 3D, containing ion 
intensity, size and mass information. The various dimensions of the data can be shown as 
a contour plot (middle, bottom), or 2D selections in drift time of m/z (lower right). A key 
for the diagram is shown (upper right). (Figure and Caption from Zhang et al.70) 
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analyzed on traveling wave instruments, and it has been demonstrated that incorporation of 
traveling wave ion mobility can increase proteome coverage by up to 60%.71 
In addition to separating proteins, ion mobility is used to probe structural information.70 
Temperature-controlled ESI sources and heated ion transfer capillaries have been used prior to IM-
MS to rapidly heat proteins and monitor their controlled denaturation.72-74  In addition, thermally-
induced protein conformational transformations as well as protein-ligand interactions are able to 
be observed. In these ways and others, IM-MS progresses from a separation strategy to an aid in 
understanding how protein clusters are formed and stabilized.73,74 
 
1.6.2 Lipidomics 
 Lipids comprise a large portion of the small molecules extracted from organisms. They 
have three major functions in biological systems: energy storage, cellular signaling, and structural 
functions. Lipids can be divided into eight major categories with many different chemical motifs 
ranging from fused cyclic molecules to long chain fatty acids. They cover a large range of m/z 
ratios and while mass spectrometry has been a powerful tool in lipidomics, it still falls short in 
some areas due to many isomeric species.75,76,77 Isomeric complexity makes the study of lipidomics 
difficult as there are many potential double bond positions, geometric (cis/trans), constitutional 
(linear and branched) and stereochemical orientations that a lipid can adopt which are all isobaric 
in mass. Identifying complex lipid structures has been a struggle in the field of lipidomics; one 
that ion mobility is well-suited to address.76-79 Similar to other mass spectrometry based omic 
fields, lipids are identified based on their fragmentation pattern obtained from tandem MS/MS 
experiments. As many lipids are chemically and structurally similar, lipids can be challenging to 
separate using LC alone, making it difficult to correlate fragment ions with their precursor ion 
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forms. As demonstrated by Paglia et al., ion mobility can be used to align fragmentation spectra 
with precursor parent ions to increase the confidence in lipid identification (Figure 1.8).80 
Additionally, ion mobility was demonstrated to be useful in separating co-eluting lipid structures 
with the same m/z ratios. 
 Ozone-induced dissociation has been recently demonstrated with IM-MS to elucidate the 
location of double bonds in the acyl tail region of lipids. Two separate strategies have been 
demonstrated:  solution-phase ozonolysis of lipids prior be being introduced to the mass 
spectrometer,81 and gas-phase ozonolysis of lipid ions within the MS, the latter technique termed 
OzID.  These ozonolysis strategies have been shown to be useful for locating the position of double 
bonds within lipids, however, one shortcoming with this approach is that it does not provide any 
information about the geometry of the double bond prior to ozonolysis.81,82 This emphasizes the 
strength of IM-MS analysis. Ion mobility allows for the differentiation of some geometric lipid 
isomers, such as cis versus trans, even when in a complex biological mixture. Groessl et al. 
demonstrated that collision cross section differences of 1% are sufficient for the baseline 
separation of lipids in DTIMS.78 Although they discuss how it is possible to use IM for 
identification purposes, it is also stressed that high precision and accuracy are needed to create and 
populate reliable reference data libraries. As these libraries become more available, it is expected 
that lipidomics will experience similar growth that has been seen in the proteomics field.  
 
1.6.3 Metabolomics 
 Metabolomics is the measurement of the thousands of small molecules in a biological 
system. Unlike genomics and proteomics, metabolomics encompasses a large amount of chemical 
diversity as it consists of molecules from many different biological classes, such as carbohydrates, 
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Figure 1.8  Schematic visualization of acquisition using data-independent acquisition (MSE) 
and MSE coupled with IM (HDMSE). Combined with IM separation, fragmentation offers 
unique capabilities to increase specificity and confidence in identifying complex lipid 
structures. (Figure and Caption from Paglia et al.80) 
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amino acids, hormones, and lipids.83 There are generally two approaches to mass spectrometry 
based metabolomics: (1) targeted analysis, in which a panel of metabolites are selected prior to 
data collection, and (2) untargeted analysis, in which all small molecules are analyzed 
simultaneously.83 Both approaches have their advantages. Targeted studies allows for semi-
quantitative analysis of small molecules on a curated list. Isotope standards can be analyzed 
concurrently with unknowns and calibrated against empirically-measured response curves 
(calibration curves) in order to determine the concentration of specific metabolites within a sample. 
While this approach provides quantitative information regarding metabolites of interest, targeted 
studies do not provide information for other small molecules present in the sample, and for 
practical reasons, generally only targets a small pool of metabolites. Untargeted approaches, on 
the other hand, focuses on separating and comprehensively measuring all of the small molecules 
present in the sample, but lacks robust means of quantifying these signals.  Also, untargeted studies 
generally utilizes analytical methods and settings that attempt to measure a large breadth of 
molecules, and thus can be less sensitive to a specific class or pool of analytes.83-85 In addition, 
identifying the oftentimes thousands of metabolites detected in an untargeted study can be an 
arduous task. For a single m/z feature, there can be hundreds of hits in any metabolomic database, 
making an absolute identification difficult.84-86 In order to improve confidence in metabolite 
identification, multiple dimensions of analytical information are obtained in the experiment, which 
can include measurements from front end chromatographic separations, as well as post-ionization 
techniques such as ion mobility and tandem ion fragmentation information.  Ion mobility in 
particular can help to alleviate some of the difficulties associated with confident metabolite 
identification.84-86  
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 As noted in the previous section, ion mobility can improve fragmentation identification in 
lipidomics, and this advantage applies to metabolomics as well. With such chemical diversity 
found in the metabolome, ion isolation is complicated by co-eluting species, and thus aligning 
precursor ions with their fragments originating from ion activation experiments is challenging. 
Using ion mobility prior to fragmentation allows co-eluting small molecules to be further resolved 
following chromatography. 84-86 This is demonstrated by Wickramasekara et al. in which co-eluting 
lipid species are classified based on the differences in their drift time (Figure 1.9).87 In addition, 
the drift time extracted spectra can be used to align fragment ions to the parent ion, as they have 
identical drift times when conducting the fragmentation post-mobility. This capability provides 
more specific ion fragmentation information which can then be used with the accurate mass 
measurement to match unknowns to entries found in one or more databases, thus increasing the 
confidence in assigning metabolite identifications.  
 In addition to utilizing the enhanced separation and fragment alignment capabilities from 
IM, CCS measurements derived from IM experiments can also be used to improve metabolite 
validation.104 CCS is linked to an intrinsic molecular property of the analyte (the microscopic cross 
section) and thus is considered more robust than other measurement parameters such as the 
chromatographic retention time. This property makes CCS useful as an additional molecular 
descriptor that can be used in metabolomic studies along with accurate mass and fragmentation 
information. Currently, there are labs attempting to use CCS in metabolite identification 
workflows. For example, Paglia et al. has described a robust analytical workflow incorporating 
CCS for both metabolite and lipid identifications, and report a ca. 2% inter-laboratory 
reproducibility of the TWIMS derived CCS.61  Stow et al. utilized standardized DTIMS 
instrumentation deployed across several laboratories to achieve an inter-laboratory CCS 
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Figure 1.9  An example of a 2D image (drift time vs retention time) showing the ion 
mobility separation of different compound classes in rat plasma samples. The encircled 
regions mark the compound classes that eluted within a similar retention time window 
(26-28 min). Drift time-extracted spectra (bottom) show that these two clusters belong 
to different lipid classes, namely Lyso-PC and SM lipids (sphingosine phosphocholines) 
that have drift time distributions centered around 7.02 ms and 4.75 ms, respectively. 
(Figure and Caption from Wickramasekara et al.87) 
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reproducibility of better than 0.5%, and recent work by Nichols et al. describes the utility of 
DTIMS CCS measurements as a molecular descriptor in untargeted studies of primary human 
metabolites.8889 As more research shifts towards incorporating CCS into metabolomic analysis, 
there is a need for databases to propagate likewise. Recent efforts for developing CCS databases 
to support metabolite identifications have included pesticides, pollutants, xenobiotics, and 
steroids.90-93 Leveraging the standardization efforts for DTIMS, Picache et al. has recently 
described a “Unified CCS Compendium” which compiles over 3,800 CCS measurements obtained 
from different studies into a single, self-consistent resource with a global average CCS precision 
of 0.25% RSD.94 These and other efforts will allow rapid and reliable metabolite identification and 
quantification, which becomes increasingly important as the field shifts towards comprehensively 
characterizing individual metabolomic pathways. 
 
1.7 Continuing Advancements in IM-MS Technology 
Innovation in IM-MS instrumentation continues at a rapid pace. Various improvements 
have been suggested and current technologies allow for ingenious solutions for challenges 
encountered in biomolecular analysis. One novel instrument design approach utilizes a scalable 
ion optical architecture consisting of electrode pads on a printed circuit board (PCB) and driven 
with electrodynamic (RF) fields that confine ions to a predefined ion optical path.  This approach, 
named by the authors as “structures for lossless ion manipulations” (SLIM), utilizes a 2-
dimensional electrode geometry that is both modular and scalable such that various different 
experiments can be achieved on the same instrument platform.42, 95-98 In SLIM, two PCBs with a 
mirrored electrode symmetry are placed above and below one another to create the ion path of 
travel in between the boards, and a dynamic electric fields are used to both contains and guides the 
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ions through the SLIM device.99 SLIM allows high transmission ion transfer through elevated 
pressure regions, and SLIM-based ion mobility separations have been demonstrated using this 
approach. The ability to print electrodes on a two-dimensional surface allows for various ion 
manipulation modules to be fabricated, including modules to move ions at 90-degree angles 
(elbows and tees).100-101 This facilitates cyclic racetrack and serpentine geometries to be fabricated 
for long path-length, high-resolution ion mobility separations, and incorporation of “tee” junctions 
allows selection of a discreet ion mobility region for further analysis by either IM or MS 
techniques. An example of SLIM-based ion mobility instrumentation is shown in Figure 1.10.102 
Current designs have created instruments with some of the highest IM resolution currently 
available.54, 103 
In addition to TWIMS and DTIMS, a relatively new ion mobility technique called trapped 
ion mobility spectrometry (TIMS) is currently available in commercial instrumentation.104-105 
TIMS performs ion mobility separations by selectively releasing ions trapped in a mobility 
analyzer cell combining a gas flow and an opposing electric field.106-107 The ions trapped in TIMS 
are released slowly by lowering the electric field barrier, which allows a mobility spectrum to be 
obtained and subsequent MS analysis to be performed. The rate at which the electric field is 
lowered corresponds with IM resolution, with slower scan rates leading to higher resolution. TIMS 
instruments are capable of high IM resolutions and are very versatile due to its variable scan rate.108 
Either high throughput or high resolution scan rates may be chosen as needed, or a scan rate may 
be variable during analysis to allow high resolution only for certain range of mobilities, enabling 
targeted high resolution experiments to be conducted. This is in contrast to high resolution cyclic 
or racetrack IM techniques, which must discard all mobilities except a select region. 
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Figure 1.10  (A) Schematic diagram of the multipass SLIM SUPER IM-MS instrument 
used in this work; (B) photo of one of the two SLIM module surfaces; and (C) illustration 
of an ion switch (switch on,  ion cycling; switch off, transmit ion to MS). (Figure and 
legend from Deng, et. al.102) 
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While most efforts have focused on improving IM resolution, some approaches have 
sought to improve sensitivity and throughput. An example of such an approach is a multi-channel 
IM spectrometer shown in Figure 1.11.5 This instrument utilizes eight discrete ion optical paths to 
perform eight ion mobility separations in parallel.109 Each ion channel can act independently, 
analyzing eight unique samples at a time, improving throughput. Alternatively, the multi-channel 
instrument can analyze the same sample simultaneously across the eight ion optical paths, 
increasing the sensitivity of the instrument. As the analytical community pushes for rapid 
extraction of more information from complex samples, advancements in high throughput 
instrument designs remain crucial. 
Additional strategies for improving the mobility separation have focused on increasing the 
chemical selectivity of existing IM instrument by using alternate drift gases.17 The understanding 
and application of the effect of drift gas on IM separations and the associated CCS measurement 
is still in early development, but there is now mounting evidence that the use of more polarizable 
drift gases (e.g., CO2, N2O, NO2) can increase the resolution for certain ion species.110-111 While 
the hard-sphere interactions between the ion and drift gas tend to predominate the mobility of ions 
in the IM experiment,112 long-range interactions also play a role in the observed IM separations 
and are exploited by varying the drift gas polarizability. Improved selectivity can occur between 
certain ionic species depending upon their susceptibility to long-range interactions.113 The effect 
on separation efficiency by varying the drift gas composition is similar to the effect of varying the 
solvent conditions in capillary electrophoresis to affect separation selectivity. It is common to alter 
the drift gas in some high-field IM techniques, such as high-field asymmetric waveform ion 
mobility spectrometry (FAIMS) and differential mobility spectrometry (DMS).114-119 In low-field 
IM techniques, this is less common, but there have been a number of significant examples.120-121 
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Figure 1.11 Schematic diagram illustrating a spatial multiplexing strategy for DTIMS 
through combining eight individual IM channels: (A) diagram showing ion simulations 
through the interfacing ion funnels and the drift tube array and (B) cutaway showing 
component details of the spatially multiplexed instrument. (Figure and legend from 
May, et. al.5) 
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Using an ambient pressure drift tube, Hill and coworkers showed that varying the drift gas 
polarizability could improve selectivity.110-111, 122-123 Using a reduced pressure drift tube, Yost and 
coworkers reported that carbon dioxide improved resolving power for several isobaric steroids.124 
Eberlin and coworkers demonstrated that replacing nitrogen with carbon dioxide in a TWIMS 
instrument could improve separation of a number of analytes such as carbohydrates and isomeric 
haloanilines.47, 125-127 However, it is common for observations of more polarizable drift gases to 
report minimal improvement to overall IM peak capacity or resolution compared to nitrogen on 
helium.113, 128-130 For example, Fjeldsted and coworkers investigated the separation of various 
small molecule pesticides, isomeric carbohydrates, and fluoroalkyl phosphazenes in a wide variety 
of drift gases, such as helium, nitrogen, argon, carbon dioxide, nitrous oxide, and sulfur 
hexafluoride. Generally, they observed that helium and nitrogen had the highest resolution and 
resolving power, with some of the more polarizable drift gases demonstrating better selectivity 
when comparing certain analyte pairs.17 To fully evaluate drift gas effect, a broader range of 
masses and biological classes needs to be reported in a variety of drift gases across multiple 
platforms and laboratories. The majority of CCS measurements have been reported in helium or 
nitrogen, hindering the evaluation of IM separation performance in alternate drift gases.12 
Normalized measurements like CCS are vital for allowing direct comparison of separations on 
different platforms (e.g. drift tube or traveling wave).103 Due to the potential analytical importance 
of drift gas composition, there is a need for further exploration into the effect of drift gas on CCS 
as a method to increase IM resolution. 
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1.8 Combining Discrete Omic Databases for Multi-Omic Experiments 
When utilized in various omics studies, ion mobility has been used primarily to partition 
analytes of interest from chemical noise originating from complex samples, resolve ambiguities 
within co-eluting features, and align precursor and fragmentation data acquired in data independent 
strategies. While the majority of IM-MS applications in biomolecular analysis have focused on 
specific omic fields (e.g., proteomics, lipidomics, metabolomics), there is increasing interest in 
utilizing IM-MS for untargeted, multi-omic studies which look at all molecule types 
simultaneously.131 A truly, multi-omic analytical workflow will facilitate the development of 
system maps which connect relationships between molecule types and allow perturbed pathways 
to be highlighted. To illustrate this concept Figure 1.12 displays work from Paglia et al. on building 
pathway maps to track metabolites being shuttled between mitochondria and the cytosol.132 An 
area that can benefit from this type of analysis is the microbiome field. The microbiome has 
experienced recent and significant attention aimed at understanding the integral role that 
commensal bacteria plays on human health.133-135 This focus, in large part, is due to advancements 
in sequencing of bacterial communities allowing for whole populations to be analyzed 
simultaneously, facilitating the comparison of healthy versus disease states.135,134 One challenge 
that remains in microbiome research is the understanding of the mechanisms that lead to disease, 
which can be addressed at least in part by building biochemical inventories of small molecule 
metabolites observed within the samples. Mass spectrometry based metabolomics nestles nicely 
into a potential multi-omic study. It can be applied to a variety of sample types, can measure 
thousands of metabolites, and requires very little sample quantities. In particular, the ability of IM-
MS experiments to separate and detect multiple biological classes and chemical motifs 
simultaneous, can allow perturbed metabolites to be observed along with changes in the bacterial 
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Figure 1.12  Mitochondrial shuttles. (a) Bar Charts of aspartate, malate, citrate, and 
glutamate obtained from normalized signals in AD (red) and ND control subjects (green). 
(b) Bar chart of N-acetylaspartate (NAA) obtained from normalized signals in AD (red) and 
control subjects (green) and MS imaging of AD and control subjects brain sections. (c) 
Mitochondrial shuttles and metabolites quantified in his experiment (blue dots). *p < 0.05 
(t test). Targeted data used for bar charts were normalized by mean centering, scaled by 
unit variance, and log-transformed. (Figure and Caption from Paglia et al.132) 
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community. Revealing changes in the metabolomic profile can give insight into the role that 
particular bacteria plays within the rich tapestry that is the microbiome.  
 Throughout this chapter, using the idea of using collision cross section as a tool for 
separation and descriptor for biomolecules has been addressed. However, this can only be useful 
for the field if there is a database that contains accurate collision cross sections. To date, there are 
several labs that are attempting to solve this problem and many labs us an in-house database. This 
is essential for ion mobility to expand its versatility. Similar to how Genbank136 and The Protein 
Database137 has helped normalize and improve the speed and cost of genomic and proteomic 
respectively, a database for collision cross sections will help to improve the speed and accuracy in 
which ion mobility experiments can be performed.  
 
1.9 Statement of Dissertation 
Herein, my contribution to this work is detailed. Chapter 1 was adapted from a book chapter 
noted in the acknowledgments section. I wrote half of the book chapter and was part of the editing 
process for the entire chapter. This chapter introduces IM in a methods and protocols book, 
describing the history, value, and effectiveness of IM to researchers not familiar with this 
analytical technique. In chapter 2, which was adapted from published work noted in the 
acknowledgments section, I searched the literature for publications with relevant data, recorded 
said data, brought ideas on data representation, and created figures for the publication. I created 
macros to give the data sheet the capability to efficiently sift through copious amounts of 
information and create graphs from a large number of data points and series. I also created three 
dimensional graphs to allow for better visualization of a large quantity of data. This work brought 
to light the major trends in the literature over a time span of 40 years. It allowed the community to 
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see both what has been done and what new areas of study are available. Chapter 3 was adapted 
from published work noted in the acknowledgments section. In this work, I was involved in data 
analysis classifying isomer groups and determining IM’s effectiveness in separation of isomer 
pairs. I created macros that sorted through large datasets to identify and quantify the number of 
isomers. These macros also determined percent difference among the pairs, aiding in identification 
of isomers that can be separated based on current IM resolving power as well as the effect that 
improvements in IM resolving power will have on isomer separation and identification. I also 
helped create charts to visualize the results of this isomer investigation. My work demonstrated 
the ability of IM to enhance identification of isobaric species where mass spectrometry can 
struggle. It also helped demonstrate the current capabilities of IM and how improvements in 
mobility resolution would affect isomer coverage. In chapter 4, which was adapted from published 
work and noted in the acknowledgments section, I analyzed IM trends and found mathematical 
descriptors appropriate for each trend. I found best fit lines for data classes from multiple possible 
mathematical descriptors and created charts demonstrating these best fit lines as well as data 
inclusion bands. I was also involved in writing a portion of the manuscript. This work provided 
the basis for demonstrating the affect helium and nitrogen drift gases have on class as well as 
establishing trends that could be used for characterization of unknowns. Chapter 5 was adapted 
from published work and noted in the acknowledgments section. I designed the experimental 
method, choosing the drift gases and classes. I designed and ran the experiments on the instrument 
to establish experimental parameters in the different drift gases. I chose and ran the classes in each 
of the drift gases. I performed all the data analysis. I created figures to demonstrate the reasoning 
behind recommendations of instrument parameters as well as creating figures demonstrating the 
effects of drift gas on CCS. I wrote the manuscript and helped edit the manuscript and figures. 
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This work establishes instrument operating parameters for multiple drift gases to achieve 
reproducible CCS values. This work also gives recommendations for drift gas selection and aids 
researchers in identification of the appropriate drift gas for their analytical application. The 
reproducible CCS values can be utilized as the basis for improving fundamental IM theory and 
determining relative elution orders of analytes in different drift gases through future creation of 
predictive algorithms. This work was the first drift gas study to look at a wide range of drift gases, 
classes, masses, mobilities, and charge states. Chapter 6 is my own work and has not been 
published. This outlines future work that may be performed to improve trend fitting with 
mathematical descriptors for better characterization of unknowns. A method for CCS prediction 
in different drift gases is also noted. Such a method, if established, would allow for comparison of 
CCS values gathered in one drift gas with those from the literature in another drift gas. 
Computational analysis of these values can be time consuming and computationally expensive. 
This method could allow for rapid CCS prediction without the need for time intensive calculations. 
Finally, recommendations are made for drift gas selection for future studies. This describes the 
important aspects of drift gas selection to consider for enhancement of fundamental IM 
understanding and prediction of drift gas effect. This guide will help future investigators as they 
seek to describe the drift gas effect on CCS separation. 
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 CHAPTER 2 
 
AN ION MOBILITY COLLISION CROSS SECTION COMPENDIUM 
 
2.1 Introduction 
In this review, we focus on an important aspect of ion mobility (IM) research, namely the 
reporting of quantitative ion mobility measurements in the form of the gas-phase collision cross 
section (CCS), which has provided a common basis for comparison across different instrument 
platforms and offers a unique form of structural information, namely size and shape preferences 
of analytes in the absence of bulk solvent.  This review surveys the over 24,000 CCS values 
reported from IM methods spanning the era between 1975 to 2015, which provides both a historical 
and analytical context for the contributions made thus far, as well as insight into the future 
directions that quantitative ion mobility measurements will have in the analytical sciences.  The 
analysis was conducted in 2016, so CCS values reported in that year are purposely omitted.  In 
another few years, a review of this scope will be intractable, as the number of CCS values which 
will be reported in the next three to five years is expected to exceed the total amount currently 
published in the literature. 
Quantitative ion mobility methods have seen a resurgence of recent and significant interest 
due to the fact that in the past three years, a number of new and updated ion mobility technologies 
combined with mass spectrometry (IM-MS) have emerged as commercially-available 
instrumentation for routine chemical analysis.  These have included updates to traveling wave 
instrumentation (TWIMS), new uniform field drift tubes (DTIMS) operated at both elevated 1 and 
reduced pressures (less than 10 Torr),2-4 and a newly-developed ion trapping device operated in a 
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 mobility-selective mode (trapped ion mobility spectrometry, TIMS) 5-7.  Other ion mobility 
techniques including cyclic and extended path length traveling wave devices are currently in 
development.8,9  This recent and unprecedented commercial accessibility of IM-MS in 
combination with existing liquid chromatography and tandem MS functionality has provided 
powerful multidimensional separation capabilities to the greater research community,10-13 which 
in turn has broadened the scope of applications and fields in which IM-MS is now making a 
significant impact.14-19  Many of the contemporary challenges being addressed by IM-MS are 
grand challenges of our era of humanity.11  
Ion mobility is generally utilized in one of three ways by researchers (Table 2.1): (1) as an 
added dimension of separation for increasing the peak capacity and partitioning the chemical noise 
from analyte signals of interest, (2) as an additional measurement for analyte identification and 
characterization, and/or (3) as a structural measurement technique, where the ion mobility 
information is used to infer some details regarding the structure (either primary or higher-order) 
of the analyte.  The latter two strategies, analyte identification and structural measurement, are 
achieved by converting the ion mobility measurement (typically drift time), to an ion-neutral 
collision cross section value, which represents a fundamental property of the analyte comparable 
across different laboratories.  Analyte identification and correlation can also proceed using the 
standardized mobility value, as has been achieved in the field of stand-alone ion mobility 
spectrometers utilized for chemical detection and screening,20,21 although the fundamental 
meaning of the mobility measurement is more accessible when discussed in the context of the 
analyte CCS. 
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TABLE 2.1 – Three key analytical uses of ion mobility. 
Analytical Use of 
Ion Mobility 
Description Additional Requirements Example Application Areas 
1. Chemical 
Separation 
Partition signal 
from chemical 
noise and increase 
peak capacity of 
the analysis 
None Detection of Illicit 
compounds (e.g., drugs and 
explosives) and screening of 
exogenous metabolites 
(e.g., pesticides and 
industrial chemicals)  
2. Analyte 
Identification and 
Characterization 
Use CCS 
measurement to 
characterize 
unknowns by 
correlation 
Reference values from 
databases and libraries 
incorporating normalized drift 
times, reduced mobilities, 
and/or CCS 
Emerging omic and small 
molecule discovery 
initiatives 
3. Structural 
Analysis 
Utilize the 
experimental CCS 
to infer structural 
information 
Computational methods to link 
theoretical structure(s) to the 
experimental CCS 
Insights into protein 
complex arrangements and 
structure 
Reprinted (adapted) with permission from Jody C. May, Caleb B. Morris, John A. McLean, “Ion 
Mobility Collision Cross Section Compendium,” Analytical Chemistry 2017, 89 (2), 1032-1044. 
Copyright 2017 American Chemical Society. 
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 2.2 The Collision Cross Section 
One of the contemporary challenges with interpreting the meaning of the CCS lies in the 
fact that it is not a true molecular cross section, but rather represents an observational property that 
averages all geometric orientations and interaction types (head-on, “glancing”, and “orbiting” 
collisions, multiple collisions within cavities of the analyte, etc.) across the experimental 
measurement time.22-25  These effects include both contributions from the drift gas itself 
(momentum transfer and gas polarization effects) and contributions arising from the ion mobility 
experiment (temperature and magnitude of the electric field).  Classically, the CCS determined 
from ion-gas collision measurements is referred to as the momentum transfer or diffusion CCS to 
specify the importance and dependence that the drift gas has on the resulting quantity being 
obtained.26,27 
As a result of these contributions, the empirical CCS is a macroscopic quantity which is 
specific to the identity of the drift gas as well as the temperature and electric field used during the 
measurement,28,29 and so by the strictest definition, CCS is not an intrinsic property of the analyte, 
although it is very closely linked to one (namely the microscopic cross section of the analyte). 
Mathematically, the CCS represents the area of a circle, and thus the structural information is 
“coarse-grained” in nature.  While significant for small molecule studies, this level of granularity 
is less of an issue when probing coarse structural features such as domain-level information for 
protein assemblies. 30,31 
The CCS is a quantity that is now routinely obtainable from a variety of ion mobility 
experiments, and, although less frequently discussed, the CCS can also be obtained from mass 
spectrometry experiments where gas collisions are present.  Mass spectrometric methods utilized 
for measuring CCS have included pressure correlated ion loss studies in magnetic sector,32-34 triple 
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 quadrupole,35,36 and time-of-flight instruments;37 ion relaxation times in an ion trap;38 and peak 
width analysis from ion cyclotron resonance measurements.39,40  Ion mobility methods currently 
provide the most precise measurements of the CCS, with precision being linked to the experimental 
certainty in all of the parameters which govern the IM separation, such as the gas temperature, 
electric field, gas number density (via pressure and temperature) and the geometric distances 
within the instrumentation.  As such, uniform field drift tubes (DTIMS) and differential mobility 
analyzers (DMA) afford the highest CCS precision since experimental quantities in these 
techniques can be well-characterized.  It should be noted here that precision and accuracy are 
important distinctions, as very reproducible CCS values can now be obtained (better than 2%),2,41 
but their accuracy cannot be validated without comparing the ion mobility results to CCS 
measurements obtained from other techniques, which at this time are still in development.42-44  
Despite these standing questions regarding the accuracy and meaning of the CCS, it is clear that 
there is immense value in reporting a standardized fundamental property of an analyte in the form 
of a CCS which is both highly-reproducible and now readily-accessible by a large number of 
researchers. 
Recent publications have utilized an elegant nomenclature for CCS reporting whereby the 
measurement technique is denoted as a superscripted prefix, while the drift gas is specified as a 
subscripted suffix, for example, DTCCSN2 to denote a nitrogen CCS value measured from a drift 
tube instrument.45-48  This nomenclature is summarized in Table 2.2 along with specific 
recommendations for the instrumentation shorthand.  Given the oftentimes ambiguous nature of 
the experimental context in which CCS values are reported, the nomenclature formalized in Table 
2.2 is recommended for future use in the field. 
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TABLE 2.2 – Formalized nomenclature for reporting CCS measurements in the context of the 
technique and drift gas utilized. 
CCS Measurement Technique Technique 
Shorthand a. 
Nomenclature for 
CCS Reporting b. 
Drift Tube Ion Mobility Spectrometry (DTIMS) DT DTCCSX 
Traveling Wave Ion Mobility Spectrometry (TWIMS) TW TWCCSX 
Trapped Ion Mobility Spectrometry (TIMS) TIMS TIMSCCSX 
Differential Mobility Analyzer (DMA) DMA DMACCSX 
a. Only the four major ion mobility techniques which report CCS are listed.  
b. X denotes the drift gas or drift gas equivalent for calibrated values (X = He, N2, Ar, CO2, etc.) 
Reprinted (adapted) with permission from Jody C. May, Caleb B. Morris, John A. McLean, “Ion 
Mobility Collision Cross Section Compendium,” Analytical Chemistry 2017, 89 (2), 1032-1044. 
Copyright 2017 American Chemical Society. 
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 2.3 Significant CCS Contributions 
The emerging importance of CCS to support contemporary analytical trends is evidenced 
by the fact that over half of the over 24,000 canonical CCS values reported between 1975 and 2015 
has been published within the last five years (Figure 2.1(A)).  Examining the histogram in Figure 
2.1(A) indicates there was an initial surge of CCS values reported between 1995 and 1999 which 
was largely in response to the introduction of ESI and MALDI ionization techniques, followed by 
a decade of relatively few new CCS values being reported (2000-2009).  Starting in 2010, the 
number of CCS values reported increased drastically, which is interpreted as being a direct 
response of the introduction of new ion mobility techniques, including commercial TWIMS 
technology in 2006,49 confining RF DTIMS in 2010,50 and DTIMS integrated with ion funnels, 
initially reported in 2005 and commercialized in 2014.2,51 
Major contributions from specific laboratories are noted in Figure 2.1(B) and include 
several large-scale studies from Clemmer and coworkers examining electrosprayed peptides and 
proteins in helium (ca. 4200 values),52-55 contributions from Bowers and coworkers on 
hydrocarbons and carbon clusters (ca. 400 values),56-59 studies from Jarrold and coworkers 
investigating carbon, silicon, and palladium clusters (ca. 550 values),60-63 contributions from 
Russell and coworkers reporting singly-charged CCS values of MALDI generated peptides and 
proteins (ca. 650 values);64,65 TWIMS and DTIMS studies from Pagel and coworkers investigating 
both helium and nitrogen CCS for carbohydrates (ca. 1300 values),45,66,67 work from McLean and 
coworkers which include a number of lipid, peptide, and carbohydrate CCS values in both helium 
and nitrogen (ca. 1000 values),2,68,69 and recent TWIMS work from Astarita and coworkers 
reporting nitrogen CCS values for both lipids and metabolites (ca. 450 values).70,71  The largest 
single quantitative ion mobility survey to date represents the ca. 8,700 nitrogen CCS values 
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Figure 2.1 (A) The number of CCS values published over the 40-year span between 1975 
and 2015. The drift gas used in the measurement or calibration is specified for each year 
bin. (B) The laboratories and studies which have made significant contributions in terms 
of number of values reported. Reprinted (adapted) with permission from Jody C. May, 
Caleb B. Morris, John A. McLean, “Ion Mobility Collision Cross Section Compendium,” 
Analytical Chemistry 2017, 89 (2), 1032-1044. Copyright 2017 American Chemical 
Society. 
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 published by Smith and coworkers for tryptic peptides in support of proteomics studies.72  While 
the early studies have focused on obtaining structural information through the measurement of the 
CCS, several of the recent contributions have been purposed as cross sectional databases in support 
of analyte characterization. The motivation for utilizing CCS as a molecular descriptor (c.f., Table 
2.1) is an emerging application area in the field of analytical chemistry. Additionally, the high 
quality CCS data from the Clemmer73 and Bush laboratories41,50,74 are routinely used for calibrating 
ion mobility instrumentation. 
While only major studies are highlighted here, the majority of contributions to the CCS 
canon (75%) have come from smaller studies which report 50 or fewer CCS values (Figure 2.2).  
In fact, there are only three individual studies which have reported over 1,000 CCS values and thus 
would be considered large-scale surveys,54,55,72 underscoring the fact that the reporting of 
quantitative ion mobility measurements is predominantly an interlaboratory initiative. 
 
2.4 Drift Gases Represented 
While measurements obtained in helium and nitrogen represent the vast majority of the 
CCS values reported (95%, c.f., Figure 2.1), there have been a few quantitative studies conducted 
in alternative drift gases, most representing the classic atomic and small molecule studies compiled 
by Mason and coworkers during the early developments of analytical ion mobility,75-78 but also 
early work from Hill and coworkers exploring CCS differences of small peptides and drug 
molecules in helium, nitrogen, argon, and carbon dioxide.79  Recent studies which explicitly report 
CCS values in alternative drift gases include measurements of ammonium in helium, nitrogen, 
argon and carbon dioxide from Viehland and coworkers,80 the combined DTIMS and TWIMS 
study from Barran and coworkers investigating myoglobin in helium, nitrogen, argon, and neon,81 
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Figure 2.2 Histogram illustrating the number of CCS values which are reported per 
publication. The bracketed bins draw attention to the fact that most of the CCS 
measurements have come from smaller studies reporting 50 or fewer cross section 
values. Reprinted (adapted) with permission from Jody C. May, Caleb B. Morris, John 
A. McLean, “Ion Mobility Collision Cross Section Compendium,” Analytical Chemistry 
2017, 89 (2), 1032-1044. Copyright 2017 American Chemical Society. 
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 DMA measurements of CCS in air from both de la Mora and coworkers82 and Hogan and 
coworkers,83 and DTIMS work from Fjeldsted and coworkers exploring the CCS differences of 
pesticides in a variety of drift gases including helium, nitrogen, carbon dioxide, nitrous oxide, 
argon, and sulfur hexafluoride.84 
The sparse amount of CCS data reported for gases other than helium and nitrogen is largely 
a combined result of both technical challenges with operating under different drift gas conditions 
(instrument tuning, pressure gauge calibration issues, and uncertainty with calculating the CCS 
from measured drift times), as well as fundamental difficulties with interpreting the structural 
meaning of CCS values obtained using gases other than helium.  The typically better correlation 
of helium CCS values to theoretical results is primarily a consequence of the lower contribution 
of ion-neutral polarization effects in atomic helium (α=0.21 Å3) as compared to diatomic nitrogen 
(α=1.74 Å3) and other neutral gases (e.g., argon, α=1.64 Å3; carbon dioxide, α=2.91 Å3),79,85-87 
although it should be noted that significant and recent efforts have been made in improving the 
fundamental theories used in predicting nitrogen-based CCS values from candidate 
structures.25,26,88,89 In addition to the better theoretical correlation of helium CCS, there is also 
some evidence that helium offers analytical benefits in reducing mass-mobility discrimination and 
improving ion transmission in dispersive (DTIMS and TWIMS) ion mobility instrumentation.90,91  
The choice of nitrogen as a drift gas stems from practical considerations of cost and availability, 
fundamental considerations regarding nitrogen’s resistance to electrical discharge (dielectric 
breakdown) and analytical improvements in resolving power due to the longer residence time of 
ions (i.e., lower reduced mobility values) within the ion mobility experiment.92  While these 
attributes are shared by other drift gases such as argon and carbon dioxide, their use in quantitative 
IM research has not yet been significantly explored.  It is anticipated that the meager quantitative 
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 IM data currently available for alternative gases represents only a temporary deficiency as the 
instrumentation and CCS measurement capabilities to support different drift gases are now 
becoming widely available, and evidence is mounting in support of the analytical benefits of 
conducting IM separations in other drift gases such as argon and carbon dioxide.93-97 
 
2.5 Composition of Measurements 
An analysis of the composition the CCS values published from 1975 to 2015 is presented 
in Figure 2.3 for a few select categories.  With regards to instrumentation (Figure 2.3(A)), most 
(87%) of the CCS values represent measurements conducted in DTIMS instruments, which include 
both elevated98-102 and reduced pressure DTIMS instrumentation,103-110 as well as instrumentation 
utilizing electric field-mediated ion focusing strategies such as periodic DC,111,112 confining RF,4,50 
and electrodynamic ion funnels.2,51,113 A cursory comparison of the measurements themselves (not 
shown) indicates there is no significant differences between the CCS values obtained using these 
different modes of DTIMS operation, suggesting these focusing strategies do not perturb the 
resulting CCS.  Because DTIMS still exhibits the highest precision when measuring the CCS and 
the direct relationship between drift time and cross section allows broad scale CCS determination 
of mixtures, it is no surprise that DTIMS has contributed to the majority of values published to 
date. TWIMS values obtained from calibration represent 9% of the CCS values,114-117 while the 
remaining values are from other IM techniques such as DMA82,83 and TIMS.118-121 
Regarding the selection of drift gas (Figure 2.3(B)), there are slightly more CCS values being 
obtained in nitrogen (49%) as compared to helium (46%), with reporting of nitrogen-based CCS 
values being a recent analytical trend in the field (c.f., Figure 2.1(A)). Measurements in ambient 
air comprise 3% of the CCS values, which are from elevated pressure DTIMS and DMA studies.  
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Figure 2.3 Composition of CCS values with respect to (A) the ion mobility 
instrumentation used, (B) the drift gas, (C) specific charge state reported, and (D) the 
chemical classes investigated. Reprinted (adapted) with permission from Jody C. May, 
Caleb B. Morris, John A. McLean, “Ion Mobility Collision Cross Section Compendium,” 
Analytical Chemistry 2017, 89 (2), 1032-1044. Copyright 2017 American Chemical 
Society. 
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 The remaining 2% of values are for measurements conducted in argon (0.5%), carbon dioxide 
(0.3%), oxygen (0.3%), neon (0.2%), nitrous oxide (0.2%), and others (0.5%). Specific 
motivations for drift gas selection are discussed in the previous section. 
Figure 2.3(C) indicates that the majority of CCS values are for low charge-state cations 
(+1, +2, and +3 ions, collectively representing 78% of all values reported), and thus anion CCS 
values are currently underrepresented, comprising only 8% of the total body of work.  This 
predominance of positive ion data is expected given that MS-based studies are preferentially 
conducted in positive ion mode. Most of the anions CCS values reported are from two recent 
carbohydrate studies, one on chemically-released glycans and corresponding ion fragments 
generated in source,67 and another reporting negative ion CCS values on dextran and pullulan 
oligosaccharides.122 Remaining anion contributions represent the classic DTIMS studies on atomic 
and molecular clusters,57,63,123 and recent negative ion measurements for proteins,124 lipids,1,71 and 
metabolites.70,125  The primary ionization method used in the quantitative measurement of the CCS 
is ESI (87%, not shown) which tends to produce primarily +2 ions for tryptic peptides.126  As 
tryptic peptides represent the majority of CCS measurements reported in the literature (vide infra), 
it is no surprise that there are more +2 ions than any other charge state.  Laser-based ionization 
(MALDI and LDI) which produce mainly +1 ions in positive ion mode comprise only 11% of the 
CCS values (not shown). Higher charge state cations (+4 or greater) comprise 14% of the CCS 
values reported, which is in line with the number of protein ion CCS values represented in the 
analysis (9% of the total, not shown). 
Finally, in Figure 2.3(D), an analysis of the contributions made within specific chemical 
classes reveal the majority of CCS values reported in the literature are for peptides and proteins 
(70%), with carbohydrates (8%), inorganics (e.g., clusters, nanomaterials, and salts; 8%), and other 
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 small molecules (e.g., hydrocarbons and metabolites; 6%) representing the remainder of values.  
The focus on peptide and protein work can be rationalized as being a result of continued efforts 
for adapting ion mobility technologies to proteomics workflows,127-129 but also a practical 
consequence of both the ease of generating large pools of peptides derived from enzymatic 
digestion130 and the fact that the structural and charge-state heterogeneity of proteins necessitates 
the reporting of many CCS values for a single protein. 131-134 To summarize the observations in 
Figure 2.3, most quantitative ion mobility studies to date have used DTIMS for peptide and protein 
analysis, with an approximate equal number of measurements represented in both helium and 
nitrogen drift gases. 
 
2.6 Chemical Space Represented by IM-MS Analysis 
Figures 2.4 and 2.5 projects all of the canonical CCS values as a function of the ion mass, 
for helium and nitrogen-based ion mobility measurements, respectively.  The scattering of 
measurements (lower panels) are noticeably different in both gases, underscoring the fact that 
different analytes and charge states are represented in each type of gas.  For example, a larger 
percentage of helium CCS values are singly-charged (37%) compared to a smaller percentage of 
singly-charged values in nitrogen (13%). Nitrogen CCS values also contain a significant number 
of triply-charged measurements (34%), in contrast to helium CCS values, which are comprised of 
only 14% triply-charged CCS values.  This is one reason for the more prominent clustering of 
higher charge-state measurements in nitrogen (Figure 2.5, lower panel). There are also a significant 
number of CCS values for atomic and molecular clusters (carbon, silicon, and inorganic salts) 
which are unique to the helium CCS measurements, resulting in the trends prominently observed 
at low CCS (Figure 2.4, lower panel). Nitrogen CCS values are larger in magnitude than helium 
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Figure 2.4 (lower panel) Helium-specific conformational space plot which projects 
helium-based CCS values as a function of the analyte mass. (middle panel) The 
composition and chemical space occupancy of specific biomolecules. (top panel) A 3-
dimensional surface plot illustrating the regions of highest density in terms of the 
numbers of CCS values. Reprinted (adapted) with permission from Jody C. May, Caleb 
B. Morris, John A. McLean, “Ion Mobility Collision Cross Section Compendium,” 
Analytical Chemistry 2017, 89 (2), 1032-1044. Copyright 2017 American Chemical 
Society. 
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Figure 2.5 Nitrogen-specific conformational space plot which projects nitrogen-based 
CCS values as a function of the analyte mass, along with (middle panel) the 
biomolecular composition and occupancy and (top panel) the 3-dimensional surface 
density plot of CCS values reported. Reprinted (adapted) with permission from Jody C. 
May, Caleb B. Morris, John A. McLean, “Ion Mobility Collision Cross Section 
Compendium,” Analytical Chemistry 2017, 89 (2), 1032-1044. Copyright 2017 
American Chemical Society. 
63
 values due to the higher momentum contribution of the nitrogen molecule as well as the stronger 
polarization which in turn leads to temporally-extended ion-neutral interactions in the IM 
experiment. 
The central panels in both Figures 2.4 and 2.5 project the average mathematical fits to 
specific biochemical classes based on a power-law relationship.2 Only the fits to singly-charged 
analyte is shown, and fits are not extrapolated beyond the range of measurements. The total 
chemical occupancy of all measurements is illustrated by a 95% data inclusion area (grey shaded 
region).  The general conformational ordering of biomolecules observed here qualitatively 
correlates to the gas-phase structural trends noted from previously studies, that is, lipids adopt 
more extended structures in the gas-phase than peptides and carbohydrates.2,135,136 The quantitative 
differences observed between helium and nitrogen are a consequence of evaluating the CCS values 
corresponding to different analytes in each figure.  This can be seen by examining the biochemical 
class compositions which are noted in the central panel of each figure, where for example, 
significantly more peptides and proteins are represented in nitrogen (80%) than helium (67%). 
The 3-dimensional surface plots and associated histograms projected on the top panels in Figures 
2.4 and 2.5 illustrate the distribution of CCS values reported for both helium and nitrogen drift 
gas.  Overall, the analytes surveyed from both gases fall within a similar mass window between 
500 to 1500 Da with more values at lower mass reported for helium than nitrogen.  As many of 
the helium measurements are from earlier work in the field and represent singly-charged analytes, 
it is no surprise that the overall coverage concerns lower mass analytes. 
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 2.7 CCS Coverage over Time 
Figure 2.6 compares the number of CCS values reported over the past 40 years as they 
correlate to mass. This analysis reveals that, as expected, the focus of quantitative ion mobility 
studies has shifted over time to higher mass due to improvements in technology and methods used 
to desorb, ionize, and stabilize large analytes such as biomolecules.  Prior to the widespread use 
of soft ionization methods (ca. 1995), the average mass of ions for which CCS values were being 
reported was less than 100 Da,75-78,137-141 and in the decade following the adoption of MALDI and 
ESI (1996-2005) in research instrumentation, a broad range of ion masses up to ca. 2500 Da were 
investigated, though the majority of measurements were centered on low mass studies around 300 
Da.  In the past decade (2006-2015), the average ion mass was approximately 1000 Da and 
represents predominately peptide CCS values, however significant efforts were also made for 
reporting CCS values of lower mass ions centered around 400 Da, the latter representing analytical 
interests in short-chain carbohydrates,142-147 metabolites,70,125,148-151 and drug-like 
molecules.84,87,89,152 Figure 2.6(B) contains the distribution of CCS reporting with analyte masses 
extending up to the megaDalton range, which illustrates the recent analytical trend of utilizing 
quantitative ion mobility methods to study the structure of large protein assemblies,50,124,153-159 
some of which are annotated in the figure. These studies specifically target IM-based 
measurements towards the interpretation of molecular structure. Note that the vertical scale in 
Figure 2.6 is the same in both panels, however, the bin size is increased in Figure 2.6(B) (from 50 
Da to 10 kDa) to accommodate the broader mass range being projected.  A final observation to 
make from Figure 2.6(A) is that the bimodal distribution observed over the past five years (2011-
2015) closely mimics the analytical trend observed within the largest chemical database, 
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Figure 2.6 Histogram illustrating the number of CCS values reported as a function of 
mass with data sets delineated into specific timespans. Panel (A) contains the 
histogram for low mass analytes below 3000 Da, with arrows denoting the 
approximate mass where each distribution exhibits a maximum. Panel (B) contains the 
histogram for high mass analytes above 3000 Da, with labels calling out select protein 
assemblies which have been studied. Note that the vertical scales are the same in both 
panels; however, the bin size in panel B (10 kDa) is different than the bin sized used in 
panel A (50 Da). Reprinted (adapted) with permission from Jody C. May, Caleb B. 
Morris, John A. McLean, “Ion Mobility Collision Cross Section Compendium,” Analytical 
Chemistry 2017, 89 (2), 1032-1044. Copyright 2017 American Chemical Society. 
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 PubChem,160,161 where chemical entries have, over time, shifted to focusing on lower mass analytes 
while the total number of entries in PubChem currently exhibits a bimodal mass distribution.11 
The bubble plot projection in Figure 2.7 compares the number of CCS values reported over 
time with respect to specific analyte classes and types.  In this projection, the bubble size correlates 
to the number of values reported for each corresponding year.  Early quantitative IM studies 
focused on atomics and small molecules. A significant number of the small molecules CCS values 
consists of aromatic hydrocarbons.98,119,139,162-164 Starting in the 1990s, interest in inorganic 
compounds (metal salts, atomic and molecular clusters) began to emerge.  Very few inorganic 
compound CCS values were reported between 2000 and 2010, with a resurgence of interest starting 
in 2013 which were primarily focused on gaining fundamental insights into the structures of 
inorganic salt and metal clusters.83,165-169  Protein CCS values were initially reported in the late 
1990’s by the Jarrold, Clemmer, and Bowers groups,170-173 with sparse numbers of measurements 
reported thereafter for several years.  From the year 2000 onward, efforts in the field were largely 
concentrated on biological molecules.  A significant number of peptide and protein CCS values 
started appearing again in the literature in 2007. The large blue bubble in Figure 2.7 corresponds 
to the 8676 peptide cross sections published by Smith and coworkers in 2010 in support of 
developing theoretical methods for predicting the IM drift time based upon the primary amino acid 
sequence.72  While most of the CCS values have been for tryptic peptides, there is recent and 
significant efforts being made in the quantitative IM analysis of structurally-interesting peptide 
and protein classes, including helical peptides,174-176  metalloproteins,177-180 intrinsically-
disordered proteins,181-184  metamorphic proteins,185,186 amyloids,187-194  and membrane-bound 
proteins and assemblies.117,195-198  The last three years has seen a balance of cross section reporting 
across most of the chemical classes, including lipids and carbohydrates.  The exception is 
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Figure 2.7 Bubble plot projecting the number of CCS values reported over time for the 
top 7 chemical classes represented. The size of each bubble encodes the relative 
number of CCS values for each respective year. Reprinted (adapted) with permission 
from Jody C. May, Caleb B. Morris, John A. McLean, “Ion Mobility Collision Cross 
Section Compendium,” Analytical Chemistry 2017, 89 (2), 1032-1044. Copyright 2017 
American Chemical Society. 
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 nucleotide CCS values, which, aside for the 2009 study from McLean and coworkers,68 have been 
published in small numbers spread across several studies and years, and currently comprise about 
1% all CCS values reported.153,199-209 This observation is reflected in the fact that while many of 
these IM-based biomolecular studies have coincided strongly with developments in MS-based 
lipidomics, glycomics and metabolomics, the role of mass spectrometry related techniques in 
genomics research is, and has always been, relatively small. 
Not shown in Figure 2.7 are the large number of studies which have focused on synthetic 
polymers,210-220 which, like nucleotides, have seen a small but gradual number of CCS value 
reporting since the initial measurements by Bowers and coworkers in the late 1990s.221-225 Several 
recent polymer studies have focused on reporting CCS values for dendrimers.226-228, and polymeric 
supermolecular assemblies utilized in molecular sensing, catalysis, and advanced materials 
applications.229-237 Overall, synthetic polymers comprise about 1% of the total number of CCS 
values reported to date, virtually all of which are measured in helium drift gas or are calibrated to 
helium-equivalent values.  Also not reflected in the analysis presented in Figure 2.7 are the recent 
interests in characterizing natural products by IM-MS based CCS measurements.69,116,238-240  Many 
natural products contain complex and unusual scaffolds which motivates their study by a 
structurally-selective technique such as IM-MS, however, natural products are conventionally 
classified based on bioactivity rather than structure and as such molecules which can be considered 
natural products are represented in virtually all of the chemical classes delineated in this review. 
A similar issue is seen in metabolites (not shown) which is a classification that includes small 
peptides, carbohydrates and lipids.  Finally, there are a number of CCS measurements which 
cannot easily be classified into a given chemical class category, such as compounds derived from 
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 chemical synthesis.241-245  It is anticipated that additional trends in the analysis of chemical classes 
not described in this review will become evident as the field of quantitative IM continues to grow. 
 
2.8 Concluding Remarks 
This current analysis of all collision cross section values published into the canonical 
literature from 1975 to 2015 reveals both important analytical trends in the field, such as the focus 
on biomolecules and drift tube studies, and also avenues where future efforts will make a 
significant impact.  These future analytical prospects include, (1) the use of emerging ion mobility 
methods and mass-spectrometry based techniques for validating the accuracy of CCS 
measurements, (2) quantitative IM experiments exploring alternative drift gases such as carbon 
dioxide and argon, (3) overlapping analyte studies which explicitly compare fundamental 
differences across different gases, charge states, and polarities (4) anion studies to test whether or 
not conformational ordering observed for cations is retained in negative ion mode, (5) quantitative 
studies of underrepresented chemical classes such as nucleotides, lipids, and synthetic polymers, 
and (6) comprehensive CCS mapping of suites of analytes (e.g., chemical classes,  
pharmacologically-active, or disease-implicated) in support of unknown identification and 
characterization by means of searching databases and libraries. In terms of the immediate 
analytical impact of this current work, the compilation of CCS measurements will provide a basis 
for correlating future measurements to the canonical literature, enable large-scale studies of the 
quantitative relationships within chemical classes and across different drift gases, and serve as a 
basis for developing predictive methods for CCS chemical space occupancy.  Importantly, the 
compilation of these measurements will provide a foundation for supporting future efforts aimed 
at utilizing the CCS as an additional metric for analyte identification, with correspondence to other 
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 analytical measurements such as exact mass, tandem MS data, and chromatographic retention time.  
Given the rapid growth now being seen in the field of quantitative ion mobility, many of the 
analytical prospects outlined in this review will likely be realized in the next few years. 
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CHAPTER 3 
 
UNTARGETED MOLECULAR DISCOVERY IN PRIMARY METABOLISM: COLLISION 
CROSS SECTION AS A MOLECULAR DESCRIPTOR IN ION MOBILITY-MASS 
SPECTROMETRY 
 
3.1 Introduction 
From the central dogma of molecular biology, studies of genomics, transcriptomics, and 
proteomics provide higher order information about gene and protein expression to better 
understand implicated phenotypes.1,2 However, these approaches provide limited information 
about real-time production of chemical species related to cellular metabolism as a function of 
external stimuli or phenotype of interest. To address the need for rapid characterization of cellular 
metabolism, metabolomics seeks to uncover molecular information on a per-molecule basis by 
examining expressed cellular products that can be correlated with a specific phenotype, stimuli, or 
other experimental conditions.3  
While several analytical approaches have been utilized to study metabolism and related 
cellular processes (e.g. NMR, electrochemistry, etc.),4,5 mass spectrometry (MS) is gaining wide-
spread adoption as a result of its high throughput, low limits of detection, and molecular specificity. 
Mass spectrometers can collect chemical information on the microsecond (μs) time scale,6 and 
with the rise of high-resolution, accurate mass techniques such as time of flight (TOF), Orbitrap, 
and ion cyclotron instruments, a unique chemical formula can often be generated based solely on 
mass measurement for a specific analyte signal.7,8 While identifying a specific chemical formula 
is advantageous, many metabolic pathways include isomeric molecules covering a range of 
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biological classes, such as carbohydrates (e.g. glucose/galactose),9 nucleosides (e.g. 
adenosine/deoxyguanosine), and lipids (7-dehydrocholesterol/desmosterol).10 As biological 
function follows molecular structure, characterization of isomeric species is imperative for 
complete molecular identification and accurate pathway analysis. In many MS experiments, 
fragmentation techniques such as collision induced dissociation (CID) or electron transfer 
dissociation (ETD) are utilized to provide structural information about a specific analyte measured 
in the study.11,12 However, as many metabolite isomers are less than 300 Dalton, these compounds 
often possess identical fragmentation spectra at similar energy thresholds and hence molecular 
fingerprinting by MS/MS and high resolution precursor mass is often not specific enough to 
identify a unique molecular structure.13 Furthermore, as quadrupoles isolate on nominal mass, 
molecules with different molecular formulas but similar exact mass (i.e. nominal mass isobars) 
cannot be isolated, thereby complicating MS/MS analysis.14 To address these challenges, pre-
separation techniques such as gas and liquid chromatography,15,16 and more recently ion mobility 
spectrometry,17 have been interfaced prior to mass analysis to provide enhanced structural 
recognition and increased analyte coverage. For untargeted analysis, metabolomic databases (e.g. 
METLIN, HMDB, etc)18 include multiple descriptors of analyte information (e.g. accurate mass, 
ion adduct form, fragmentation pattern, and retention time) to increase confidence in molecular 
identification.19 With the advent of commercially-available ion mobility-mass spectrometers in 
2006,20 collision cross section (CCS) has become an additional molecular descriptor for untargeted 
experiments. CCS measurements are being standardized across instrumental platforms using rigid 
experimental protocols, and as such provide a molecular descriptor independent of system settings 
which are transferable between laboratories.17,21–23 These collected CCS measurements provide 
the capability to distinguish isomeric species in complex mixtures, provided enough resolution is 
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accessible in the IM dimension.24  In order to provide additional confidence in molecular 
identification for untargeted metabolomic analysis, significant efforts are being made in the IM 
community to establish reliable CCS databases for analyzing unknown features across a range of 
biochemical classes, including lipids, metabolites, and xenobitics.21,22,25,26 In this work, we use 
uniform field IM-MS to develop a library of CCS values focused on primary metabolites 
established with analytical standards to facilitate chemical identification in untargeted 
metabolomic workflows. Furthermore, we demonstrate the utility of these measurements by 
analyzing a commercially available extract of human serum (NIST 1950) which has been 
characterized previously in traditional GC and LC-MS experiments.27,28  
 
3.2 Experimental Methods  
 
3.2.1 MSMLS Sample Preparation 
The Mass Spectrometry Metabolite Library of Standards (MSMLS, IROA technologies) is 
supplied as dried standards distributed across seven 96-well plates (Sigma-Aldrich; St. Louis, MO) 
and each well contains 5 μg of analytical standard. All solvents used to reconstitute the analytes 
prior to analysis, including water (H2O), methanol (MeOH), acetonitrile (ACN), isopropanol 
(IPA), and chloroform (CHCl3) were Optima LC-MS grade purchased from Fisher Scientific (Fair 
Lawn, NJ). Stock solutions of the hydrophilic standards were prepared by adding 100 μL 1:9 
(MeOH: H2O) to each well prior to mixing on a waving rotator for 5 minutes. The stocks were 
then distributed in 20 μL aliquots throughout five 96-well plates (Waters part no. 186005837). 
Stock plates that were not immediately analyzed were capped and transferred to -80 °C for storage. 
Working solutions of the hydrophilic standards were prepared by adding 80 μL of water with 0.1% 
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formic acid to the 20 μL stock solutions, sealed with plate covers (Waters part no. 186006332), 
and subsequently mixed on a waving rotator for 5 minutes. The hydrophobic analyte set was 
prepared similarly, where stock solutions were prepared with 100 μL 2:1:1:0.3 (MeOH: CHCl3: 
IPA: H2O), and distributed in 20 μL aliquots throughout five 96-well plates. Working solutions 
were prepared by adding 80 μL of 1:1 (MeOH: IPA). The concentration of the working solutions 
used for IM-MS analysis was 10 μg/mL. 
 
3.2.2 Collision Cross Section Measurements 
CCS measurements for the MSMLS were obtained on a commercially available drift tube 
ion mobility-mass spectrometer (DTIMS, Agilent 6560) operated with nitrogen gas (3.95 Torr) at 
room temperature (~25 °C) and using both single-field and stepped-field approaches previously 
established in an inter-laboratory study.21 The single-field CCS values reported here were 
measured in triplicate, while the stepped-field values were collected in a single acquisition. 
Stepped-field measurements were acquired using an automated flow injection analysis (FIA) 
stepped-field approach described previously.29 Briefly, the FIA method was performed with a 
liquid chromatography system (Agilent 1290) modified with a 100 μL sample loop (Agilent part 
no. G4226-87303) coupled to an IM-MS (6560, Agilent). 20 μL of the working solution was 
injected from the 96-well plate with 1:1 (water: isopropanol) as the carrier solvent. For traditional 
stepped-field CCS determination by FIA, following a 0.5 s delay, an entrance potential was stepped 
every 0.5 min. in increments of 100 V from 1074 V to 1674 V; the first step from 1074 to 1174 
occurred at 1.0 minute rather than 0.5 min. For stepped-field measurements, the fundamental low 
field ion mobility equation is used to determine CCS values. For single-field CCS determination 
using FIA, 4 μL of sample was injected into the carrier solvent at a flow of 800 μL/min. Data was 
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collected for 0.5 min, followed by a 0.4 min postrun flushing cycle. A drift tube entrance voltage 
of 1574 V was used with an exit voltage of 224 V, which corresponds to a drift field of 17.3 V/cm. 
DTIMS exhibits a linear relationship between drift time and CCS,6 and single-field CCS values 
are determined by first measuring the drift time of reference standards (ESI Low Concentration 
Tuning Mix, Agilent) with a known CCS. The reference ions were infused for 0.5 minutes while 
IM-MS spectra are collected; calibration experiments were preformed intermittently to ensure 
instrument stability. IM-MS Browser (Agilent, B.08) was used to plot the linear regression of the 
calibration ions for single field experiments, and the instrumental coefficients β and Tfix, were 
extracted and used to convert raw ion drift times to CCS.21 The resulting single- and stepped-field 
CCS library can be found in Appendix A. 
 
3.2.3 IM-MS Source and Drift Cell Conditions 
To obtain high coverage of analytes within the MSMLS, both electrospray (Agilent Jet 
Stream, AJS) and chemical ionization (APCI) sources were used. The majority of the samples 
collected with the AJS source in both ion modes were measured using the following conditions: 
gas temperature, 250 °C; drying gas flow rate, 8 L/min; nebulizer gas, 60 psig; sheath gas 
temperature, 300 °C; sheath gas flow rate, 11 L/min; capillary voltage (VCap), 3500 V; nozzle 
voltage, 800 V; fragmentor, 340 V; octopole 1 RF, 750 Vpp. All metabolites were first investigated 
using the AJS source; those which were not observed in either ion polarity were subsequently 
investigated using the APCI source under the following conditions: gas temperature, 250 °C; 
vaporizer, 200 °C; drying gas flow rate, 7 L/min; nebulizer gas, 30 psig; VCap, 3800 V; corona 
needle current, 5 μA; fragmentor, 350 V; octopole 1 RF, 750 Vpp. Some of the low m/z ions 
(typically ≤ 200 Da) exhibited metastable ion dissociation in the DTIMS which resulted in 
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uncorrelated mobilities (Figure B.1). In these cases, we increased the fragmentor potential to > 
350 V and decreased the Trap Funnel RF to ≤ 80 Vpp to correlate the ion signal into a single IM 
distribution. The IM-MS settings for the CCS values reported herein are as follows: 0.9 frames/s; 
18 IM transients/frame; 60 ms max drift time; 600 TOF transients/IM transient; 20000 μs trap fill 
time; 180 μs trap release time; drift tube exit voltage, 224 V; rear funnel entrance voltage, 217.5 
V; rear funnel exit voltage, 45 V. 
 
3.2.4 Nonlinear Regression Analysis 
Iterative nonlinear regression modeling for the super classes was performed using 
GraphPad Prism 7, and 99% confidence intervals were generated for each biomolecular super 
class. Three fits were tested for each super class: power fit (PF), 4-parameter sigmoidal (4P), and 
5-parameter sigmoidal (5P). The most parsimonious fit was chosen by a probabilistic comparison 
of the corrected Akaike information criterion (AICc) values.  
 
3.2.5 Human Serum Preparation 
Protein precipitation was performed by adding 800 μL of ice cold MeOH to 100µL NIST 
1950 serum and stored at -80 ˚C for one hour. The sample was centrifuged at 14,000 rpm for 5 
minutes before collecting the supernatant. Next, 2.4 mL ice cold methyl tert-butyl ether and 800 
µL ice cold water were added. The sample was vortexed then centrifuged at 10,000 rpm at 4˚C for 
10 minutes. The polar and nonpolar fractions were separated and dried separately in vacuo. 
Samples were stored at -20 ˚C until analysis. Dried fractions were resuspended in 200 µL of the 
initial mobile phase solvent and analyzed via LC-IM-MS. 
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3.2.6 Liquid Chromatography 
LC-IM-MS was performed on the prepared NIST 1950 serum using HILIC 
chromatography for the hydrophilic layer of the liquid-liquid extraction. For this method, 4 μL of 
sample was injected onto a column heated to 40 °C. The Millipore SeQuant Zic-HILIC (2.1 x 100 
mm, 3.5 μm) column was used with mobile phase A and B being 9:1 and 1:9 (water: acetonitrile, 
buffered with 5 mM ammonium formate), respectively. The mobile phase flow rate was 200 
μL/min. The gradient was initially held at 98 %B from 0 to 1 minutes, decreased to 45 %B from 1 
to 20 minutes, held at 45 % B from 20 to 22 minutes, increased to 98 %B from 22 to 40 minutes, 
and subsequently held at 98 %B from 40 to 45 minutes prior to the next injection. 
 
3.3 Results and Discussion  
 
3.3.1 MSMLS Plate Coverage  
In total, the MSMLS plates analyzed in this work contained 554 unique compounds across 
a large breadth of biological classes found in canonical metabolite pathways (See Figure 3.1(A)). 
Of these 554 analytes, one or more CCS values were measured for 417, resulting in ca. 75% 
coverage. Of these 554 analytes, one or more CCS values were measured for 417, resulting in ca. 
75% coverage. Many of the remaining analytes were detected by MS but were unable to produce 
a measurable CCS. Of these compounds, many were not well ionized by ESI and, therefore, were 
of insufficient abundance to generate the signal required to result in a confident mobility 
distribution. Other species were subject to metastable transitions in the drift tube, leading to 
uncorrelated mobility (See Figure B.1). Collectively, these 417 analytes produced 1246 CCS 
measurements using both positive (701 measurements) and negative ion polarities (545 
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Figure 3.1 (A) Distribution of biological categories associated with the primary 
metabolites examined in the MSMLS plate library. (B, C, and D) Conformational space plots 
of three singly charged molecular super classes contained in the MSMLS library. 
Representative nonlinear regression fits (solid black lines) along with 99 % confidence 
intervals (black dotted lines) are shown for each. Gray dots denote all molecules CCS 
values obtained in the library. All CCS error bars are smaller than their respective symbols. 
(B) “Organic acids and derivatives” with a 4-parameter sigmoidal fit. (C) “Organic oxygen 
compounds” with a power fit and (D) “Nucleosides, nucleotides, and analogues” with a 
power fit. Reprinted (adapted) with permission from Charles M. Nichols, James N. Dodds, 
Bailey S. Rose, Jaqueline A. Picache, Caleb B. Morris, Simona G. Codreanu, Jody C. May, 
Stacy D. Sherrod, John A. McLean, “Untargeted Molecular Discovery in Primary 
Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass 
Spectrometry,” Analytical Chemistry 2018, 90 (24), 14484-14492. Copyright 2018 
American Chemical Society. 
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measurements) across several adduct types (e.g. [M+Na]+, [M-H]-, etc., see Figure B.2). Analyte 
identification and relevant descriptors (chemical name, formula, KEGG ID, Metlin ID, adduct 
type, measured mass, CCS, and other information) have been uploaded to Metabolomics 
Workbench.30  
 
3.3.2 Mass-Mobility Correlation Analysis 
In these data, we observed several distinct relationships between m/z and CCS for 
individual structural super classes represented in the MSMLS library similar to previous IM-MS 
literature.31–35 Mass-mobility relationships have been shown to have utility as an additional rapid 
identifier of biomolecular class for uncharacterized biological samples,36 making the mathematical 
description of these relationships by nonlinear regression modeling particularly useful. Unlike the 
canonical biochemical classes (nucleotides, proteins, carbohydrates, and lipids), metabolites 
exhibit less distinguished structural differences between chemical classes, and so several 
mathematical fits were investigated in order to find mass-mobility correlations which exhibit high 
class specificity.  Fits and confidence intervals for representative super classes are shown in Figure 
3.1 (B, C, and D), and detailed mathematical expressions are provided in Appendix B (Equations 
B.1-B.6). 
 
3.3.3 Metabolic Pathway Coverage 
As the MSMLS was designed to provide analytical standards of primary metabolism, we 
also evaluated metabolite coverage using pathway analysis by inputting KEGG IDs for all of the 
analytes measured in our CCS database in MetaboAnalyst 4.0.37 In total, 64 pathways were 
covered with a wide range of biological activity including key metabolic processes such as the 
94
citric acid cycle, amino acid metabolism, and glycolysis (Figure 3.2(A) and Table B.1). Pathway 
coverage presented in this work is solely based on analyte coverage from the standards, and 
therefore provides qualitative reflection on the number of analytes in each specific pathway which 
are accounted for in the CCS library. MetaboAnalyst 4.0 also provides detailed information for 
specific pathways of interest, wherein molecular coverage can be evaluated on a per-analyte basis. 
For example, 10 pivotal metabolites in the citric acid cycle (see Figure 3.2(B)) are represented 
within the standards, and out of 20 total, 8 of these molecules exhibited a measurable CCS (green), 
while only 2 (orange) were observable in the mass spectrum but did not result in a collected CCS 
due to low ion intensity. Of note, many other compounds described in the KEGG pathways which 
are not components in the standard set (10 compounds, light blue) are protein enzymes or oxidized 
derivatives, and only 3 of these 10 are available for purchase as analytical standards. Hence it is 
unlikely that 100% coverage of canonical pathways is obtainable with chemical standards. As an 
analogy, it is not necessary to have 100% peptide coverage for a specific protein in proteomic 
analysis for confident identification. 
 
3.3.4 Isomers in Metabolomics 
Of the more than 500 compounds in the MSMLS library, almost one-third (31%) have a 
chemical formula in common with another compound, forming an isomeric pair, Figure B.3. 
Isomeric compounds are ubiquitous in metabolomic processes across a wide range of biological 
classes, for example the carbohydrate rearrangements for glucose 6-phosphate isomerization to 
fructose 6-phosphate in glycolysis. Figure 3.2(B) highlights two key metabolic intermediates of 
the citric acid cycle, citrate and isocitrate, which are constitutional rearrangements of a single 
hydroxyl group along the central carbon chain. As these compounds have the same chemical 
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Figure 3.2 (A) KEGG pathway coverage of metabolites with measured CCS evaluated in 
this study. A total of 64 pathways are covered by metabolites in our CCS library based on 
the MSMLS. After a specific pathway is selected (B), metabolite-specific coverage can be 
evaluated. In many pathways, isomerization is a key intermediate in primary metabolism, 
noted by the callouts for citrate and isocitrate in the citric acid cycle. Reprinted (adapted) 
with permission from Charles M. Nichols, James N. Dodds, Bailey S. Rose, Jaqueline A. 
Picache, Caleb B. Morris, Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, John A. 
McLean, “Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section 
as a Molecular Descriptor in Ion Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 
90 (24), 14484-14492. Copyright 2018 American Chemical Society. 
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formula, they will also possess identical masses, requiring additional separation in the 
chromatographic dimension for increased identification confidence in pathway analysis.17,38 In the 
example depicted in Figure 3.2(B), ion mobility allows for differentiation of these two isomeric 
metabolites (CCS = 143.1 Å2 vs. CCS = 142.7 Å2, for citrate and isocitrate, respectively), which 
are indistinguishable by mass alone. Adding the ion mobility dimension to existing untargeted 
workflows allows for additional separation and characterization of isomeric metabolites that 
interfaces within the timescale of traditional chromatographic techniques.6  
As a specific example, adenosine 5-diphosphate, adenosine 3,5-diphosphate, and 2’-
deoxyguanosine-5’-diphosphate are nucleoside isomers which are key metabolites in purine 
metabolism and are depicted in Figure 3.3(A). Note that the only structural difference between A-
5-DP (blue) and A-3,5-DP (green) is the location of a phosphate group from the central ribose unit. 
These two isomers are in turn differentiated structurally from 2’-deoxyguanosine-5’-diphosphate 
(DGDP, orange) by molecular substitutions on the purine ring, where a hydroxyl group has been 
relocated from the ribose sugar to the guanine ring, as well as an amine rearrangement in the same 
region. Structurally, these three nucleoside compounds are also constitutional isomers, a 
subcategory of isomeric compounds which have been heavily characterized in previous ion 
mobility literature.39–41 Also noted in Figure 3.3(A), adduct formation has a substantial effect on 
the overall selectivity of the IM separation. Specifically, each nucleoside isomer has a distinct 
cross sectional distribution which are distinguishable in the protonated [M+H]+ and sodium 
adducted [M+Na]+ species, however the rearrangement of the phosphate group between A-5-DP 
and A-3,5-DP provides no resolution for the deprotonated form observed in negative ion mode 
[M-H]-. Other metabolite separations in this study were more readily separated in negative ion 
mode such as the isomers L-glutamic acid and N-methyl-D-aspartic acid (see Figure B.4). The 
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Figure 3.3 (A) IM separation of nucleoside isomers (chemical structures illustrated at the 
top of the panel) for [M+H]+, [M+Na]+, and [M-H]- ion forms, respectively. For these 
particular isomers, enhanced separation is noted for the sodium adducts, while the 
negative mode A-5-DP [M-H]-  and A-3,5-DP CCS distributions are indistinguishable. After 
sorting all observed isomer sets in the MSMLS dataset, pairwise matches were created 
and evaluated based on their percent difference in CCS. The resulting difficulty in 
separations is noted in panels (B) for positive and (C) negative ion forms. Reprinted 
(adapted) with permission from Charles M. Nichols, James N. Dodds, Bailey S. Rose, 
Jaqueline A. Picache, Caleb B. Morris, Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, 
John A. McLean, “Untargeted Molecular Discovery in Primary Metabolism: Collision Cross 
Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry,” Analytical 
Chemistry 2018, 90 (24), 14484-14492. Copyright 2018 American Chemical Society. 
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broad range of chemical diversity present in small molecules presents unique advantages in the 
range of ion types that can be utilized. Collectively, these results demonstrate the advantage of 
utilizing both ion polarities in untargeted analyses in which various charge adducts formed during 
the ionization process can be exploited to substantially enhance the selectivity in IM-MS analysis 
by increasing the absolute CCS difference between isomers. This allows a significant improvement 
in separation without instrumental upgrades that would otherwise be necessary to achieve 
improved separation via increased resolving power. This enhanced separation, in turn, provides 
additional confidence in identification through CCS library matches and enhanced ion mobility 
resolution. A potential future direction in the field will utilize molecular modeling and machine 
learning approaches for prediction of adduct specific CCS values and optimal separation 
conditions. 
 
3.3.5 IM-MS Separation in Primary Metabolites 
In addition to enhanced separation through charged adduct formation, recent advances in 
ion mobility resolving power (Rp) have provided increased separation coverage of isomeric 
species.42,43 In order to determine the resolving power in the IM dimension needed for untargeted 
metabolomic experiments, we analyzed pairwise matches of all isomers which provided a usable 
CCS and binned the resulting pairs by percent difference in cross section (%ΔCCS). In brief, 
analytes with identical chemical formulas were grouped into isomeric sets and were subsequently 
matched in a pairwise comparison. Each pairwise match was generated using an enumeration 
strategy wherein a percent difference in CCS was calculated for each possible combination of 
isomers. Most isomeric sets consist of 2-3 compounds, whereas the largest isomeric set was 
comprised of 9 unique analytes (see Figure B.3). In one example, there are 5 sugar compounds 
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which share the same chemical formula (C6H13O9PNa+, exact m/z 283.0195), which results in a 
total of 10 pairwise isomer matches in this analysis. The percent difference in CCS for all isomer 
matches were calculated, and the compiled results for all isomer pairings are displayed in Figure 
3.3(B) (positive ion mode) and Figure 3.3(C) (negative ion mode). Approximately half of the 
isomer pairs generated are ≥ 2.0% different in CCS and require ca. 70 resolving power 
(CCS/ΔCCS) to separate at half height.43,44 In order to separate additional isomers, more resolving 
power would be required (ca. 140 for ~1.0-2.0% difference in CCS, and ca. >300 for ~0.5% CCS 
difference). Currently, only two commercially available IM-MS platforms provide this level of 
resolving power (i.e. atmospheric pressure DTIMS and trapped IMS),39,44 although several 
research instrument prototypes have been developed which are capable of accessing resolving 
powers in excess of 300 (CCS/ΔCCS).6,45 
While IM instruments are continually increasing in resolving power capabilities, current 
untargeted metabolomic workflows identification is based first on primary mass measurement and 
subsequently supported with retention time, isotope ratios, and fragmentation matching. From this 
viewpoint, it is also imperative to describe how much resolving power in the mass dimension is 
necessary for metabolomic studies. By sorting the entire MSMLS library based on primary mass 
alone, our analysis shows that most analytes (64%) are resolvable based only on the mass 
dimension utilizing 40,000 mass resolving power (e.g. high resolution TOF, see Figure 3.4). 
Increasing levels of mass resolving power (300,000 for Orbitrap and up to 40,000,000 for FT-ICR, 
respectively)46,47 provides minimal increases in resolution of these metabolites (ca. 3% more). As 
ca. 30% of the compounds in the MSMLS library are isomers, essentially no level of increased 
mass spectrometry efficiency (short of exited state isomer resolution with MS resolving power of 
ca. 10 billion as theorized by Marshall and coworkers.48) will be able to resolve these compounds, 
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Figure 3.4 MSMLS plate coverage using different separation strategies. (A) Many analytes 
contained in the library can be resolved in the mass dimension at modest resolving power 
(TOF Rp = 40,000), with only incremental increases in coverage resulting from the use of 
an instrument with significantly higher resolving power (FT-ICR Rp = 40,000,000). (B) The 
addition of IM prior to mass analysis allows for isomeric separation and thus increases 
plate coverage by 10%. Reprinted (adapted) with permission from Charles M. Nichols, 
James N. Dodds, Bailey S. Rose, Jaqueline A. Picache, Caleb B. Morris, Simona G. 
Codreanu, Jody C. May, Stacy D. Sherrod, John A. McLean, “Untargeted Molecular 
Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion 
Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 90 (24), 14484-14492. 
Copyright 2018 American Chemical Society. 
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and hence orthogonal separation techniques are still required (i.e. GC, LC, or IM). Modest 
resolving power for commercially available IM instrumentation (ca. 70 CCS/ΔCCS) resolves an 
additional 10% of compounds in the library, which outweighs the benefits of additional mass 
resolving power beyond 40,000 (e.g. TOF MS). We note, however, that this analysis does not 
consider mass measurement accuracy, which is typically higher for FTMS instruments (Orbitrap 
and FT-ICR). Nevertheless, in order to obtain the widest scope of molecular coverage in untargeted 
workflows, possessing sequential separation dimensions based on chemical affinity, gas-phase 
area, and m/z (LC-IM-MS) would strengthen analyte identification strategies. 
 
3.3.6 LC-IM-MS Characterization of NIST 1950 Serum  
The NIST 1950 human serum standard has been previously characterized in the 
literature,27,28,49 and is analyzed in this work to underscore the importance of isomeric 
characterization in untargeted experiments. Separation and characterization of isomeric species in 
biological extracts often requires multiple steps of chemical separation in order to gain increased 
confidence in assigning molecular structure. For example, the base peak chromatogram in Figure 
3.5(A) shows the molecular complexity of the NIST 1950 human serum and the extracted ion 
chromatogram (lower trace) details a specific molecular feature at m/z 203.0528 that elutes into an 
unresolved broad peak over a ca. 2 minute chromatographic window. This broad distribution in 
the elution profile indicates the potential presence of multiple isomeric forms with similar, yet not 
identical, retention times. Although TOF MS has high resolving power (ca. 40,000), potentially 
two chemical formulas are within 10 ppm of the measured m/z (C6H12O6Na and C7H8N4O2Na, at 
1.7 ppm and 8.3 ppm respectively; see Figure 3.5(C)). While assignment of this feature to chemical 
formula C6H12O6Na is more probable due to lower observed mass error, isotope ratios were used 
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Figure 3.5 (A) HILIC base peak chromatogram for NIST 1950 human serum sample and 
(lower trace) the extracted ion chromatogram of m/z 203.0528, which consists of two 
distributions of interest that were further examined by isotope ratio pattern and ion 
mobility for structural characterization. (B) Expected and measured isotope ratio 
abundances for two possible chemical formulas corresponding to m/z 203 within 10 ppm. 
The chemical formula C6H12O6 [M+Na]+ more closely aligns with experimental 
measurements from the NIST serum both on basis of mass accuracy (2 ppm) and isotope 
ratio pattern (M+1). (C) Fragmentation spectra for isomers with the shared chemical 
formula C6H12O6 [M-H]-. (D) Selected ion mobility distributions for m/z 203 extracted over 
three time points in the chromatographic dimension. Reprinted (adapted) with 
permission from Charles M. Nichols, James N. Dodds, Bailey S. Rose, Jaqueline A. Picache, 
Caleb B. Morris, Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, John A. McLean, 
“Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a 
Molecular Descriptor in Ion Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 90 
(24), 14484-14492. Copyright 2018 American Chemical Society. 
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to confirm this molecular formula assignment, wherein the relative abundance of the M+1 peak in 
the serum more closely aligns with the isotope model for C6H12O6Na as opposed to C7H8N4O2Na 
(Figure 3.5(B)). However, even after a specific molecular formula is determined, 9 potential 
isomers (including both constitutional rearrangements and stereochemistry for this chemical 
formula) exist within the MSMLS standards, all of which are carbohydrates. These isomers possess 
almost identical fragmentation profiles (see [M-H]- ion, Figure 3.5(C)), and sophisticated 
algorithms for identification by MS/MS are needed, an observation which has been previously 
noted in other carbohydrate studies.50 Note that Figure 3.5(C) utilizes the deprotonated ion of  
C6H12O6, as the [M+Na]+ species noted in the other panels provides no fragmentation spectra due 
to preferential loss of the sodium charge carrier during collisional activation. Although previous 
energy-correlated MS/MS studies utilized relative abundance ratios of fragment ions to determine 
molecular structure, these techniques are time intensive and currently is not readily amended to 
rapid structural determination in untargeted workflows.50 Similar to the chromatographic profile, 
ion mobility distributions obtained at three separate time points in the chromatogram (lower case 
Roman numerals) also indicate two separate chemical species present in the serum (Figure 3.5(D)). 
The collision cross sections measured for these two distributions helps narrow potential chemical 
structures from 9 potential isomeric forms down to 4 tentative identifications based on a CCS 
match within 1%. The smaller distribution at 140.7 Å2 (light red, A) closely aligns with 3 isomers 
of C6H12O6 in the standards (fructose, galactose and mannose at ca. 141.5 Å2. The larger 
distribution at 147.0 Å2 (light blue, B) closely aligns with α-D-glucose, which is noted at 146.3 Å2 
in the database. Although in this example ion mobility does not provide definitive identification 
of the compounds observed in the NIST serum, it does significantly reduce the possible candidates, 
from the 9 potential structures noted in the database down to 3. Whereas the 1% CCS threshold 
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match used in this example effectively reduced the number of possible isomers by two-thirds, 
using a less conservative threshold could further reduce the ambiguity in assigning these molecular 
features with structural identities. By using collision cross section as additional metric for tentative 
identification, higher confidence in identifying molecular signatures can be gained in untargeted 
metabolomics. 
 
3.4 Conclusions 
In this work we have developed a CCS library based on primary metabolites obtained from 
the MSMLS library of analyte standards. As many key intermediates across metabolic pathways 
are formed through isomerization processes, utilizing orthogonal dimensions of separation in 
addition to mass analysis is imperative to fully characterize metabolic pathways. The intrinsic 
mass-mobility relationships for metabolites noted in this work, and others, illustrates a 
reproducible method of characterization for biochemical classes which interfaces seamlessly into 
the timescale of traditional LC/GC-MS workflows. Furthermore, we demonstrated that while 
additional resolving power in the m/z dimension is always advantageous, the diminishing returns 
of these efforts may not offset the additional costs associated with these instruments and the longer 
analysis times required for ultra-high resolution mass acquisition (i.e. FT processes). However, 
orthogonal separation techniques such as LC and IM can often resolve many isomeric forms, 
facilitating their identification for a more comprehensive understanding of the biochemical 
implications of experimental samples. Finally, we have demonstrated the advantages of adding 
CCS as a molecular descriptor in untargeted metabolomic analyses through characterization of a 
well-studied human serum extract (NIST 1950) by LC-IM-MS. 
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CHAPTER 4 
 
CONFORMATIONAL ORDERING OF BIOMOLECULES IN THE GAS PHASE: 
NITROGEN COLLISION CROSS-SECTIONS MEASURED ON A PROTOTYPE HIGH 
RESOLUTION DRIFT TUBE ION MOBILITY-MASS SPECTROMETER 
 
4.1 Introduction 
With the rising demand for high-throughput analyses of increasingly complex samples, ion 
mobility-mass spectrometry (IM-MS) has found broad application in the analysis of biological 
systems, as this rapid 2D separation (ms and μs, respectively) provides comprehensive molecular 
information regarding analyte size, mass, and relative abundance. In ion mobility, separation is 
achieved by low-energy interactions of charged analytes with an inert buffer gas (conventionally 
helium or nitrogen), where analyte size-to-charge ratio is measured as a function of the time 
required to traverse the mobility region.1 As a means of comparison with other laboratory 
measurements, drift time values are either normalized to standard temperature and pressure as a 
reduced mobility (K0) or converted to a collision cross-section (CCS) value, the latter of which is 
a size parameter related to the averaged momentum transfer impact area of the molecule.2 
Structural information in the form of CCS values assists in the characterization of analytes by 
biomolecular class, as these classes are known to separate in IM-MS space and adopt 
conformational correlations due to prevailing class-specific structural folding in the gas-phase.3,4 
These class-specific mobility-mass correlations can be used as a predictor for molecule class, 
demonstrating the potential value of IM-MS structural separations for life sciences research which 
seek systems biology level information. Expanding upon this concept, CCS-based molecular 
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prediction has previously been explored for peptides, utilizing intrinsic size parameter 
calculations5,6 and machine learning algorithms7 for sequence prediction, but no detailed study of 
other biochemical classes has yet been undertaken. 
The separation and characterization of biological samples by IM-MS has been achieved 
using both commercial and laboratory built instrumentation. Virtually all contemporary 
commercial IM-MS instruments utilize nitrogen as the buffer gas for IM separations, motivated by 
practical considerations of cost, availability, and technical considerations for pumping 
requirements and electrical discharge. The most common commercial IM-MS platform utilizes an 
electrodynamic field (i.e., a traveling wave potential) for mobility separation,8 and drift time 
measurements must be calibrated against electrostatic drift tube data in order to convert these 
measurements to CCS values.9,10 Conversely, many independently constructed instruments 
incorporate uniform electrostatic field mobility regions utilizing helium as the buffer gas. Uniform 
field measurements serve as the benchmark for electrodynamic CCS value determination, as the 
CCS obtained from a uniform field drift tube can be determined empirically through kinetic theory. 
11,12 
One common practice among researchers utilizing IM-MS is calibration of nitrogen-based 
traveling wave ion mobility measurements against helium-based CCS values reported in the 
literature.13,14 The use of helium-based CCS values to calibrate nitrogen-based drift time 
measurements results in calibrated “helium-equivalent” CCS values, which can be useful for 
comparing with literature values and correlating measurements to theory.15,16 There is, however, 
concern that this practice introduces added experimental error, as nitrogen vs. helium mobility 
measurements differ substantially in magnitude, and the success of calibration strategies relies 
heavily on careful selection of calibrants that accurately describe the sample conditions, charge 
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state, mass range and chemical class of the system of interest.9,14,17 Differences in CCS values in 
helium versus nitrogen arise due to several factors including intrinsic size differences between the 
buffer gases, mass effects which factor into the momentum transfer cross-section (the experimental 
CCS), and the over 8 fold difference in gas polarizability between helium and nitrogen (0.21 x 10-
24 and 1.74 x 10-24 cm3, respectively).12,18 
Recently, a prototype IM-MS instrument utilizing nitrogen drift gas was developed 
(Agilent Technologies, Santa Clara, CA). This instrument incorporates a uniform electrostatic field 
ion mobility separator bracketed by electrodynamic focusing devices (ion funnels), which allows 
for high sensitivity and direct measurements of CCS values in nitrogen.7,19 Presented in this report 
is an extensive and diverse database of empirically-derived nitrogen CCS measurements (594 
values), which comprises four molecular classes and expands upon several previous databases for 
the structural characterization of biological molecules.5,7,9,20-23 This affords the opportunity to 
explore the fundamental considerations of buffer gas composition and the subsequent effects on 
ion mobility parameters (reduced mobility and CCS) across different molecular classes. 
 
4.2 Experimental Methods 
 
4.2.1 Preparation of Standards 
4.2.1.1 Lipids All solvents and buffers were purchased as HPLC grade from Sigma-
Aldrich (St. Louis, MO, USA). Dry lipid extracts were purchased from Avanti Lipids 
(Birmingham, AL, USA) and constituted in chloroform prior to analysis. Lipid extracts include 
sphingomyelins (SM, porcine brain), glycosphingolipids (GlcCer, porcine brain), 
phosphatidylcholines (PC, chicken egg), phosphatidylserines (PS, porcine brain), and 
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phosphatidylethanolamines (PE, chicken egg). For analysis, lipid standards were diluted in 90% 
chloroform/10% methanol (v/v) with 10 mM sodium acetate to a final concentration of 10 μg/mL. 
Putative identification of lipids was performed using the exact mass measurement through the 
Lipid Metabolites and Pathways Strategy (LIPID MAPS) Structural Database (LMSD).24 A full 
list of identified lipids can be found in Appendix C. 
4.2.1.2 Carbohydrates Carbohydrate dextrins (linear and cyclic) and sugar alcohol 
standards were purchased from Sigma-Aldrich. Lacto-N-difucohexaose I and II and lacto-N-
fucopentaose I and II were purchased from Dextra Laboratories (Reading, UK). All carbohydrate 
standards were prepared as received and reconstituted in water with 10 mM ammonium acetate to 
final concentrations of 10 μg/mL. For cationization, 10 mM NaCl, 10 mM LiCl, 10 mM CsCl, 10 
mM KCl, and 10 mM RbCl solutions were prepared in water to a final concentration of ca. 10 μM. 
A full list of identified carbohydrates can be found in Appendix C. 
4.2.1.3 Peptides Predigested peptide standards (MassPREP) were purchased from Waters 
(Milford, MA, USA). Peptide standards (SDGRG and GRGDS) were purchased from Sigma-
Aldrich. All peptide standards were received as a lyophilized powder and reconstituted in 10 mM 
ammonium acetate in water to a final concentration of 10 μg/mL. The MassPREP digestion 
standard mix contained approximately equimolar concentrations of four tryptically digested 
proteins: Alcohol Dehydrogenase (ADH, yeast), Serum Albumin (BSA, bovine), Phosphorylase 
B (PHOSPH, Rabbit) and Enolase (ENOLASE, yeast). Peptide identifications were assigned based 
on exact mass of all possible tryptic peptides (no missed cleavages) produced by the Expert Protein 
Analysis System (ExPASy) PeptideMass proteomics tool25 (Swiss Institute of Bioinformatics, 
Lausanne, Switzerland) using the SWISS-PROT database entry number for each intact protein 
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(P00330, P02769, P00924 and P00489, respectively). A full list of identified peptides can be found 
in Appendix C. 
4.2.1.4 Quaternary Ammonium Salts Tetraalkylammonium (TAA) salts with alkyl chain 
lengths between 1 and 18 carbons (TAA1 to TAA18) were purchased from the following sources: 
TAA2, TAA4, TAA6, TAA7, TAA10, TAA12, and TAA16 from Sigma-Aldrich; TAA1, TAA3, 
TAA5, and TAA8 from Acros Organics; and TAA18 from Alfa Aesar. All TAA salts were 
supplied with a stated purity of greater than 98% and were prepared as received. TAA1 to TAA8 
were prepared in 50% methanol/50% water, while TAA10, TAA12, TAA16 and TAA18 were 
prepared in 50% methanol/50% isopropanol. Final concentrations were ca. 1 μg/mL. A full list of 
primary TAA salt standards and concomitant ions identified in the samples can be found in 
Appendix C. 
 
4.2.2 Instrumentation 
A schematic of the instrumentation used to obtain the cross-section measurements is shown 
in Figure 4.1. The instrument used in this work is a commercial prototype IM-MS which 
incorporates a drift tube coupled to a quadrupole time-of-flight mass spectrometer (IM-Q-TOFMS, 
Agilent Technologies, Santa Clara, CA). For this work, an orthogonal electrospray ionization (ESI) 
source (Agilent Jet Stream) was utilized which incorporates a heated sheath gas nebulizer to 
aerodynamically focus and desolvate ions prior to introduction into the vacuum system. Ions from 
the ESI are introduced to a single-bore glass capillary tube which is resistively coated across its 
length, allowing the nebulizer to be maintained at ground potential, while the exit end of the 
capillary can be biased to around 2100 V.26 Ions exiting the capillary are introduced into a tandem 
ion funnel interface consisting of a high-pressure transmission ion funnel in the first stage,27 
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Figure 4.1 Details of the prototype IM-MS instrumentation used in this study. (A) A 
picture of the ion optical elements of the ion mobility component. (B) A representative 
schematic of the instrumentation used with significant components annotated. 
Adapted from Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, 
Caleb B. Morris, Ruwan T. Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. 
Overney, K. Imatani, George C. Stafford, John C. Fjeldsted, John A. McLean, 
“Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross 
Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass 
Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. 
(https://pubs.acs.org/doi/10.1021/ac4038448) Note that further permissions related 
to the material excerpted should be directed to the ACS. 
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followed by a second stage trapping ion funnel which incorporates a dual-grid ion gate.28 The 
second stage ion funnel trap operates as an ion focusing and accumulation region whereby 
temporally narrow (typically 100 to 150 μs) ion pulses are gated into the IM spectrometer. Mobility 
separation occurs in a 78 cm uniform field drift tube comprised of a series (ca. 150) of 50 mm 
internal diameter gold-plated ring electrodes. The buffer gas is high purity nitrogen. Ions traverse 
the drift tube under the influence of a weak electric field (10 to 20 V·cm-1) and consequently drift 
under low-field conditions. The combination of extended drift length, precision electronics, and 
high drift voltages enables high resolution ion mobility separations in excess of 60 resolving power 
(t/Δt, observed for a +1 ion, m/z 294). Ions exiting the drift region are refocused axially using an 
ion funnel and traverse a differential pressure interface region by means of a resistively-coated 
hexapole ion guide. Following the hexapole, ions are introduced into a modified Q-TOFMS 
(Agilent 6550), which incorporates a quadrupole mass filter and collision cell to enable mass-
selective ion fragmentation experiments. The TOFMS is capable of greater than 40,000 mass 
resolving power and can acquire MS spectra at a rate of up to 8.3 kHz (120 μs transients at m/z 
1700). Additional instrumentation details are provided in Figure 4.1. 
 
4.2.3 Experimental Parameters 
All 2D IM-MS spectra were acquired via direct infusion using positive mode electrospray 
ionization (Agilent Jet Stream Source) with a flow rate of ca. 10 μL/min. The Jet Stream source 
was operated with a nitrogen sheath gas temperature between 400 and 600 K (solvent dependent) 
at a flow rate of 12 L/min. Nitrogen drying gas applied at the source entrance was heated to ca. 
570 K at a flow rate of 10 L/min. The source was operated in positive mode with the following 
voltages: ground potential emitter, -4.5 kV capillary entrance, and -1.8 kV nozzle. The three ion 
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funnels were operated as follows: high-pressure funnel RF 100 Vpp (peak-to-peak) at 1.5MHz, 
150 V DC; trapping funnel RF 100 Vpp at 1.2 MHz, 180 V DC; rear funnel RF 100 Vpp at 1.2 
MHz, 200 V DC. The IM drift gas pressure (nitrogen) was maintained at ca. 4 Torr  and ca. 300 
K, while the drift potential varied from 750 V to 1450 V, which represents an E/N ratio of 7 to 15 
Td. In this E/N range, the mobility operates under low field conditions as all analytes investigated 
exhibited a linear change in drift times with respect to the electric field. Data was acquired with a 
modified version of the MassHunter software (Agilent Technologies). The mass measurement was 
calibrated externally using a series of homogeneously-substituted fluorinated triazatriphosphorines 
(Agilent tuning mixture, ca. 100 to 3000 m/z), which are characterized as being amphoteric and 
nonreactive. Additionally, a mixture of tetraalkylammonium salts (TAA1 to TAA18) was added 
to all samples as an internal mass and mobility calibration standard for positive mode analysis. 
 
4.2.4 Collision Cross-Section Calculations 
Uncorrected drift times are extracted as centroid values using a beta version of the IM-MS 
Browser (Agilent Technologies). This uncorrected drift time represents the total transit time of the 
ions, including the mobility drift time and the flight time through the interfacing IM-MS ion optics 
and MS. Because the non-mobility flight time component (the transit time of ions outside the drift 
region) is independent of the drift voltage, this value can be determined from a plot of the measured 
drift time versus the inverse drift voltage,29 where a linear fit to the data will indicate the non-
mobility time component (y-intercept) in the limit of infinite electric field (1/V of zero). Time 
measurements are obtained from a minimum of six different drift voltages, ranging from 750 V to 
1450 V. The determined non-mobility time is subtracted from the uncorrected drift times in order 
to obtain the corrected ion mobility drift time. Corrected drift times are used to determine the gas-
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phase momentum transfer collision cross-section (CCS) using the Mason-Schamp relationship,30 
incorporating the scaling terms for standard temperature and pressure. Based on a propagation-of-
error analysis incorporating the limits of precision for individual experimental parameters, we 
estimate the accuracy of all CCS values to be better than 2% (see Appendix C). 
 
4.3 Results and Discussion 
 
4.3.1 Database Description and General Cross-Section Trends in Nitrogen 
A total of 594 nitrogen collision cross-section values were measured empirically in this 
study, representing three biomolecular classes (lipids, carbohydrates, and peptides), and TAA 
salts. This includes 92 peptides, 125 carbohydrates, 314 lipids, and 63 TAA salts and TAA salt 
derivatives. The range of CCS values measured spans from 140-460 Å2, covering a mass range of 
130-2150 Da. Summary statistics regarding the CCS database are provided in Table 4.1. The 
average RSD of all database values was 0.3% (±0.1%), with each CCS value representing an 
average of 11 (±4) measurements. A complete list of all analytes and respective CCS 
measurements is provided as supplemental material in Appendix C.  
TAA salts ranging from tetraethylammonium (TAA2) to tetraoctadecylammonium 
(TAA18) were analyzed and their subsequent CCS values were compared with literature values in 
order to estimate the CCS measurement accuracy.16 Results of this comparison are summarized in 
Table 4.2. Where CCS literature values existed for nitrogen, the absolute differences were found 
to be less than 2% and, in most cases, less than 1% deviation was observed. All TAA salts 
investigated exhibited excellent CCS measurement reproducibility (less than 0.5% RSD). TAA2 
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Table 4.1 A summary of statistics related to the CCS database. 
 Collision Cross-Section Statistics Fits to Empirical Data 
 
Number 
of CCS 
Values 
Mass 
Range 
[Da] 
CCS 
Range 
[Å2] 
Average 
CCS Pre-
cision1 
Average 
N for 
Each 
Value 
Fit 
Equation 
Coeffic-
ients 
(y = AxB) 
Coeffic-
ient of 
Deter-
mination
2 
Amount 
of Data 
Included 
Within 
±5% of 
Fit3 
Peptides 92 
430 – 
1760 
200 – 
450 
0.2% 
(±0.1%) 
7 
(±2) 
A= 6.8440 
B= 0.5547 
R2= 0.975 91% 
Carbo-
hydrates 
125 
190 – 
2150 
140 – 
410 
0.3% 
(±0.1%) 
12 
(±3) 
A= 11.553 
B= 0.4656 
R2= 0.983 89% 
Lipids 314 
500 – 
1600 
220 – 
460 
0.2% 
(±0.1%) 
10 
(±2) 
A= 5.2469 
B= 0.6000 
R2= 0.949 96% 
Tetraalkyl-
ammonium 
Salts 
63 
130 – 
1030 
140 – 
400 
0.4% 
(±0.1%) 
18 
(±8) 
A= 8.2631 
B= 0.5561 
R2= 0.991 98% 
1. The precision reported here represents the reproducibility across replicate measurements. The total 
precision due to propagation of uncertainty in experimental parameters is estimated to be less than 2%. 
2. The observed R2 value for the nonlinear power fit. 
3. The data inclusion band chosen is based on the smallest sized band which incorporates the most amount 
of data (refer to Figure 4.2(B), inset). 
Adapted from Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. 
Morris, Ruwan T. Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, 
George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules 
in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution 
Drift Tube Ion Mobility-Mass Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. 
(https://pubs.acs.org/doi/10.1021/ac4038448) Note that further permissions related to the 
material excerpted should be directed to the ACS. 
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Table 4.2 Measured CCS values for the TAA salts compared with literature values. 
Name 
Exact 
Mass 
[Da] 
CCS 
(This Work)1 
[Å2] 
CCS 
(Literature)2 
[Å2] 
Abs. Percent 
Difference3 [%] 
Tetramethylammonium TAA1 74.14 - 107.40 - 
Tetraethylammonium TAA2 130.25 - 122.20 - 
Tetrapropylammonium TAA3 186.36 144.1 ± 0.7 (23) 143.80 0.22% 
Tetrabutylammonium TAA4 242.46 166.6 ± 0.9 (16) 166.00 0.36% 
Tetrapentylammonium TAA5 298.57 190.1 ± 1.0 (28) 190.10 0.02% 
Tetrahexylammonium TAA6 354.68 213.5 ± 1.0 (31) 214.00 0.23% 
Tetraheptylammonium TAA7 410.78 236.4 ± 0.4 (31) 236.80 0.17% 
Tetraoctylammonium TAA8 466.54 256.6 ± 0.7 (31) 258.30 0.64% 
Tetradecylammonium TAA10 579.11 293.5 ± 0.7 (24) - - 
Tetradodecylammonium TAA12 691.32 319.0 ± 0.9 (24) - - 
Tetrahexadecylammonium TAA16 915.04 361.5 ± 0.9 (24) - - 
Tetraoctadecylammonium TAA18 1027.16 379.0 ± 1.7 (21) - - 
1. Number of measurements are reported in parenthesis. The error due to experimental uncertainty is 
reported next to each value and is less than 0.5% for all measurements. The total error based on 
propagating the limits of precision in experimental parameters is estimated to be less than 2%. 
2. Literature values from: Campuzano et al. Analytical Chemistry 2011, 84, 1026-1033. 
3. The absolute percent difference is the difference in CCS compared to the average of both values. 
Adapted from Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. 
Morris, Ruwan T. Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, 
George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules 
in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution 
Drift Tube Ion Mobility-Mass Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. 
(https://pubs.acs.org/doi/10.1021/ac4038448) Note that further permissions related to the 
material excerpted should be directed to the ACS. 
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was included in the sample, but ultimately did not appear in significant abundance in the IM-MS 
spectra. 
A scatter plot of CCS versus m/z for all database values is presented in Figure 4.2(A), 
separated into chemical classes. We refer to this type of 2D IM-MS projection as conformational 
space analysis,4,31 as the differential scaling of mass (m/z) and size (CCS) between molecular 
classes is indicative of differences in gas-phase packing efficiency.20 
 
4.3.2 Description of the Fits to the Empirical Data 
Several different equation functional forms were evaluated in order to determine which 
expression best described molecular class correlations between CCS and m/z values, and, it was 
found that the datasets were adequately described by a power-law relationship (y=AxB), based 
upon the coefficient of determination (R2). Conceptually, power-law equations are descriptors for 
several phenomena related to mass-size scaling, including allometric scaling laws in biology,32 
stellar velocity dispersion relative to black hole mass (M-sigma relation),33 and the well-known 
square-cube law, first described by Galileo,34 which universally relates any shape’s increase in 
volume relative to its surface area. Additionally, power-law relationships are scale-invariant such 
that different power-law functions can be related by a simple scaling factor, which has implications 
for describing universal relationships independent of the specific details of the measurement.  
The resulting power-law fits to the empirical data are presented in Figure 4.2(B). 
Coefficients and associated R2 values are summarized in Table 4.1. The data inclusion bands 
projected in Figure 4.2(B) representing ±5% deviation from the line of best fit. Other inclusion 
band sizes are summarized in Figure 4.2(B), inset, averaged across the four datasets. For all 
datasets, a ±5% inclusion band incorporated an average of 94% (±4%) of data. Decreasing the 
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Figure 4.2 (A) A scatter plot of the CCS values measured in this study, separated by 
chemical class. (B) Best fit lines of the data, separated into class and fit to a power-law 
function. Also shown are data inclusion bands representing ±5% deviation from the 
best fit line. The inset bar graph represents the amount of data included within 
different sized inclusion bands. Fit equations and their corresponding coefficients of 
determination (R2) can be found in Table 4.1. Adapted from Jody C. May, Cody R. 
Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. 
Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, 
George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of 
Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a 
Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer,” Analytical 
Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/doi/10.1021/ac4038448) 
Note that further permissions related to the material excerpted should be directed to 
the ACS. 
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band to ±4% results in an average of 86% (±3%) of data being included (a decrease of ca. 8% data 
inclusion), whereas increasing the band to ±6% only incorporated an additional 3% (±2%) of data 
on average. Thus, the ±5% data inclusion band represents an optimal balance between specificity 
and data incorporation. Interestingly, the ±5% band describes all datasets similarly, regardless of 
chemical class. 
Several observations can be made from the data contained in Figure 4.2. The TAA salts 
were found to exhibit the highest CCS values relative to m/z, and were located in a region of 2D 
IM-MS space which was disparate from the biomolecules. Previously, TAA salts were 
recommended as an ion mobility calibrant due to their low propensity for forming clusters, which 
otherwise complicates the interpretation of mobility data.35 Here, it is found that in addition to the 
lack of clustering, the TAA salts are useful mobility-mass calibrants as the complete series (1 to 
18 carbons) span a wide range of CCS values (107 to 400 Å2), m/z values (75 to 1027 Da), and 
occupy a region of 2D IM-MS space where biomolecules are not predicted to occur. Carbohydrates 
were observed to have the lowest CCS values relative to their mass, while peptides and lipids 
occupy similar regions of conformational space. In general, all of the biochemical classes surveyed 
were readily separated above a mass of ca. 1200 Da, indicating that differences in relative gas-
phase packing scale with molecular size and mass. 
 
4.3.3 Extraction of Sub-Trend Information from the Data 
From a cursory analysis of the CCS database described in this report, it is evident that the 
general chemical class information is retained through the specific mobility-mass correlation 
trends in the 2D IM-MS projection. Such trends hold promise for conducting comprehensive omics 
experiments whereby unknown analytes originating from a complex sample (e.g., blood, tissue, 
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whole cell lysate) can be prioritized based upon their likely chemical class. This biomolecular 
filtering would allow for the sorting of unknown analytes into distinct identification workflows, 
as lipid, peptide, metabolite, and glycan identification methods often warrant searching of specific 
databases. In order to determine the detail of class-specific information obtained from the 
conformational space analysis, select coarse biomolecular classes were further categorized into 
finer specific sub-classes. Figure 4.3 contains a detailed analysis of carbohydrates, which were 
further delineated into glycans (human milk oligosaccharides), cyclic dextrins (cyclodextrins), and 
linear dextrins (maltose polysaccharides). Figure 4.3(A and B) illustrates the relative location of 
each carbohydrate sub-class in conformational space, while Figure 4.3(C) describes the data as a 
histogram relative to the best fit line. In general, there is no strong correlation between the 
carbohydrate sub-classes, with all signals distributed in relatively the same locations with respect 
to the power-law fit. This suggests that the carbohydrates surveyed do not adopt strong structural 
differences which can be easily differentiated in the 2D analysis. On the other hand, the sub-classes 
chosen here represent broad descriptors for carbohydrate structure, and as such are not structurally-
descriptive sub-classifications. For example, glycans can represent both linear and branched 
oligosaccharides and thus occupy a broad region of the total carbohydrate conformational trend. 
Interestingly, the cyclization of sugars (cyclodextrins) does not seem to enhance gas-phase packing 
efficiency as compared with their linear analogues. A more comprehensive carbohydrate dataset 
may engender sub-class differentiation, or differences may bear out for more limited situations 
such as positional and structural isomers or various metal-coordinated species.36 
Application of a similar sub-class analysis to the lipid dataset is illustrated in Figure 4.4. 
In this case, the lipid dataset is substantially larger than the carbohydrate dataset (N=314 vs. 
N=125, respectively), and measurements were obtained from five distinct lipid structural classes. 
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Figure 4.3 A sub-class analysis of carbohydrates, with sub-classes comprised of human 
milk derived glycans, cyclic, and linear dextrins. (A) A scatter plot of the relative 
location of carbohydrate sub-classes in 2D IM-MS conformational space. (C) An 
expanded region of the scatter plot where all three sub-classes of carbohydrates are 
observed. (C) A histogram analysis of carbohydrate sub-class deviation in 2D IM-MS 
space relative to the best fit line. In general, the carbohydrate sub-classes do not 
differentiate into distinct regions of conformational space. Adapted from Jody C. May, 
Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. 
Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, 
George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of 
Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a 
Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer,” Analytical 
Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/doi/10.1021/ac4038448) 
Note that further permissions related to the material excerpted should be directed to 
the ACS. 
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Figure 4.4 A sub-class analysis of lipids comprised of PE, PC, PS, GlcCer, and SM lipids. 
These lipids are further categorized into two general structural groups: 
glycerophospholipids (PE, PC, PS) and sphingolipids (GlcCer, SM). (A) A scatter plot of 
the conformational ordering of each sub-class of lipid. (B) An expanded region of the 
scatter plot detailing a preferential ordering of the different lipid sub-classes in 
conformational space. (C) A histogram analysis and locations of general lipid structural 
groups relative to the best fit line. Unlike carbohydrates, individual lipid sub-classes 
partition into distinct regions of 2D IM-MS space, allowing for finer structural 
information to be extracted from the conformational space analysis. Adapted from 
Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, 
Ruwan T. Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. 
Imatani, George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational 
Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured 
on a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer,” Analytical 
Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/doi/10.1021/ac4038448) 
Note that further permissions related to the material excerpted should be directed to 
the ACS. 
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These lipid sub-classes can be broadly categorized into two structural classes as sphingolipids 
(SM, GlcCer) and glycerophospholipids (PE, PC, PS). It is qualitatively evident in Figure 4.4(A 
and B) that each class of lipid exists in a distinct region of conformational space. The histogram 
distribution analysis in Figure 4.4(C) (right panel) indicates that sphingolipids fall predominantly 
above the best fit line (97% in region 1), whereas glycerophospholipids (Figure 4.4(C), middle 
panel) are more broadly dispersed around the mobility-mass correlation (33% in region 1, 65% in 
region 2), and adopt denser gas phase conformations than sphingolipids. These results suggest that, 
with proper structural sub-class descriptors, conformational space analysis is capable of 
differentiating finer structural detail beyond general biomolecular class. 
 
4.3.4 Comparisons between Helium and Nitrogen CCS Values 
The diverse compilation of CCS values described in this report allows for direct 
comparisons against helium-derived CCS values reported in the literature. Of the over 3000 singly-
charged helium CCS values surveyed from the literature, overlapping measurements exist for 121 
nitrogen CCS values in the current database (8 TAA salts, 49 lipids, 40 peptides, and 24 
carbohydrates; refer to Appendix C). Differences between helium and nitrogen-derived CCS 
measurements have been previously noted for atomic species,37 small molecules and peptides,38 
and, more recently, proteins and large protein complexes.9,23 Here, we add the differences observed 
for TAA salts, lipids, and carbohydrates, in addition to corroborating previous peptide 
observations. 
A scatter plot of the overlapping helium and nitrogen CCS values is provided in Figure 
4.5(A). Vertical error bars representing ±2% are also included, although this error is sufficiently 
small such that most of the error bars are obscured within the scale of individual data points. Figure 
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Figure 4.5 Comparisons between helium and nitrogen-derived CCS values. (A) A 
scatter plot of class-specific subsets of CCS data measured in both helium and nitrogen. 
(B) Power fits to the data projected in panel A. (C) Correlation plot of helium vs. 
nitrogen CCS values. (D) Absolute differences in CCS between helium and nitrogen 
measurements, plotted as a function of mass-to-charge. In general, nitrogen CCS 
values are significantly larger than helium, with subtle differences being observed 
between different chemical classes. Adapted from Jody C. May, Cody R. Goodwin, 
Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. Kurulugama, A. 
Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, George C. Stafford, 
John C. Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules in the 
Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution 
Drift Tube Ion Mobility-Mass Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-
2116. (https://pubs.acs.org/doi/10.1021/ac4038448) Note that further permissions 
related to the material excerpted should be directed to the ACS. 
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4.5(B) contains the power fits to the data, which are useful in visualizing differences between 
datasets. In general, gross separation trends between chemical classes are retained within the 
helium and nitrogen-based datasets, with qualitatively similar conformational space ordering being 
exhibited regardless of the drift gas (i.e. carbohydrate density > peptide density > lipid density > 
TAA salt density). However, subtle differences exist with respect to the amount of average 
separation observed between class-specific fits. For example, the lipids and peptides exhibit 
slightly better average separation as a group in helium than in nitrogen, whereas the peptides and 
carbohydrate are better separated in nitrogen than in helium. These trends can also be observed in 
Figure 4.5(C), which contains the same overlap data as projected on a plot of nitrogen versus 
helium CCS values. In Figure 4.5(C), all of the class-specific data reside within the same region 
of the projection, indicating that overall differences between helium and nitrogen CCS are 
systematic within this range, and thus can be accounted for to allow conversion of one dataset to 
another, with some loss in precision associated with error propagation. This possibility of 
generating effective helium-based CCS values from nitrogen measurements was previously noted 
by Bush et al. for peptides and proteins.9,22 Recently, Pagel and Harvey noted good correlation 
(less than 1.5% error) between helium and nitrogen CCS measurements for singly-charged 
carbohydrates, though significant error was introduced when multiply-charged values were 
incorporated into the calibration.17 Here we confirm a strong correlation between singly-charged 
helium and nitrogen CCS values for lipids, peptides, carbohydrates and TAA salts. It should be 
cautioned, however, that the relationship between helium and nitrogen-based CCS values are both 
charge-state and mass-dependent,39 and it is expected that any correlation between the two 
measurements would deviate at the extremes of low and high mass. In fact, Bush et al. previously 
noted that cross-calibration error from nitrogen to helium CCS is higher at lower masses (up to 
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15% error) where the magnitude of the CCS value is small, while at higher masses, the error can 
be reduced to as low as 2.2% for predicting helium CCS from nitrogen measurements.9 It was also 
noted in this study and elsewhere that calibration across different chemical classes (e.g., using 
literature peptide values to calibrate lipids14) introduces additional and significant error (ca. 7%), 
further underscoring the importance of compiling a chemically diverse set of empirical drift tube 
CCS values. Figure 4.5(C), inset contains the linear best fits to the data, with the axes rescaled to 
a region where data exists for all four chemical classes. Linear fits are extrapolated (dotted lines) 
for visualization purposes. Here, the small but notable differences between chemical classes can 
be observed as offset correlation lines, which corroborate with the absolute CCS differences 
between helium and nitrogen noted previously for each chemical class. Specifically, peptides, 
carbohydrates, and lipids fall along a similar helium-nitrogen CCS correlation trend, while the 
TAA salts exhibit a slightly lower correlation. Interestingly, all class correlations exhibit similar 
slopes (ca. 1), suggesting that the factors which give rise to the cross-sectional differences between 
helium and nitrogen (buffer gas size, mass and polarizability) affect different chemical classes in 
a similar manner across a broad range of both size and mass. 
Absolute CCS differences between the helium and nitrogen datasets are plotted as a 
function of mass in Figure 4.5(D), with error bars representing ±2% CCS uncertainty. Average 
absolute CCS differences are projected as a horizontal line through each class distribution, with 
the following values: TAA salts, 58 (±3) Å2; lipids, 70 (±4) Å2; carbohydrates, 74 (±8) Å2; and 
peptides, 73 (±5) Å2. Cross-sectional differences are lowest for the TAA salts, while lipids, 
carbohydrates and peptides differ by approximately the same amount. Overall, there is a small but 
notable increase in the helium-nitrogen CCS difference with increasing mass for all classes except 
lipids where a limited mass range is surveyed. This suggests that the nitrogen and helium CCS are 
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not increasing at the same rate relative to the mass of the analyte, with the greater CCS increase 
occurring in nitrogen. Wyttenbach et al. recently noted that ion systems up to ca. 760 Da (sodiated 
PEG17) still exhibit strong contributions from the ion-neutral interaction potential in their measured 
CCS.40 From their atomic superposition argument, it would be expected that with nitrogen buffer 
gas, the combined effect of each atomic potential for large polyatomic systems would give rise to 
a steeper increase in CCS than with helium buffer gas, since the atom-nitrogen interaction potential 
is stronger than the atom-helium interaction potential. In other words, the stronger interaction 
potential of nitrogen would be expected to scale with the number of atoms in the ionic system 
being measured, at least to a first approximation. Ion systems with different heteroatom 
compositions (e.g., lipids vs. peptides) would also be expected to exhibit different scaling of mass 
to CCS between helium and nitrogen; this effect cannot be definitively observed in the relatively 
narrow mass range surveyed in this work, though cursory effects of gas polarization seem to be 
present in the enhanced high-mass separation of lipids and peptides in nitrogen vs. helium. Such 
class-specific CCS differences may bear out as more overlapping measurements are obtained in 
future studies.  
 
4.4 Conclusions 
The large database of nitrogen-derived CCS values presented here offers a glimpse at the 
intrinsic intermolecular packing forces of four chemically-different molecular classes across a 
relatively wide range of both size (ca. 150 to 450 Å2) and mass (ca. 150 to 2200 Da). Four 
molecular classes were investigated in this study, with relative gas-phase densities observed as 
follows, from least to most efficient packing: TAA salts, lipids, peptides and carbohydrates. The 
biopolymers (carbohydrates and peptides) demonstrated the highest efficiency for gas-phase 
132
packing, and among these, carbohydrates tend to adopt the most compact gas-phase CCS values. 
This observation is somewhat intuitive in that carbohydrates have considerable degrees of freedom 
and can adopt both linear and branched primary structures. In contrast, lipids exhibit the largest 
CCS values among the biomolecules investigated, and this observation appears to be intrinsic to 
the inability of lipids for forming compact, self-solvated structures in the gas-phase. Noteworthy 
among these findings is that despite the significant differences between helium and nitrogen in 
terms of mass, degrees-of-freedom (atomic vs. diatomic) and polarization, the biomolecular class 
trends observed here for the nitrogen-based ion mobility are qualitatively the same as those 
previously observed in helium.3,20 We do observe evidence that these qualitative trends between 
the two drift gases are not retained at low mass, and a more detailed investigation of helium and 
nitrogen-based ion mobility studies for low mass analytes (less than 200 Da) will be the subject of 
future studies. 
We emphasize that these studies are only possible by the remarkable advances made over 
the past decade in the development of biological IM-MS instrumentation. The IM-MS described 
in this report can achieve high resolving powers with high sensitivity, making it possible to observe 
and characterize low abundance isomeric species in highly complex samples with unprecedented 
scale and throughput. While we have purposely chosen to report only the highest abundant species, 
we note that the observation of multiple ion mobility peak features (mass isomers) is routine with 
this instrumentation, requiring that a new paradigm be accepted whereby it is no longer a question 
of if a particular isomer exists, but rather how much if it is present and in what context. 
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CHAPTER 5 
 
EVALUATING SEPARATION SELECTIVITY AND COLLISION CROSS SECTION 
MEASUREMENT REPRODUCIBILITY IN HELIUM, NITROGEN, ARGON, AND CARBON 
DIOXIDE DRIFT GASES FOR DRIFT TUBE ION MOBILITY-MASS SPECTROMETRY 
 
5.1 Introduction 
Ion mobility spectrometry (IM) is an important analytical technique for the rapid separation 
and identification of a wide variety of chemical compounds 1-6. In a conventional drift tube, the 
separation of chemical species results from numerous, near-thermal collision between analyte ions 
and a chemically-inert drift gas. Total IM separation times occur on the order of milliseconds, and 
thus are both high throughput and sufficiently fast to allow for integration with other analytical 
separation techniques 7-8. Whereas in conventional gas and liquid phase chromatography, it is well-
established that the chemical selectivity of the separation can be enhanced by choosing different 
stationary phases, IM is more appropriately described as a gas-phase electrophoretic technique, 
and as such does not incorporate a stationary phase. Instead, varying the drift gas composition has 
been demonstrated to affect separation efficiency in a similar manner as changing solvent condi-
tions in capillary electrophoresis to tune separation selectivity. Most notably in high-field IM tech-
niques such as high-field asymmetric waveform ion mobility spectrometry (FAIMS) and differen-
tial mobility spectrometry (DMS), the carrier gas composition is commonly altered to increase the 
resolution for closely spaced analytes 9-15. For conventional low field IM techniques such as drift 
tube (DTIMS) and traveling wave (TWIMS), this practice is less common, although several nota-
ble cases exist 16-18. For example, seminal work from Hill and coworkers demonstrated enhanced 
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analyte selectivity on an ambient pressure drift tube when varying the drift gas from low to high 
polarizability (helium, nitrogen, argon, and carbon dioxide) 19-22. Eberlin and coworkers reported 
improved separation of isomeric haloanilines, carbohydrates, and petroleum constituents when op-
erating a traveling wave instrument in CO2 as opposed to conventional N2 gas 23-26. Recently, Yost 
and coworkers demonstrated increased resolving power for several isobaric steroids, analyzed in 
a reduced-pressure drift tube instrument, using CO2 as the drift gas 27. In many cases, however, the 
more polarizable drift gases (e.g., Ar, CO2, and N2O) are not reported to dramatically improve the 
overall IM peak capacity and resolution for chemically-similar analytes, including peptides, amino 
acids, structural isomers, and protein conformers, in comparison to He or N2 drift gases 28-31. A 
large survey of various drift gases (He, N2, Ar, CO2, N2O, SF6) recently conducted on a commercial 
drift tube instrument by Fjeldsted and coworkers investigated the separation of isomeric carbohy-
drates, fluoroalkyl phosphazenes, and various small molecule pesticides. Higher resolution was 
generally observed for drift gases with access to the highest resolving powers in the instrumenta-
tion, namely conventional He and N2. Some enhanced selectivity and resolution was observed for 
the more polarizable drift gases (CO2, N2O, and SF6), although results were specific to the analyte 
pairs being investigated 32. The literature examining the roles various drift gases play on IM sepa-
ration capabilities are complicated and must be taken case-by-case. Given the potential analytical 
power that the drift gas composition can play in enhancing the IM resolution, there is a need for 
exploring IM separations in alternate drift gases across a broader range of analytes, and reporting 
quantitatively-comparable metrics of separation capabilities obtained from various laboratories. 
To accomplish this, a common framework for acquiring and comparing ion mobility data obtained 
in different drift gases needs to be established. 
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In addition to providing analyte structural information, collision cross section (CCS) values 
are useful for comparing IM measurements obtained using different IM instrumentation and tech-
niques 1, 33-35 and recently have been used as an additional molecular description combined with 
accurate mass and retention time information for high confidence identification of unknowns aris-
ing from complex samples 34, 36-40. While some fundamental work has been done using matrix-
assisted laser desorption ionization (MALDI) 41-42, the majority of CCS measurements has been 
conducted using electrospray ionization (ESI), including the work here. For alternate drift gas 
work, separations conducted across different instrument platforms, such as drift tube and traveling 
wave, cannot be directly compared without utilizing a normalized measurement such as CCS 33. 
Comparisons of IM separation performance are hindered by the fact that the majority (95%) of 
CCS measurements have been reported only in conventional He and N2 drift gas 1. In addition to 
the general lack of reporting CCS measurements in alternate drift gas work, a large-scale study of 
the effects of drift gas on a wide mass range, multiple biological classes, and varying charge states 
has yet to be accomplished. In this work, we investigate four of the most commonly used drift 
gases, helium (He), nitrogen (N2), argon (Ar), and carbon dioxide (CO2), and establish instrument 
conditions necessary to achieve high reproducibility and enhanced separation efficiency for di-
verse sets of structurally-homogeneous analytes representing various charge states and chemical 
classes. We assess the separation efficiency in each gas using a combination of single-peak resolv-
ing power, two-peak resolution, and peak capacity, and provide detailed reporting of the CCS 
measured in each drift gas for low field DTIMS. 
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5.2 Methods  
 
5.2.1 Instrumentation  
A commercial drift tube ion mobility-mass spectrometer (6560, Agilent Technologies) 
equipped with a thermally-assisted electrospray ionization source (Jet Stream, Agilent) was used 
for all measurements described herein 43. The drift gases used were high purity N2, He, Ar, and 
CO2 (Air Liquide). N2, He, and Ar were UHP grade supplied at 99.999% purity, whereas CO2 was 
Coleman grade, at 99.99% purity. The high-pressure funnel (HPF), trap funnel (TF), and drift tube 
(DT) regions of the instrument, shown in the schematic in Figure 5.1, were supplied with either 
He, N2, Ar, or CO2 using a commercially-upgraded drift gas manifold (Alternate Gas Kit, Agilent). 
Briefly, the gas kit consists of a precision closed-loop pressure controller (640B, MKS Instru-
ments) which makes real-time adjustments to the pressures based on readings from a capacitance 
manometer (CDG-500, Agilent) mounted on the DT chamber. Prior to being directed into the in-
strument, each drift gas was passed through a passive purifier specific for He, Ar (RMSH-4, Ag-
ilent), N2 (RMSN-4, Agilent), or CO2 (P600-2, VICI Metronics). Instrument tuning utilized the 
vendor autotune function in standard mass range (m/z 3200 mode). For He, tuning was performed 
in N2 before switching to He to mitigate issues related to gas breakdown at high voltage, manifest-
ing as uncorrelated low m/z noise in the 2D ion mobility-mass spectrometry (IM-MS) spectrum. 
For N2, Ar, and CO2, tuning was performed in the chosen drift gas. During gas switching, the DT 
was allowed to equilibrate for at least 60 minutes, after which, pressures were confirmed to be 
stable and minor adjustments made as necessary. The HPF was operated at 4.80 Torr for N2 and 
Ar, 4.35 Torr for He, and 4.30 Torr for CO2. The TF was operated at 3.80 Torr for N2, 3.74 Torr for 
Ar, and 3.72 Torr for both CO2 and He. CCS measurements utilize a stepped-field procedure in 
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Figure 5.1 A conceptual schematic of the commercial drift tube ion mobility-mass spectrometer 
(6560, Agilent) used in this work. The selected drift gas is supplied to the high-pressure funnel 
(HPF), trap funnel (TF), and drift tube (DT) regions. The flow controller adjusts the gas flow into 
TF region based on the DT pressure readback, maintaining a constant pressure in the DT. The DT 
is isolated from the vacuum system, and gas evacuation from DT is thus facilitated via the entrance 
and exit apertures of the chamber. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, 
and John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section Measurement 
Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mo-
bility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 2019 (in press). 
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which several drift fields are surveyed in order to determine the ion transit time within the mobility 
drift region. For N2, Ar, and CO2 the specific voltages used for the DT and associated ion transfer 
optics (TF exit, rear ion funnel, and post-IM hexapole) are identical to settings used in a standard-
ized CCS method described in a recent interlaboratory study 34. Specifically, this standardized, 
stepped-field method incorporates seven electric field strengths (E/N, where E is electric field and 
N is the molecular number density) between 8 and 15 Td with a static pressure of 3.95 Torr in the 
DT. For He, the same DT pressure (3.95 Torr) is utilized, however, a different range of electric 
fields are surveyed between 6 and 13 Td to optimize resolving power across a broad mass range 
while mitigating electrical breakdown of the gas. Detailed experimental settings for each drift gas 
are provided in Table D.1. The trap release time (referred to as ion gating time in other IM instru-
mentation) was set to 100 μs for all experiments to maximize instrument resolving power 44, and 
the TF exit voltage (defining the ion “injection” voltage into the DT) was kept at 10 V, minimizing 
end effects which otherwise shift drift times to lower values 45. Ion source conditions were as 
follows: 325°C gas temperature, 13 L/min drying gas flow rate, 275°C and 12 L/min sheath gas 
temperature and flow rate, and nebulizer pressure at 20 psig. Additional experimental conditions 
for each drift gas are summarized in Table D.1. The vendor-supplied software (LC/MS Data Ac-
quisition B.07.00, Agilent) was used for all data acquisition. 
 
5.2.2 Variable Pressure Experiments 
In prior work with He drift gas, it was found that the operational pressures of the HPF and 
TF had an effect on the measured CCS, presumably due to changes in gas purity within the DT 35, 
46. In order to better characterize these pressure dependencies, the gas pressures were varied in 
increments of 0.10 Torr and 0.02 Torr for the HPF and TF regions, respectively, while keeping the 
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DT at 3.95 Torr. This allowed CCS measurements to be obtained at multiple pressure combinations 
for both regions. The upper pressure limits surveyed for N2, Ar, and CO2 were based upon pres-
sures utilized for normal N2 operation (i.e., 4.80 Torr in the HPF and 3.80 Torr in the TF) 32. Op-
erational limits of the flow controller (calibrated for N2) restricted helium experiments to a maxi-
mum of 4.63 Torr in the HPF with 3.80 Torr in the TF. To obtain CCS values comparable to those 
reported in the literature, measurements were taken above the minimum operational pressure 
bounds of the HPF and TF; however, despite the proximity to operational pressure limits, CCS 
measurements were reproducible and subsequently represent the values reported in this work. 
 
5.2.3 Effective Length 
All CCS values observed in all drift gases are listed in Table D.2, with CCS values not 
observed in all drift gases listed in Table D.3, and calculated using a drift tube effective length of 
78.06 cm. The effective length differs slightly from the geometric length of the instrument (ca. 
78.12 cm), and is determined using a previously-reported protocol whereby CCS values for the 
MS tuning mixture (hexakis(fluoroalkoxy)phosphazenes, HFAP, m/z 322-m/z 2722) are scaled to 
reference measurements obtained using a gridded DT instrument 34, 47. The effective length deter-
mined from this procedure is instrument-specific and was used to calculate CCS values for all drift 
gases. 
 
5.2.4 Chemical Standards 
Isopropanol, acetonitrile, water, and formic acid (Optima LC-MS grade) were obtained 
from Fisher Scientific. The chemical standards were purchased from several vendors, summarized 
in Table D.4. Tetraalkylammonium salts (TAA) were received as dry powder and reconstituted in 
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isopropanol. All chemical standards except the HFAP tuning mixture were prepared at 10 μg/mL 
and directly infused into the ESI source at a flow rate of 10 µL/min. Poly-DL-alanine and maltose 
standards were prepared in methanol:water (50:50% v:v) with 0.1% formic acid. The MS tuning 
mixture containing HFAP (ESI-L Low Concentration Tuning Mixture, Agilent) is supplied from 
the vendor as a mixture of components dissolved in acetonitrile:water (95:5% v:v), and was pre-
pared as per the vendor instructions by diluting the solution by a factor of ten using acetonitrile:wa-
ter (98:2% v:v).  
 
5.3 Results and Discussion  
 
5.3.1 Analyte Selection 
The analytes chosen for this study were selected as belonging to sets of structurally-homo-
geneous molecules spanning a wide mass coverage (Figure 5.2(a)). Specifically, HFAP increases 
by symmetric additions of fluoroalkyl (CF2) subunits to the six terminal ethers, while TAA cations 
increase symmetrically by alkyl (CH2) subunits, and the carbohydrates represent oligosaccharides 
with repeating α-D-glucose units linked by an α(1→4) glycosidic bond. Although the MS tuning 
mixture also contains m/z 118 (betaine), this molecule is not a HFAP, and thus was not included in 
this study.Poly-DL-alanine has been used in previous IM studies for CCS calibration 48-49 and, in 
addition to possessing repeating alanine subunits, forms multiple charge states from ESI, allowing 
for the investigation of charge state effects in different drift gases.  
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Figure 5.2 (a) Mass coverage of each class of molecules investigated. (b) Representative struc-
tures for each of the four classes of molecules investigated in this study, with their respective 
masses indicated by the white dots in panel a. Adapted from Caleb B. Morris, Jody C. May, 
Katrina L. Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross 
Section Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift 
Gases for Drift Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass 
Spectrometry 2019 (in press). 
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5.3.2 Pressure Effects 
Pressure conditions in the ion transfer funnels prior to the drift tube were systematically 
investigated for each drift gas to determine the effect on the measured CCS. The cesium cation 
(Cs+) was used for quantitative comparisons of the CCS measurement due to ease of ionization, 
lack of multiple conformations, and CCS measurements have been previously documented in the 
literature for the drift gases investigated in this present study. The Cs+ CCS results for select com-
binations of pressure conditions are presented in Figure 5.3, representing the upper (red boxes) 
and lower limits of pressures (blue boxes) surveyed for each funnel region. In all cases, the drift 
tube pressure was maintained at 3.95 Torr. The CCS value and corresponding variance reported in 
the literature for Cs+ is also shown at the bottom of each panel (unfilled bars), as reported for He, 
N2, Ar, and CO2 50. While there was no significant change in the N2 CCS (DTCCSN2) values for Cs+ 
(0.08% difference or less), CCS measurements in the other drift gases were sensitive to HPF and 
TF pressure changes, most notably with changes to the TF pressure, where as high as 47.96%, 
7.99%, 0.81% differences in CCS were observed for He, CO2, and Ar respectively. Previously, it 
has been suggested that for this particular instrument configuration, the pressure difference be-
tween the TF and the DT affects the gas purity within the IM region, and our results support this 
idea, with lower pressure differences shifting the Cs+ DTCCSHe to higher values, and lower CCS 
values for the other gases, implicating contamination of the drift tube with gas from the ion source, 
the latter of which is N2 sourced from the boil-off of a cryogenic tank 32, 46. Though not reported 
previously, it was found in this study that lower pressures in the upstream HPF could also improve 
gas purity in the DT, and this effect is shown in Figure 5.3 for He, Ar, and CO2. As with the TF 
pressure, lowering the HPF pressure affected the Cs+ CCS measurement by shifting it to lower 
values for He, and higher values for Ar and CO2. In He, the CCS continues to decrease as the HPF 
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Figure 5.3 A comparison of the CCS values obtained for Cs+ (132.91 Da) in multiple drift gases 
(filled bars) and at various HPF and TF operational pressures (vertical axes labels, in Torr) along 
with the CCS and corresponding error (outlined bars) reported by Ellis et al. (Ellis, HW; McDaniel, 
EW; Albritton, DL; Viehland, LA; Lin, SL; Mason, EA; Atomic Data and Nuclear Data Tables 22, 179-
217, 1978). Error bars for data obtained in this study correspond to 7 repeat measurements. Red 
and blue shading in the vertical axes labels indicates high or low relative pressure conditions for 
HPF and TF. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, 
“Evaluating Separation Selectivity and Collision Cross Section Measurement Reproducibility in 
Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spec-
trometry,” Journal of the American Society for Mass Spectrometry 2019 (in press). 
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and TF pressures are reduced, with the lowest pressures surveyed exhibiting the closest CCS cor-
relation to the literature. The CCS response to HPF and TF pressures indicate improved drift gas 
purity at lower HPF and TF pressures for drift gases other than nitrogen. At some pressures, the 
CCS response is minimal as the pressure is further lowered. Since the interpretation is that lower 
HPF and TF pressures show increased gas purity, as evidenced by better CCS agreement with 
literature values, the lowest pressures that could be achieved in He, Ar, and CO2, without signal 
degradation of the reported analytes, are recommended. This CCS shift exhibits some mass-de-
pendence, as evidenced by comparing the CCS of the HFAP tuning mixture ions across various 
pressure conditions (cf., Figure D.1). Specifically, the lower mass HFAP ions (m/z 322 and m/z 
622) experience a greater shift in CCS in response to changes in HPF and TF operational pressures, 
which we interpret as due to a greater magnitude of the so-called “end effect” documented for 
DTIMS, where ions subject to either higher fields or less collisional dampening (i.e., He) at the 
entrance to the IM region experience deeper penetration into the drift region 45, 51. This delayed 
thermalization of ions results in a shorter effective drift length, and thus a shift in the apparent 
measured CCS to lower values as the TF operational pressure is decreased. For the lower limits of 
pressure, operating the TF and HPF regions at pressures below those recommended here was found 
to significantly degrade ion transmission in He, Ar, and CO2. Additionally for Ar, lower pressures 
resulted in non-linear behavior in the drift times obtained across multiple drift fields, while in He, 
gas discharge occurs, which manifests as uncorrelated spectral noise in the lower m/z range. The 
lower pressure limits for N2 were chosen to overlap with the limits observed for the other drift 
gases. The high pressure limits for operating the TF and HPF regions for each drift gas were de-
termined based on the recommended values previously established for N2 32. Recommended pres-
sure settings for all drift gases evaluated are summarized in Table D.1. 
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5.3.3 Ion Source Temperature Effects 
CCS changes were also observed when adjusting the ion source gas temperatures (i.e., 
nebulizer sheath gas and source entrance drying gas). Specifically, when varying ion source gas 
temperatures, as much as a 2.7% change in the DTCCSHe was observed, while the DTCCSN2 shifted 
by a more modest amount, 0.3% or less. This result is interpreted as being due to changes in the 
gas flow dynamics between the ion source and the DT, which results in gas impurities being intro-
duced into the drift region despite efforts to maintain constant operational pressures in the HPF, 
TF, and DT regions. Thus, the CCS results presented in this study are obtained under constant ion 
source temperature conditions which were selected in order to achieve close correlation of Cs+ 
CCS values to those described in the literature. 
 
5.3.4 Ion Injection Potential 
The TF exit voltage establishes the potential bias between the TF and the DT. This potential 
affects the ion “injection” into the DT and plays a role in ion transmission, resolving power, ion 
internal energy, and the measured drift time.45, 52-53 In order to quantitatively evaluate these effects, 
the potential difference between the TF exit and DT was varied from 0 to 45V (35V in He) using 
the HFAP tuning mixture ions as a test system. Ion transmission, CCS, and resolving power were 
measured for each injection voltage (Figures D.2-D.4). It was found that in all drift gases, ion 
injection voltages between 5 and 15V yielded the highest ion transmissions based on peak area 
analysis (Figure D.2), whereas resolving powers were found to be the highest for 10 and 15V. In 
this range, no strong correlation was observed for any particular HFAP ion, suggesting that be-
tween 10 and 15V the mass and mobility-dependent effects were minimal. Importantly, the ion 
injection voltage was found to shift the measured CCS for all gases surveyed, most dramatically 
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for the low (0 and 5V) and high (≥15V) potential settings. For example, DTCCSN2 differences rel-
ative to 10V for m/z 1522 was found to be between 2.13% and 1.24%, respectively. Specifically, 
low ion introduction voltages (≤5V) yielded high CCS values, whereas the high ion introduction 
voltages (≥15V) resulted in low CCS values regardless of the identity of the drift gas. These results 
can be interpreted as a consequence of different ion injection energies, specifically, for low volt-
ages, ions spend more time at the DT entrance prior to being entrained in the drift field, whereas 
for high voltages, ions penetrate deeper into the drift region before reaching a steady-state drift 
velocity. It is somewhat surprising that, without an ion introduction potential (0V), ions still trans-
fer against a pressure gradient into the DT, although this observation is not investigated further in 
this work. Also of note is that, despite what is typically observed for drift tube instruments, the 
higher ion injection potentials in this DTIMS configuration did not yield more ion signal, but rather 
decreased ion transmission and resolving power. The default setting for the injection potential 
(designated as the TF exit voltages in the software) is 10V, which yielded good results in terms of 
high ion transmission and high resolving power for all gases and HFAP ions evaluated. As such, 
the TF exit voltage used for all subsequent experiments was 10V. 
 
5.3.5 CCS Measurements 
The CCS measurement reproducibility (precision) was found to depend on the drift gas. 
For example, 95% of the DTCCSHe values exhibit an RSD of less than 1.4%, whereas in Ar, CO2, 
and N2, the precision was found to be much better, with the majority (95%) of CCS values exhib-
iting less than 0.6%, 0.5%, and 0.3% RSD, respectively (c.f., Figure D.5). The cause of the lower 
precision in He is likely due to pressure fluctuations during CCS measurements as a result of the 
pressure controller valve orifice used in this work being optimized for N2, although it should be 
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noted here that the vendor offers high flow valve configurations which should improve the pressure 
control when operating in He drift gas. In order to keep the recommended parameters in this work 
accessible to a wider network of researchers, an alternate pressure controller optimized for He was 
not used. Instead, the pressure controller shipped with the alternate gas kit was used for all four 
drift gases. As noted previously, both the HPF and TF pressures affect the CCS and operating the 
instrument at the lower HPF and TF pressures yield measurements which are closely aligned with 
canonical CCS values. Note that Cs+ in He never matched with the literature value, even account-
ing for error. As only a single literature source could be found which reported DTCCSHe values for 
the cesium cation, this observation could not be further evaluated. While HFAP ion CCS values 
have not been previously published for gases other than N2, HFAP ions were subsequently com-
pared to previously published DTCCSN2 values (Figure D.6) 34, 54, demonstrating excellent agree-
ments of 0.56% or less, with a relative standard deviation of measurements taken for this study of 
0.31% or less. For poly-DL-alanine, CCS values obtained in this work showed less agreement with 
the literature, with a maximum bias of 1.7% observed for N2 and a 4.8% bias for He (Figure D.7). 
This agreement is still seen as reasonable, given these measurements were from disparate instru-
ment designs and the error reported for the literature values was estimated at 3% 34, 54. Previously 
published He and N2 values for TAA cations 34, 54 were also compared to the current measurements 
(Figure D.8), and it was found that, in general, the literature values were typically higher, with 
differences ranging from -2.96% to 3.67% observed among the different reports. Overall, the set-
tings recommended in this study (Table D.1) provide good CCS measurement reproducibility 
while corresponding reasonably well to prior measurements. Ongoing international efforts are 
aimed at further improvements in CCS measurement precision and accuracy. 
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5.3.6 Chemical Class Behavior 
The gas-specific conformational space plots for all analytes investigated is shown in Figure 
5.4. The low mass region is highlighted in each of the insets and depicts a region of IM-MS space 
where multiple chemical classes reside in close proximity. In general, all of the class-specific mo-
bility-mass trends are qualitatively the same with the higher charge state ions exhibiting larger 
CCS values than the lower charge state ions, while for singly-charged ions, the CCS increases in 
the following order: HFAP<carbohydrates<peptides<TAA cations. As discussed in a number of 
previous reports, this conformational ordering is indicative of the relative gas-phase packing effi-
ciency of each chemical class, with ions exhibiting less-restrictive degrees of freedom (peptides 
and carbohydrates) are able to arrange themselves into more compact gas-phase structures 55-56. 
For singly-charged ions, the relative CCS values in N2 and Ar are similar, whereas DTCCSAr values 
are all slightly lower than those measured in N2. Note that for multiply charged species, the CCS 
differences are greater between the various gases than singly charged species. This is apparent in 
Figure 5.4 when comparing the relative spacing between the poly-DL-alanine +2 and +3 ion trends 
(dark blue triangles) to the +1 trend (light blue triangles), as well as plotting CCS as a function of 
gas polarizability (Figure D.9), where linear fits to the higher charge states exhibit larger slopes. 
In addition to charge state effects, the carbohydrates as a whole are strongly affected by the identity 
of the drift gas compared to the other classes investigated. This effect is shown in Figure 5.5, where 
the carbohydrates shift in drift time to a greater extent than other classes, resulting in an inversion 
in the IM elution orders. For example, in CO2, polyalanine 13-mer (blue dashed trace, m/z 
942.5008) exhibits a lower measured drift time than the carbohydrate, maltohexaose (orange 
dashed trace, m/z 1013.3173). In all other drift gases, however, this relative elution order is re-
versed. This effect has been noted previously for small molecules with masses below 500 Da 19, 57 
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Figure 5.4 Mass versus CCS plots for each drift gas investigated. The location of all measure-
ments are designated with grey symbols for comparison. The inset in each panel shows an ex-
panded region at low m/z which contains various compound classes. Note that the CCS of car-
bohydrates (orange squares) relative to the other compounds exhibits a strong dependency on 
the identity of the drift gas utilized. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leap-
trot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section Meas-
urement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift 
Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 
2019 (in press). 
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Figure 5.5 Relative abundance (R.A.) vs drift time for two ions from each class are shown for the 
four drift gases at the same field strength. Solid lines show four ions of similar mass, with one ion 
from each of the four classes (structures are depicted in Figure 5.2(b)); dashed lines show four 
ions of higher mass, with one ion from each class. (b) Two peak resolution (Rpp) is shown as his-
togram plots for each closest-mass ion pair of the lower mass group, those depicted with solid 
lines in the IM spectra. Note the drift time inversion for the high mass carbohydrate (dashed or-
ange) and polyalanine (dashed blue) in CO2 compared to the other three drift gases. Adapted 
from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, “Evaluating Separa-
tion Selectivity and Collision Cross Section Measurement Reproducibility in Helium, Nitrogen, Ar-
gon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spectrometry,” Journal of 
the American Society for Mass Spectrometry 2019 (in press). 
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and this present work demonstrates that CCS inversion can occur at higher masses as well. This 
drift gas selectivity can be useful depending upon the ion species being separated. For instance, in 
the peak-to-peak resolution (Rpp) example shown in Figure 5.5, utilizing N2 or Ar would be ideal 
for separation of the lower mass ions shown, however, the best resolution for certain ion pairs is 
observed in CO2 specifically between HFAP m/z 322 and maltose (labeled as analytes A and B). It 
is interesting to note that, with respect to the relative elution orders and resolutions observed, IM 
separations in Ar (39.96 Da, 1.64 Å3) are most similar to those observed in N2 (28.01 Da, 1.74 Å3), 
rather than CO2 (43.99 Da, 2.91 Å3), 58 indicating CCS is more dependent on the polarizability of 
the drift gas than the neutral drift gas mass for the species measured here. While the experimental 
CCS is a function of both ion and drift gas size, the relative size of the drift gas as experienced by 
the ion is dominated by its polarizability, and thus plots of CCS versus polarization exhibit near 
linear trends 22. This is shown in Figure 5.6(a), with the select ions investigated plotted as a func-
tion of the drift gas polarizability. Of note is that, despite the relative differences in CCS observed 
across the different drift gases surveyed, ions of similar chemical class exhibit similar slopes in 
the CCS vs. polarizability plot. 
 
5.3.7 Drift Gas Selection Criteria 
In choosing the appropriate drift gas, analytical figures-of-merit such as single-peak re-
solving power (Rp), two-peak resolution (Rpp), and peak capacity are important considerations. 
Equations associated with these analytical figures-of-merit can be found in Appendix D. Peak ca-
pacity, a measure of the number of peaks that can occupy a given analytical separation space at 
half height, was found to be the highest in Ar, followed by N2 at the lower mass range (Figure 
5.6(b), top panel), whereas N2 outperformed all of the other gases for higher mass analytes due to 
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Figure 5.6 (a) The CCS for select ions plotted against the polarizability of the drift gas as given in 
the CRC Handbook of Chemistry and Physics.45 All ions are singly charged except polyalanine 14-
mer (PAla 14) which is doubly charged. Increasing the polarizability of the drift gas is correlated 
with an increase in CCS. However, the relative change in CCS with the drift gas polarizability is 
both class and charge-state specific, as indicated by the different slopes. The slope, intercept, and 
regression coefficient values are given in Table D.5. Error bars are within the marker size. (b) Re-
solving power (Rp) and peak capacity bar graphs for each drift gas. Maximum Rp values are shown, 
requiring a different drift field for He (8.3 V/cm) versus the other drift gases (16.0 V/cm). Peak 
capacity was calculated between HFAP and TAA cations of similar mass. Error bars were based on 
five measurements conducted on different days. Adapted from Caleb B. Morris, Jody C. May, 
Katrina L. Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross 
Section Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases 
for Drift Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spec-
trometry 2019 (in press). 
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the ability for N2 to access higher resolving powers in this mass range (Figure 5.6(b), bottom 
panel). CO2 exhibited the lowest peak capacities for the two mass ranges investigated, but certain 
systems may benefit from the increased analytical selectivity as previously described. Overall, N2 
would be recommended in most cases due to low %RSD, excellent peak capacity, and a consist-
ently high resolving power over a wide mass range. Helium may be chosen when comparison to 
computational or literature values is needed. Argon performed similarly to nitrogen but may be 
chosen over nitrogen if a slight increase in resolving power is needed for lower mass analytes. CO2 
may be chosen to improve separation for specific analyte pairs.  
 
5.4 Conclusion 
This work evaluates detailed experimental conditions necessary for operating a commercial 
drift tube instrument (Agilent 6560) with a variety of drift gases that include He, N2, Ar, and CO2. 
Criteria used to evaluate the optimal instrument settings needed for each gas include those param-
eters which provided the highest measurement repeatability of the CCS and the closest correspond-
ence of CCS (e.g., cesium, tuning mixture ions, and poly-DL-alanines) to previously published 
values. Using these optimal operational settings, a large and highly-consistent set of CCS meas-
urements (N=280, 56 unique ions with 5 replicates each) for a variety of structurally-heterogene-
ous compounds (TAA cations, poly-DL-alanines, fluoroalkyl phosphazenes, and α(1→4)-linked 
glucose oligosaccharides) are subsequently compiled, which are suitable as reference values for 
future studies. Comparison between the CCS response of the various classes, charge states, and 
masses surveyed in each drift gas is provided to aid future investigators in selecting the appropriate 
drift gas for their particular applications. The specific CCS trends observed were found to correlate 
strongly with the drift gas polarizability, thus providing a basis for predicting relative elution orders 
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for gases not yet investigated. Overall, it was found that N2 exhibited the highest resolving powers 
and peak capacities across a broad range of masses with a correspondingly high CCS reproduci-
bility (less than 0.40% RSD). CO2 exhibited relatively low peak capacities, but demonstrated high 
chemical class and charge state specific selectivity, and in some cases, resulted in inverted analyte 
elution times as compared to the other drift gases. In general, the reference CCS values and rec-
ommended experimental parameters outlined in this manuscript are expected to aid IM researchers 
in selecting the drift gas appropriate for their analytical problem, as well as providing guidance for 
incorporating alternative drift gases in future work. Finally, the highly-consistent CCS values 
measured in this study can be used as a basis for improving fundamental IM theory and developing 
algorithms which consider the identity of the drift gas in predicting IM elution behavior. 
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CHAPTER 6 
 
CONCLUSION AND FUTURE DIRECTIONS 
 
6.1 Conclusion 
Ion mobility-mass spectrometry (IM-MS) has been established as a valuable technique by 
adding a reproducible molecular descriptor that allows for enhanced identification of unknowns 
beyond using mass spectrometry alone. In addition, IM improves peak capacity and allows 
inference of structural information based on the experimental CCS. For improvement of unknown 
identification, databases have been created. Databases with multiple descriptors including collision 
cross section (CCS) have great utility in untargeted workflows or large-scale analyses with 
complex biological samples to which IM-MS is well suited. Databases also enable development 
of predictive methods for CCS to further assist unknown identification. This work has 
encompassed a large collection of canonical literature CCS values, identifying important analytical 
trends in IM and underrepresented areas of study where a significant impact can be made. This 
CCS compilation provides the basis for predicting CCS chemical space occupancy and enables 
large-scale studies of chemical class relationships. It also provides a foundation for utilizing CCS 
as a molecular descriptor in future work. Furthermore, utilizing a commercially available drift tube 
IM-MS, a CCS database was created of metabolite standards. This descriptor adds information 
that can allow identification of isomers without the need for costly ultra-high resolution mass 
spectrometers with long analysis times, hindering high throughput methods. This study shows the 
benefits in using an orthogonal separation such as IM to improve isomer separation. Further 
improvement on separation is still needed. Alternate drift gases show potential in this area but have 
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not been well studied. An initial study of multiple classes was conducted in nitrogen and compared 
to helium literature values. Class filtering was shown in both drift gases, creating disparate trend 
lines for each class based on gas-phase packing efficiency. It was noted that TAA salts were the 
least efficient in packing followed by lipids, peptides, and carbohydrates. Differences at low mass 
could be seen between helium and nitrogen trend lines, indicating that drift gas can affect 
separation. Instrument operating parameters had to be developed for further investigation of CCS 
under a variety of conditions such as alternate drift gases. After development of such methodology, 
the effect of drift gas on CCS was investigated and further instrument parameters defined for 
operation under different drift gases to include He, N2, Ar, and CO2. A large set of various classes 
spanning a wide range of mobilities, masses, and charge states were investigated in these four drift 
gases. Recommendations were made for the selection and use of each drift gas based on this 
investigation. It was found that CCS trends correlated strongly with drift gas polarizability, 
allowing for prediction of relative elution orders in drift gases not yet investigated. This work 
presents a significant study of drift gases spanning a broad range of classes, mobilities, masses, 
and charge states to aid future work with alternate drift gases. The recommendations made here 
give future investigators the tools for selection of alternate drift gases. This work also can be used 
to improve fundamental IM theory as well as aid in generating algorithms that predict mobility 
elution order based on drift gas parameters. Based on this work, there are several avenues for future 
investigations. 
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6.2 Future Directions 
 
 6.2.1 Mathematical Descriptors in Databases 
 As databases become increasingly populated with high quality CCS data, it becomes 
imperative to describe this data in a meaningful way for analysis of trends and enabling predictive 
capabilities. Mathematical descriptors can be used as a predictive tool where unknowns are 
classified based on proximity to various trends. This prediction can be used as an enhancement to 
other descriptors such as mass, charge state, ion adduct, and LC retention time to improve unknown 
identification. Mathematical descriptors have already been discussed in this work but relied on the 
relatively simple power fit. This is an appropriate descriptor until inclusion of low mass (<200 Da) 
data. With this inclusion, more complex descriptors such as sigmoidal fits become necessary. 
These equations can predict the minimum cross section achievable in a drift gas. This value has 
been calculated with the mobility of polarization where the minimum mobility in a drift gas is 
based off the drift gas polarizability.1 However, with these equations, such drift gas values can be 
empirically derived from large datasets in multiple drift gases in the future. Such mathematical 
descriptors need further development. Complex mathematical formulas may not be utilized by 
many investigators as quickly as more simple power law descriptors. However, with online 
databases being developed, such complexity can be programmed into an online interface to 
facilitate ease of use. For example, a user should need to only input the unknown’s CCS, mass, 
and other relative information into the interface and the mathematical descriptor should be applied 
immediately to generate predictions on class. Simultaneously, using this generated class prediction 
and the information entered by the user, the unknown should be compared to the entire database, 
generating a series of possible matches scored based on how well each possible match aligns with 
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the unknown. With current IM-MS technology able to generate highly reproducible CCS values 
in a wide range of drift gases, databases will continue to grow and with it, the need for 
mathematical descriptors. 
 
 6.2.2 CCS Prediction 
 There is a need for rapid prediction of CCS in a variety of drift gases. Algorithms based on 
first principles are both complex and computationally expensive.2 Here, a possible way of 
predicting CCS is presented using an empirical method to achieve CCS prediction. This method 
would be simpler than current computational methods, which can take hours or days for a predicted 
CCS, and could be implemented using an online interface. A user would enter an unknown’s mass, 
CCS, charge state, and the drift gas used to generate the CCS, and this method would generate a 
list of CCS values in other drift gases in seconds. The method starts with the understanding that 
CCS is a rotationally averaged collision cross section. As such, CCS can be described as a circle 
𝐶𝐶𝑆 = 𝜋(𝑟𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒 + 𝑟𝑔𝑎𝑠)
2     (6.1) 
where the radius is made up of the sum of the molecular and drift gas radii. From this, an equation 
can be derived describing the relationship between the CCS of an analyte in one drift gas to the 
CCS of that analyte in another drift gas. The derivation is shown in Figure 6.1 with the final 
relationship shown as 
𝐶𝐶𝑆𝑔𝑎𝑠1 = 𝐶𝐶𝑆𝑔𝑎𝑠2 + 𝐶1√𝐶𝐶𝑆𝑔𝑎𝑠2 + 𝐶2    (6.2) 
where C1 and C2 are constants defined in Figure 6.1. The equation solely accounts for hard sphere 
interactions. If a helium CCS is attempted to be converted into a nitrogen CCS, this equation will 
underestimate the nitrogen CCS as it does not account for all interactions. To account for long 
range interaction potentials, the radius definition for each drift gas in the equation must be 
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Figure 6.1 Derivation of a mathematical relationship between CCS in gas 1 to CCS in gas 2 
based solely on hard sphere interactions. 
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modified. It has been noted that to describe empirical mobility data, the drift gas radius should 
vary based on the analyte mass,3 where a given gas radius is defined as4 
𝑟𝑔𝑎𝑠 = (𝑟0𝑔𝑎𝑠 + 𝑧𝑔𝑎𝑠 ∗ 𝑚𝑎𝑠𝑠𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒) ∗ (1 + (
𝑚𝑎𝑠𝑠𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒
𝑚𝑎𝑠𝑠𝑔𝑎𝑠
)
1
3
)   (6.3) 
where r0gas is the hard sphere radius of the gas, zgas is a correction factor and a constant, massmolecule 
is the analyte mass, and massgas is the drift gas mass. Note that when the analyte mass reaches zero, 
the radius of the drift gas is equivalent to its hard sphere radius. Substituting Equation 6.3 for 
radius in the definitions for C1 and C2 in Equation 6.2 results in a complex equation where the 
constants z and r0 must be defined for each drift gas through numerical analysis for a given class 
and charge state. A table of constants could be generated this way. Though these initial calculations 
would be computationally expensive, the advantage over current methods is that once completed, 
the equation can be paired with previously generated constants to quickly predict the CCS value 
for an analyte based on its previous drift gas CCS value, its charge state, and class. This last 
calculation could easily be completed through an online interface where users would enter the 
relevant data and the equation would be ran with the necessary constants pulled from the 
previously generated table. To generate reliable constants, these numerical analyses will require a 
large set of analytes across multiple drift gases. With the parameters established in this work to 
achieve reproducible CCS in multiple drift gases, such a large set can now be obtained across a 
wide range of drift gases for further development of this CCS prediction method. 
 
 6.2.3 Drift Gas Selection 
 Drift gases have been shown in this work to exhibit selectivity for certain classes. It has 
been shown here and elsewhere5-6 that polarizability correlates strongly with CCS, with certain 
classes and charge states exhibiting greater CCS increase as drift gas polarizability increases. This 
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trend hints at the potential use of drift gas polarizability for prediction of relative IM elution orders 
if class and charge state are known. Additionally, this effect has the potential to allow classification 
of unknowns based on behavior in multiple drift gases. Where an unknown in one drift gas may 
not easily be classified based on proximity to known class trends in said drift gas, analysis of this 
unknown in multiple alternate drift gases may allow a mobility profile to be developed. This 
mobility profile would track the unknown’s mobility as a function of drift gas polarizability and 
be compared to profiles of known classes. In this way, a more definitive classification may be 
made. Further analysis of this trend as well as developing a large database of values in multiple 
drift gases will require careful selection of alternate drift gases. Drift gas selection in future studies 
should consider the mass and polarizability of the drift gas. The magnitude of the effect of drift 
gas mass and drift gas polarizability across multiple classes, mobilities, analyte masses, and charge 
states is still unclear. Certain drift gases chosen in this work allowed for comparison of results 
from drift gases that either have similar polarizability or similar mass. Argon has similar 
polarizability to nitrogen but similar mass to carbon dioxide. CCS values in argon were closer to 
that of nitrogen than carbon dioxide, indicating that polarizability may have a greater effect on 
CCS than drift gas mass. If such an observation were to be further described along with 
investigation of this effect in other drift gases selected in the same fashion, this would greatly 
improve fundamental IM understanding and prediction of drift gas effect. Other drift gases to 
investigate beyond nitrogen, argon and carbon dioxide include but are not limited to krypton, 
carbon tetrafluoride, xenon, and sulfur hexafluoride. From this list, several groups of three can be 
made wherein two of the three have similar polarizability and another two of the three have similar 
mass. This is graphically represented in Figure 6.2. Such analysis would build upon the methods 
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Figure 6.2 A list of possible drift gases for use in future drift gas studies. A method for 
selecting a group comprised of three drift gases is shown. Such a selection results in two 
of the three drift gases (nitrogen and argon) having similar polarizability and two of the 
three drift gases (argon and carbon dioxide) having similar mass. In future work, groups of 
three drift gases can be chosen to achieve a similar result, such as a group comprised of 
krypton, carbon tetrafluoride, and xenon. 
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and instrumental parameters demonstrated in this work and enable further description of the drift 
gas effect in terms of drift gas polarizability and mass. 
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APPENDIX B 
 
SUPPLEMENTAL INFORMATION FOR CHAPTER 3 
 
 
 
Figure B.1. IM-MS spectra for D-Ornathine. The standard is subject to metastable  ion dissociation 
in the DTIMS, resulting in uncorrelated mobility. The true reported conformer is circled in red. 
Reprinted (adapted) with permission from Charles M. Nichols, James N. Dodds, Bailey S. Rose, 
Jaqueline A. Picache, Caleb B. Morris, Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, John 
A. McLean, “Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a 
Molecular Descriptor in Ion Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 90 (24), 
14484-14492. Copyright 2018 American Chemical Society.  
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Mass/Mobility Fitting Equations: Power fits for biomolecular superclasses selected in the 
manuscript (See Figure 3.2). 
 
Power Association (General) 
𝑦 =  𝑦0 + (plateau − 𝑦0) ∗ (1 − 𝑒
−𝐾𝑥)  (B.1) 
4P sigmoidal (General) 
𝑦 = 𝑦𝑜 +  
𝑦𝑚𝑎𝑥  − 𝑦0
1 + 10(log 𝑦50 − 𝑥) ∙ 𝐻
 (B.2) 
Lipids and lipid-like molecules- Power association 
𝑦 =  75.41 + (516.9 − 75.41) ∗ (1 − 𝑒−0.000851𝑥) (B.3) 
Organic oxygen compounds- Power association 
𝑦 =  101.9 + (935.0 − 101.9) ∗ (1 − 𝑒−0.000251𝑥) (B.4) 
Nucleosides, nucleotides, and analogues- Power association 
𝑦 =  117.6 + (1.52 × 107 − 117.6) ∗ (1 − 𝑒−1.06×10
−8𝑥) (B.5) 
Organic acids and derivatives – 4P sigmoidal 
𝑦 = 104.8 +  
216.3 − 104.8
1 + 10(277.4  − 𝑥) ∙ 0.00376
 (B.6) 
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Table B.1. Metabolic pathways covered by compounds with at least one measured CCS the 
MSMLS plate study. (See Figure 3.3) Reprinted (adapted) with permission from Charles M. 
Nichols, James N. Dodds, Bailey S. Rose, Jaqueline A. Picache, Caleb B. Morris, Simona G. 
Codreanu, Jody C. May, Stacy D. Sherrod, John A. McLean, “Untargeted Molecular Discovery in 
Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass 
Spectrometry,” Analytical Chemistry 2018, 90 (24), 14484-14492. Copyright 2018 American 
Chemical Society. 
 
Pathway Total Expected Hits Raw p #NAME
? 
Holm 
adjust 
FDR Impact % of 
Hits 
Pyrimidine metabolism 60 10.2 31 5E-10 21.4 4E-08 4E-08 0.7 52 
Purine metabolism 92 15.7 34 2E-06 13.0 2E-04 9E-05 0.5 37 
Tyrosine metabolism 76 12.9 25 5E-04 7.7 4E-02 1E-02 0.5 33 
Alanine, aspartate and glutamate metabolism 24 4.1 11 9E-04 7.0 7E-02 2E-02 0.6 46 
beta-Alanine metabolism 28 4.8 12 1E-03 6.8 9E-02 2E-02 0.4 43 
Galactose metabolism 41 7.0 15 2E-03 6.2 1E-01 3E-02 0.3 37 
Arginine and proline metabolism 77 13.1 23 3E-03 5.7 2E-01 4E-02 0.5 30 
Cysteine and methionine metabolism 56 9.5 18 4E-03 5.6 3E-01 4E-02 0.8 32 
Glycine, serine and threonine metabolism 48 8.2 15 1E-02 4.5 8E-01 9E-02 0.4 31 
Citrate cycle (TCA cycle) 20 3.4 8 1E-02 4.4 9E-01 1E-01 0.3 40 
Sulfur metabolism 18 3.1 7 2E-02 3.8 1 2E-01 0.3 39 
Nicotinate and nicotinamide metabolism 44 7.5 13 3E-02 3.6 1 2E-01 0.4 30 
Amino sugar and nucleotide sugar 
metabolism 
88 15.0 22 3E-02 3.4 1 2E-01 0.5 25 
Glutathione metabolism 38 6.5 11 5E-02 3.1 1 3E-01 0.4 29 
Phenylalanine metabolism 45 7.7 12 7E-02 2.7 1 3E-01 0.1 27 
Ascorbate and aldarate metabolism 45 7.7 12 7E-02 2.7 1 3E-01 0.4 27 
Pantothenate and CoA biosynthesis 27 4.6 8 7E-02 2.6 1 3E-01 0.3 30 
Biotin metabolism 11 1.9 4 1E-01 2.3 1 4E-01 0.4 36 
Taurine and hypotaurine metabolism 20 3.4 6 1E-01 2.2 1 4E-01 0.5 30 
Tryptophan metabolism 79 13.5 18 1E-01 2.2 1 4E-01 0.5 23 
Nitrogen metabolism 39 6.6 10 1E-01 2.2 1 4E-01 0.0 26 
Histidine metabolism 44 7.5 11 1E-01 2.2 1 4E-01 0.4 25 
Butanoate metabolism 40 6.8 10 1E-01 2.0 1 4E-01 0.1 25 
Starch and sucrose metabolism 50 8.5 12 1E-01 2.0 1 4E-01 0.5 24 
Riboflavin metabolism 21 3.6 6 1E-01 2.0 1 4E-01 0.1 29 
Caffeine metabolism 21 3.6 6 1E-01 2.0 1 4E-01 0.5 29 
D-Arginine and D-ornithine metabolism 8 1.4 3 1E-01 2.0 1 4E-01 0.5 38 
Pentose phosphate pathway 32 5.5 8 2E-01 1.8 1 5E-01 0.4 25 
Vitamin B6 metabolism 32 5.5 8 2E-01 1.8 1 5E-01 0.4 25 
Synthesis and degradation of ketone bodies 6 1.0 2 3E-01 1.3 1 7E-01 0.9 33 
Pentose and glucuronate interconversions 53 9.0 11 3E-01 1.3 1 7E-01 0.2 21 
D-Glutamine and D-glutamate metabolism 11 1.9 3 3E-01 1.3 1 7E-01 0.1 27 
Aminoacyl-tRNA biosynthesis 75 12.8 15 3E-01 1.2 1 7E-01 0.2 20 
Lysine biosynthesis 32 5.5 7 3E-01 1.2 1 7E-01 0.3 22 
Phenylalanine, tyrosine and tryptophan 
biosynthesis 
27 4.6 6 3E-01 1.2 1 7E-01 0.3 22 
Glycerophospholipid metabolism 39 6.6 8 3E-01 1.1 1 8E-01 0.3 21 
Valine, leucine and isoleucine degradation 40 6.8 8 4E-01 1.0 1 8E-01 0.2 20 
One carbon pool by folate 9 1.5 2 5E-01 0.8 1 1E+00 0.2 22 
Glyoxylate and dicarboxylate metabolism 50 8.5 9 5E-01 0.7 1 1E+00 0.1 18 
Valine, leucine and isoleucine biosynthesis 27 4.6 5 5E-01 0.7 1 1E+00 0.1 19 
Lysine degradation 47 8.0 8 6E-01 0.6 1 1E+00 0.3 17 
Fructose and mannose metabolism 48 8.2 8 6E-01 0.5 1 1E+00 0.2 17 
Ubiquinone and other terpenoid-quinone 
biosynthesis 
36 6.1 6 6E-01 0.5 1 1E+00 0.2 17 
Thiamine metabolism 24 4.1 4 6E-01 0.5 1 1E+00 0.3 17 
Fatty acid biosynthesis 49 8.3 8 6E-01 0.5 1 1E+00 0.0 16 
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Propanoate metabolism 35 6.0 5 7E-01 0.3 1 1E+00 0.1 14 
Selenoamino acid metabolism 22 3.7 3 8E-01 0.3 1 1E+00 0.1 14 
Linoleic acid metabolism 15 2.6 2 8E-01 0.3 1 1E+00 0.7 13 
Cyanoamino acid metabolism 16 2.7 2 8E-01 0.2 1 1E+00 0.0 13 
Glycolysis or Gluconeogenesis 31 5.3 4 8E-01 0.2 1 1E+00 0.1 13 
Sphingolipid metabolism 25 4.3 3 8E-01 0.2 1 1E+00 0.2 12 
Folate biosynthesis 42 7.2 5 9E-01 0.1 1 1E+00 0.1 12 
Inositol phosphate metabolism 39 6.6 4 9E-01 0.1 1 1E+00 0.2 10 
Pyruvate metabolism 32 5.5 3 9E-01 0.1 1 1E+00 0.0 9 
Glycerolipid metabolism 32 5.5 3 9E-01 0.1 1 1E+00 0.0 9 
Terpenoid backbone biosynthesis 33 5.6 3 9E-01 0.1 1 1E+00 0.1 9 
Methane metabolism 34 5.8 3 9E-01 0.1 1 1E+00 0.0 9 
Primary bile acid biosynthesis 47 8.0 4 1E+00 0.0 1 1E+00 0.0 9 
Fatty acid metabolism 50 8.5 4 1E+00 0.0 1 1E+00 0.1 8 
Retinol metabolism 22 3.7 1 1E+00 0.0 1 1E+00 0.2 5 
Fatty acid elongation in mitochondria 27 4.6 1 1E+00 0.0 1 1E+00 0.0 4 
N-Glycan biosynthesis 38 6.5 1 1E+00 0.0 1 1E+00 0.0 3 
Steroid hormone biosynthesis 99 16.9 6 1E+00 0.0 1 1E+00 0.1 6 
Porphyrin and chlorophyll metabolism 104 17.7 6 1E+00 0.0 1 1E+00 0.1 6 
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Figure B.2. A distribution of the adduct types observed from the MSMLS study. Reprinted 
(adapted) with permission from Charles M. Nichols, James N. Dodds, Bailey S. Rose, Jaqueline A. 
Picache, Caleb B. Morris, Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, John A. McLean, 
“Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular 
Descriptor in Ion Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 90 (24), 14484-14492. 
Copyright 2018 American Chemical Society. 
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Figure B.3. The distribution of isomeric families within the MSMLS. Most isomeric sets contain 2 
or 3 isomers per group, and the largest set contained 9 isomers. Reprinted (adapted) with 
permission from Charles M. Nichols, James N. Dodds, Bailey S. Rose, Jaqueline A. Picache, Caleb 
B. Morris, Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, John A. McLean, “Untargeted 
Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in 
Ion Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 90 (24), 14484-14492. Copyright 
2018 American Chemical Society. 
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Figure B.4. IM separation of the deprotonated (A) and protonated (B) isomers of neutral mass 
147.0532 (L-glutamic acid and N-methyl-D-aspartic acid). Reprinted (adapted) with permission 
from Charles M. Nichols, James N. Dodds, Bailey S. Rose, Jaqueline A. Picache, Caleb B. Morris, 
Simona G. Codreanu, Jody C. May, Stacy D. Sherrod, John A. McLean, “Untargeted Molecular 
Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion 
Mobility-Mass Spectrometry,” Analytical Chemistry 2018, 90 (24), 14484-14492. Copyright 2018 
American Chemical Society. 
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APPENDIX C 
 
SUPPLEMENTAL INFORMATION FOR CHAPTER 4 
 
C.1 Comments Regarding Limits of Precision for the CCS Measurements  
The experimental uncertainty is determined from technical replicates representing a 
minimum of six measurements of CCS, obtained during separate instrument acquisitions. We 
consider a parsimonious approach essential when compiling a database, and thus individual CCS 
measurements which contributed to a percent relative standard deviation (RSD) beyond 0.5% were 
generally found to be indicative of a poor centroid fit (i.e., multiple peak features or low ion 
counting statistics) and ultimately were not included in the datasets reported in this manuscript. 
While all CCS values reported are better than 0.5% in experimental uncertainty, the accuracy 
associated with the result is a sum of this experimental reproducibility and the uncertainty 
associated with measuring each experimental parameter. The CCS uncertainty for significant 
experimental parameters is estimated as follows for the lowest CCS value measured in this work 
(TAA3, 144 Å2): Pressure ±0.05 Torr (±1.3%), temperature ±1 K (±0.3%), drift voltage ±2.5 V 
(±0.2%), and time centroid extraction ±0.1 ms (±0.6%), resulting in a total uncertainty of ±1.5%, 
as propagated through the Mason-Schamp equation. There is good reason to believe that the 
measurement precision is better than what is estimated in the above example. Thus, the accuracy 
of all values within the database is estimated to be better than 2%.  
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C.2 Notes on Supplemental Tables 
In many cases, lower abundance concomitant species were present in the analytical 
standards, denoted as derivative signal in the tables. Analyte identities for the derivative signals 
are putative and based on the mass measurement. No special considerations were made to optimize 
for accurate mass data, and so the measured mass and associated accuracies reported in the tables 
are as obtained from the production prototype instrumentation using an offline calibration. CCS 
and K0 measurement precision representing experimental reproducibility error (σ) is reported 
along with the number of measurements (N). The total accuracy of all transport property values 
(CCS and K0) is estimated to be better than 2% (refer to the above discussion). 
 
C.3 Symbol Key, Definitions, and Associated Equations: 
Mass Accuracy – Mass accuracy (in ppm) is calculated from the following expression: 
𝑀𝑎𝑠𝑠 𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝐸𝑥𝑎𝑐𝑡 𝑀𝑎𝑠𝑠−𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑀𝑎𝑠𝑠
𝐸𝑥𝑎𝑐𝑡 𝑀𝑎𝑠𝑠
∙ 106   (C.1) 
K0 – Reduced mobility (the mobility scaled to standard temperature and pressure), as 
calculated from the following equation: 
𝐾0 =
𝐿2
𝑉∙𝑡𝑑
(
273.15
𝑇
) (
𝑃
760
)     (C.2) 
Here, L is the drift length (cm), V is the drift voltage (V), td is the corrected drift times (s), 
T is the drift gas temperature (K), and P is the drift gas pressure (Torr).  This gives the units 
of K0 in cm2·V-1·s-1. Reduced mobility values are classically reported for small mass ions, 
and provided in the following tables for convenience. 
CCS – The first approximation solution of the momentum transfer collision cross-section, 
as calculated from the following equation (the expanded Mason-Schamp relationship, 
Mason & Schamp 1958): 
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𝐶𝐶𝑆 = (
3∙𝑍∙𝑒𝑐
16∙𝑁
) ∙ (
2𝜋
𝑘𝐵∙𝑇
)
1
2
∙ (
𝑚𝑖𝑜𝑛+𝑚𝑔𝑎𝑠
𝑚𝑖𝑜𝑛∙𝑚𝑔𝑎𝑠
)
1
2
∙ (
𝑉∙𝑡𝑑
𝐿2
∙
273.15
𝑇
∙
𝑃
760
)   (C.3) 
Here, Z is the integer charge state of the ion (unitless), ec is the constant for elementary 
charge (1.60217657 x 10-19 C), N is the gas number density (determined from the ideal gas 
law, in units of molecules/m3),kB is the Boltzmann constant (1.3806488 x 10-23 J·K-1), mion 
is the ion mass (Da), and mgas is the neutral drift gas masses (N2 in this work, Da), 
respectively.  Other terms are as described previously.   
Note that here and by convention, the CCS is reported in units of Å2 (square 
angstroms).  In order to obtain square angstroms directly from the above calculation, it is 
necessary to multiply the expression (in m2) by 10-20, with consideration given for 
converting the above terms to the proper units:  ec (C), N (molecules/m3), kB (J·K-1), T (K), 
mion and mgas (kg), V (V), td (s), L (m), and P (Torr). 
The CCS expression above is considered a first approximation due to the actual 
dependency on the cross section on the effective ion temperature (two-temperature theory, 
Mason & McDaniel 1988, Chapter 6-2-C), which is the gas temperature plus the field-
induced ion temperature.  In the Agilent IM-MS instrument described in this manuscript, 
for the smallest ion investigated (TAA3, m/z 186) at the highest drift field utilized (20 
V·cm-1 at 4 Torr, or ca. 15 Td) the field-induced ion temperature is ca. 3 K greater than the 
gas temperature (Wannier 1953).  This affects the magnitude of the CCS by less than 0.5% 
for the ions investigated in this work and so only the drift gas temperature is used for all 
CCS calculations.  For low mass ions where the CCS values are small, incorporating a 
higher-order (two- or three-temperature) scaling may be significant. 
RSD – Relative standard deviation represents the measurement precision (reported as a 
unitless percentage) and is calculated as follows: 
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𝑅𝑆𝐷 =
𝜎
𝑎𝑣𝑒𝑟𝑎𝑔𝑒
∙ 100      (C.4) 
Here, σ is the standard deviation from multiple measurements. 
Analyte Source – Can be either from a known analytical standard, or as a derivative signal 
which represents a concomitant ion signal that appears in the samples, often at lower 
abundances than the standard.  For example, the TAA salts were analyzed as received with 
a reported purity of 98%.  The instrument sensitivity was high enough to observe additional 
ions representing differences of CH2 (m/z 14), which is suggestive of low abundance 
impurities possessing various alkyl chain lengths.  Note that for the lipid samples, the 
analyte sources were biological extracts purified into specific lipid classes, thus analyte 
identifications are putatively based on the mass measurement and the expected mobility-
mass correlation trends. 
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Figure  C.1 Cation-Specific Conformational Space Analysis of Carbohydrates. Adapted from 
Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, 
Ruwan T. Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, 
George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of 
Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype 
High Resolution Drift Tube Ion Mobility-Mass Spectrometer,” Analytical Chemistry 2014, 
86 (4), 2107-2116. (https://pubs.acs.org/doi/10.1021/ac4038448) Note that further 
permissions related to the material excerpted should be directed to the ACS. 
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Figure  C.2 Class-Specific Mobility-Mass Correlations at Intermediate Mass-to-Charge. 
Adapted from Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb 
B. Morris, Ruwan T. Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, 
K. Imatani, George C. Stafford, John C. Fjeldsted, John A. McLean, “Conformational 
Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on 
a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer,” Analytical 
Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/doi/10.1021/ac4038448) Note 
that further permissions related to the material excerpted should be directed to the ACS. 
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Table C.1 Collision Cross-Section Database of Tetraalkylammonium Salt Cations. Adapted from 
Jody C. May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. 
Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, George C. 
Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules in the Gas 
Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion 
Mobility-Mass Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. 
(https://pubs.acs.org/doi/10.1021/ac4038448) Note that further permissions related to the 
material excerpted should be directed to the ACS. 
Analyte Z 
Exact 
m/z 
Meas-
ured 
m/z 
K0 
K0 
σ 
CCS 
CCS 
σ 
RSD 
(%) 
N Analyte Source 
Vendor 
Source 
TAA3 - 2H + 184.21 184.21 1.517 0.007 142.8 0.7 0.5% 14 Derivative Signal  
TAA3 + 186.22 186.22 1.506 0.010 144.0 0.7 0.5% 23 Analytical Standard Acros Organics  
TAA4 - CH4 + 226.25 226.25 1.306 0.005 163.9 0.6 0.3% 16 Derivative Signal  
TAA4 - (CH2) (peak 
1) 
+ 228.27 228.27 1.313 0.005 162.9 0.7 0.4% 15 Derivative Signal  
TAA4 - (CH2) (peak 
2) 
+ 228.27 228.27 1.326 0.006 161.3 0.7 0.5% 7 Derivative Signal  
TAA4 + 242.28 242.28 1.280 0.007 166.6 0.9 0.5% 16 Analytical Standard Sigma-Aldrich 
TAA5 - (CH2)2 - 2H + 268.30 268.30 1.166 0.004 181.9 0.6 0.3% 8 Derivative Signal  
TAA5 - (CH2)2 + 270.32 270.32 1.163 0.005 182.3 0.7 0.4% 16 Derivative Signal  
TAA5 - (CH2) + 284.33 284.33 1.155 0.006 183.2 0.9 0.5% 15 Derivative Signal  
TAA5 + 298.35 298.35 1.116 0.003 190.1 1.0 0.5% 28 Analytical Standard Acros Organics  
TAA6 - (CH2)3 - 2H + 310.34 310.35 1.046 0.003 201.5 0.7 0.3% 16 Derivative Signal  
TAA6 - (CH2)3 + 312.36 312.36 1.074 0.004 196.3 0.7 0.4% 16 Derivative Signal  
TAA6 - (CH2)2 + 326.38 326.38 1.032 0.004 203.7 0.7 0.4% 16 Derivative Signal  
TAA6 - (CH2) - 2H + 338.37 338.38 1.031 0.004 203.8 0.7 0.4% 15 Derivative Signal  
TAA6 - (CH2) + 340.39 340.40 1.008 0.002 208.4 0.4 0.2% 16 Derivative Signal  
TAA6 - 2H + 352.39 352.39 0.971 0.002 215.4 0.9 0.4% 31 Derivative Signal  
TAA6 + 354.41 354.41 0.986 0.003 213.5 1.0 0.5% 31 Analytical Standard Sigma-Aldrich 
TAA7 - (CH2)2 + 382.44 382.44 0.926 0.003 225.8 0.8 0.4% 16 Derivative Signal  
TAA7 - (CH2) (peak 
1) 
+ 396.46 396.45 0.913 0.004 228.7 1.1 0.5% 15 Derivative Signal  
TAA7 - (CH2) (peak 
2) 
+ 396.46 396.45 0.910 0.003 229.4 0.9 0.4% 13 Derivative Signal  
TAA7 - 2H + 408.46 408.46 0.898 0.004 232.3 0.8 0.3% 28 Derivative Signal  
TAA7 + 410.47 410.47 0.883 0.001 236.4 0.4 0.2% 31 Analytical Standard Sigma-Aldrich 
TAA8 - (CH2)2 - 2H + 436.49 436.49 0.852 0.002 244.4 0.6 0.3% 31 Derivative Signal  
TAA8 - (CH2)2 (peak 
1) 
+ 438.50 438.50 0.874 0.002 238.3 0.5 0.2% 16 Derivative Signal  
TAA8 - (CH2)2 (peak 
2) 
+ 438.50 438.50 0.855 0.002 243.6 0.7 0.3% 16 Derivative Signal  
TAA8 - (CH2) + 452.52 452.52 0.827 0.004 251.6 1.2 0.5% 16 Derivative Signal  
TAA8 - 2H + 464.52 464.52 0.818 0.003 254.3 0.9 0.4% 16 Derivative Signal  
TAA8 + 466.54 466.54 0.808 0.001 256.6 0.7 0.3% 31 Analytical Standard Acros Organics  
TAA10 - (CH2)7 + 480.55 480.55 0.791 0.003 262.5 1.1 0.4% 16 Derivative Signal  
TAA10 - (CH2)6 + 494.57 494.57 0.779 0.002 266.6 0.6 0.2% 31 Derivative Signal  
TAA10 - (CH2)5 + 508.58 508.58 0.769 0.002 269.9 0.7 0.3% 31 Derivative Signal  
TAA10 - (CH2)4 - 2H + 520.58 520.58 0.781 0.003 265.4 0.9 0.3% 16 Derivative Signal  
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TAA10 - (CH2)4 
(peak 1) 
+ 522.60 522.60 0.793 0.003 260.7 1.2 0.5% 31 Derivative Signal  
TAA10 - (CH2)4 
(peak 2) 
+ 522.60 522.60 0.754 0.003 275.5 1.0 0.4% 31 Derivative Signal  
TAA10 - (CH2)2 + 550.63 550.63 0.729 0.002 284.7 0.9 0.3% 28 Derivative Signal  
TAA10 - (CH2) + 564.64 564.64 0.711 0.002 290.8 0.6 0.2% 28 Derivative Signal  
TAA10 + 578.66 578.66 0.702 0.001 293.5 0.7 0.2% 28 Analytical Standard Sigma-Aldrich 
TAA12 - (CH2)7 + 592.68 592.66 0.697 0.002 296.0 0.8 0.3% 27 Derivative Signal  
TAA12 - (CH2)6 + 606.69 606.68 0.686 0.003 301.5 1.3 0.4% 28 Derivative Signal  
TAA12 - (CH2)4 + 634.72 634.72 0.668 0.003 308.6 1.3 0.4% 14 Derivative Signal  
TAA12 - (CH2)3 + 648.74 648.74 0.649 0.002 317.6 1.2 0.4% 9 Derivative Signal  
TAA12 - (CH2)2 + 662.75 662.75 0.655 0.002 316.3 1.6 0.5% 22 Derivative Signal  
TAA12 - (CH2) + 676.77 676.77 0.641 0.002 320.1 1.5 0.5% 21 Derivative Signal  
TAA12 + 690.79 690.79 0.644 0.002 319.0 0.9 0.2% 24 Analytical Standard Sigma-Aldrich 
TAA16 - (CH2)15 + 704.80 704.80 0.627 0.000 325.5 1.6 0.5% 18 Derivative Signal  
TAA16 - (CH2)14 + 718.82 718.82 0.625 0.002 327.2 1.6 0.5% 22 Derivative Signal  
TAA16 - (CH2)12 + 746.85 746.85 0.624 0.002 329.6 1.0 0.3% 12 Derivative Signal  
TAA16 - (CH2)11 + 760.86 760.86 0.611 0.003 336.3 1.6 0.5% 9 Derivative Signal  
TAA16 - (CH2)10 - 
2H 
+ 772.86 772.87 0.613 0.002 335.3 1.0 0.3% 11 Derivative Signal  
TAA16 - (CH2)10 + 774.88 774.88 0.619 0.001 332.1 0.4 0.1% 12 Derivative Signal  
TAA16 - (CH2)2 + 887.00 887.01 0.562 0.002 364.6 1.3 0.4% 9 Derivative Signal  
TAA16 - (CH2) + 901.02 901.03 0.584 0.002 350.9 1.3 0.4% 8 Derivative Signal  
TAA16 + 915.04 915.04 0.569 0.004 360.3 0.9 0.2% 25 Analytical Standard Sigma-Aldrich 
TAA18 - (CH2)7 + 929.05 929.04 0.577 0.003 355.1 1.8 0.5% 10 Derivative Signal  
TAA18 - (CH2)6 + 943.07 943.07 0.554 0.002 369.7 1.4 0.4% 10 Derivative Signal  
TAA18 - (CH2)4 + 971.10 971.09 0.578 0.002 354.5 1.4 0.4% 6 Derivative Signal  
TAA18 - (CH2)2 + 999.13 999.12 0.540 0.002 379.2 1.2 0.3% 6 Derivative Signal  
TAA18 + 1027.16 1027.16 0.538 0.002 379.0 1.7 0.3% 6 Analytical Standard Alfa Aesar 
TAA (1064) + 1064.17 1064.15 0.521 0.002 392.7 1.3 0.3% 8 Derivative Signal   
TAA (1120) + 1120.23 1120.22 0.495 0.002 412.8 1.9 0.5% 6 Derivative Signal   
TAA (1232) + 1232.36 1232.34 0.476 0.002 428.6 1.9 0.4% 6 Derivative Signal   
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Table C.2 Collision Cross-Section Database of Carbohydrates. Adapted from Jody C. May, Cody R. 
Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. Kurulugama, A. 
Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, George C. Stafford, John C. 
Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen 
Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass 
Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/ 
doi/10.1021/ac4038448) Note that further permissions related to the material excerpted should 
be directed to the ACS. 
Analyte Z 
Exact 
m/z 
Meas-
ured 
m/z 
K0 
K0 
σ 
CCS 
CC
S 
σ 
RSD 
(%) 
N 
Analyte 
Source 
Vendor 
Source 
Mannitol +Li 189.10 189.10 1.497 0.001 144.5 0.1 0.1% 14 Analytical Standard Sigma-Aldrich 
Sorbitol +H 189.10 189.09 1.470 0.004 147.2 0.4 0.3% 8 Analytical Standard Sigma-Aldrich 
Mannitol +Na 205.07 205.07 1.531 0.006 140.6 0.5 0.4% 14 Analytical Standard Sigma-Aldrich 
Sorbitol (peak 1) +Na 205.07 205.07 1.544 0.004 139.4 0.3 0.2% 8 Analytical Standard Sigma-Aldrich 
(Hex)2 - H2O +Na 347.10 347.09 1.220 0.006 172.0 0.8 0.5% 14 Derivative Signal  
Lactose +Li 349.13 349.13 1.126 0.003 186.3 0.5 0.3% 7 Analytical Standard Sigma-Aldrich 
Lactose/Mannose 
Mixture 
+Na 365.11 365.11 1.178 0.005 177.8 0.8 0.4% 15 Analytical Standard Sigma-Aldrich 
Lactose +Na 365.11 365.10 1.176 0.002 178.1 0.3 0.1% 8 Analytical Standard Sigma-Aldrich 
Lactose/Mannose 
Mixture 
+K 381.08 381.08 1.155 0.005 181.1 0.8 0.5% 16 Analytical Standard Sigma-Aldrich 
HexNAc-Hex - H2O +Na 388.12 388.12 1.134 0.004 184.3 0.6 0.3% 16 Derivative Signal  
HexNAc-Hex +Na 406.13 406.14 1.097 0.003 190.2 0.5 0.3% 16 Derivative Signal  
HexNAc-Hex +K 422.11 422.11 1.091 0.003 191.1 0.6 0.3% 16 Derivative Signal  
Hex-(Fuc)2 - H2O 
(peak 1) 
+H 455.18 455.18 1.071 0.005 194.2 0.9 0.5% 13 Derivative Signal  
Hex-(Fuc)2 - H2O 
(peak 2) 
+H 455.18 455.18 1.053 0.004 197.6 0.8 0.4% 9 Derivative Signal  
Maltotriose +H 505.18 505.18 0.959 0.005 216.3 1.0 0.5% 14 Analytical Standard Sigma-Aldrich 
Melezitose +H 505.18 505.18 1.023 0.005 202.6 1.0 0.5% 10 Analytical Standard Sigma-Aldrich 
(Hex)3 - H2O +Na 509.15 509.15 1.012 0.003 204.9 0.7 0.3% 16 Derivative Signal  
Melezitose +Li 511.19 511.18 1.022 0.001 202.9 0.3 0.1% 14 Analytical Standard Sigma-Aldrich 
HexNAc-Fuc-Hex - 
H2O 
+H 512.20 512.20 0.996 0.003 208.2 0.5 0.3% 16 Derivative Signal  
Melezitose +Na 527.16 527.16 0.974 0.004 212.8 0.8 0.4% 16 Analytical Standard Sigma-Aldrich 
Maltotriose +Na 527.16 527.16 1.022 0.001 202.7 0.2 0.1% 14 Analytical Standard Sigma-Aldrich 
Raffinose +Na 527.16 527.15 0.983 0.001 210.7 0.2 0.1% 8 Analytical Standard Sigma-Aldrich 
HexNAc-Fuc-Hex - 
H2O 
+Na 534.18 534.17 0.969 0.005 213.7 1.1 0.5% 16 Derivative Signal  
Maltotriose +K 543.13 543.13 0.955 0.003 216.8 0.7 0.3% 16 Analytical Standard Sigma-Aldrich 
melezitose +K 543.13 543.13 0.933 0.004 221.9 0.9 0.4% 14 Analytical Standard Sigma-Aldrich 
Raffinose +K 543.13 543.13 0.973 0.002 212.7 0.3 0.2% 8 Analytical Standard Sigma-Aldrich 
HexNAc-(Hex)2 - 
H2O 
+Na 550.17 550.17 0.957 0.005 216.3 1.0 0.5% 15 Derivative Signal  
HexNAc-Fuc-Hex +Na 552.19 552.18 0.969 0.005 213.6 1.1 0.5% 13 Derivative Signal  
HexNAc-(Hex)2 +Na 568.19 568.18 0.940 0.004 220.0 1.0 0.5% 16 Derivative Signal  
Melezitose (peak 1) +Rb 589.08 589.08 1.012 0.001 204.1 0.2 0.1% 13 Analytical Standard Sigma-Aldrich 
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Melezitose (peak 2) +Rb 589.08 589.08 0.943 0.004 219.2 0.9 0.4% 13 Analytical Standard Sigma-Aldrich 
Raffinose (peak 1) +Rb 589.08 589.09 0.945 0.004 218.7 0.9 0.4% 7 Analytical Standard Sigma-Aldrich 
Raffinose (peak 2) +Rb 589.08 589.09 0.900 0.003 229.7 0.9 0.4% 7 Analytical Standard Sigma-Aldrich 
Melezitose +Cs 637.07 637.07 1.002 0.001 205.8 0.2 0.1% 14 Analytical Standard Sigma-Aldrich 
(Hex)4 - H2O +H 649.22 649.21 0.878 0.004 234.7 1.2 0.5% 15 Derivative Signal  
HexNAc-(Fuc)2-Hex  
- H2O 
+H 658.26 658.25 0.827 0.004 249.3 1.1 0.4% 14 Derivative Signal  
Maltotetraose +H 667.23 667.23 0.865 0.004 238.3 1.2 0.5% 14 Analytical Standard Sigma-Aldrich 
(Hex)4 - H2O +Na 671.20 671.20 0.877 0.003 234.8 0.8 0.3% 16 Derivative Signal  
HexNAc-(Fuc)2-Hex 
- H2O 
+Na 680.24 680.23 0.858 0.004 240.2 1.1 0.5% 16 Derivative Signal  
Maltotetraose +Na 689.21 689.21 0.875 0.002 235.3 0.5 0.2% 16 Analytical Standard Sigma-Aldrich 
HexNAc-Fuc-(Hex)2 
- H2O 
+Na 696.23 696.23 0.845 0.004 243.8 1.2 0.5% 16 Derivative Signal  
(Hex)4 +K 705.19 705.18 0.870 0.003 236.6 0.8 0.3% 16 Derivative Signal  
HexNAc-(Hex)3 - 
H2O 
+Na 712.23 712.22 0.840 0.003 244.9 1.0 0.4% 16 Derivative Signal  
HexNAc-Fuc-(Hex)2 +Na 714.24 714.24 0.822 0.004 250.3 1.2 0.5% 16 Derivative Signal  
HexNAc-(Hex)3 +Na 730.24 730.23 0.843 0.002 244.0 0.4 0.2% 16 Derivative Signal  
HexNAc-(Hex)3 +K 746.21 746.20 0.829 0.004 248.2 1.1 0.5% 16 Derivative Signal  
(Hex)5 - H2O +H 811.27 811.27 0.727 0.002 282.3 0.7 0.3% 14 Derivative Signal  
(Hex)5 - H2O +Na 833.25 833.25 0.780 0.002 263.1 0.8 0.3% 16 Derivative Signal  
(Hex)5 +Na 851.26 851.26 0.791 0.003 259.5 0.8 0.3% 16 Derivative Signal  
HexNAc-Fuc-(Hex)3 
- H2O (peak 1) 
+Na 858.29 858.28 0.780 0.004 263.1 1.3 0.5% 14 Derivative Signal  
HexNAc-Fuc-(Hex)3 
- H2O (peak 2) 
+Na 858.29 858.28 0.783 0.003 262.0 0.9 0.3% 7 Derivative Signal  
HexNAc-(Fuc)2-
(Hex)2 
+Na 860.30 860.30 0.752 0.004 272.8 1.4 0.5% 16 Derivative Signal  
Lacto-N-
Fucopentaose I 
+Li 860.32 860.32 0.761 0.002 269.6 0.6 0.2% 14 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Fucopentaose II 
+Na 876.30 876.29 0.756 0.001 271.1 0.3 0.1% 8 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Fucopentaose I 
+Na 876.30 876.29 0.743 0.001 276.1 0.4 0.1% 13 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Fucopentaose II 
+K 892.27 892.26 0.767 0.002 267.2 0.7 0.3% 8 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Fucopentaose I 
+K 892.27 892.27 0.746 0.001 274.7 0.5 0.2% 14 Analytical Standard 
Dextra 
Laboratories 
HexNAc-(Hex)4 
(peak 1) 
+Na 892.29 892.27 0.751 0.004 272.9 1.3 0.5% 16 Derivative Signal  
HexNAc-(Hex)4 
(peak 2) 
+Na 892.29 892.27 0.744 0.002 275.5 0.9 0.3% 16 Derivative Signal  
Lacto-N-
Fucopentaose II 
+Rb 938.22 938.21 0.736 0.003 278.4 1.0 0.4% 7 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Fucopentaose I 
+Rb 938.22 938.21 0.744 0.002 275.2 0.8 0.3% 13 Analytical Standard 
Dextra 
Laboratories 
Alpha-Cyclodextrin +H 973.32 973.32 0.718 0.002 285.2 0.8 0.3% 14 Analytical Standard Sigma-Aldrich 
Lacto-N-
Fucopentaose I 
+Cs 986.21 986.21 0.743 0.003 275.6 0.9 0.3% 14 Analytical Standard 
Dextra 
Laboratories 
HexNAc-(Fuc)4-Hex 
(peak 1) 
+Na 990.36 990.35 0.728 0.002 281.2 0.7 0.2% 14 Derivative Signal  
HexNAc-(Fuc)4-Hex 
(peak 2) 
+Na 990.36 990.35 0.726 0.001 282.1 0.5 0.2% 6 Derivative Signal  
Alpha-Cyclodextrin +Na 995.31 995.31 0.717 0.001 285.5 0.4 0.1% 14 Analytical Standard Sigma-Aldrich 
Lacto-N-
Difucohexaose I 
+Li 1006.38 1006.38 0.679 0.001 301.4 0.3 0.1% 14 Analytical Standard 
Dextra 
Laboratories 
Alpha-Cyclodextrin +K 1011.28 1011.28 0.711 0.001 287.7 0.6 0.2% 14 Analytical Standard Sigma-Aldrich 
Maltohexaose +Na 1013.32 1013.31 0.714 0.002 286.4 0.7 0.2% 14 Analytical Standard Sigma-Aldrich 
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Lacto-N-
Difucohexaose II 
(peak 1) 
+Na 1022.35 1022.34 0.703 0.003 291.2 1.4 0.5% 8 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Difucohexaose II 
(peak 2) 
+Na 1022.35 1022.34 0.668 0.001 306.3 0.6 0.2% 8 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Difucohexaose I 
(peak 1) 
+Na 1022.35 1022.35 0.704 0.003 290.6 1.3 0.5% 14 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Difucohexaose I 
(peak 2) 
+Na 1022.35 1022.35 0.673 0.001 304.2 0.5 0.2% 14 Analytical Standard 
Dextra 
Laboratories 
Maltohexaose +K 1029.29 1029.29 0.698 0.002 293.3 0.6 0.2% 14 Analytical Standard Sigma-Aldrich 
Lacto-N-
Difucohexaose II 
+K 1038.33 1038.31 0.669 0.002 305.8 0.8 0.3% 8 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Difucohexaose I 
+K 1038.33 1038.33 0.674 0.001 303.5 0.4 0.1% 14 Analytical Standard 
Dextra 
Laboratories 
(HexNAc)2-(Hex)3-
Fuc (peak 2) 
+Na 1079.38 1079.37 0.692 0.003 295.5 1.4 0.5% 12 Derivative Signal  
(HexNAc)2-(Hex)3-
Fuc (peak 1) 
+Na 1079.38 1079.37 0.668 0.003 306.0 1.5 0.5% 10 Derivative Signal  
Lacto-N-
Difucohexaose I 
+Rb 1084.28 1084.27 0.674 0.002 303.2 0.7 0.2% 14 Analytical Standard 
Dextra 
Laboratories 
Lacto-N-
Difucohexaose I 
+Cs 1132.27 1132.27 0.679 0.002 301.2 0.7 0.2% 14 Analytical Standard 
Dextra 
Laboratories 
Beta-Cyclodextrin 
(peak 1) 
+H 1135.38 1135.37 0.678 0.002 301.3 0.9 0.3% 14 Analytical Standard Sigma-Aldrich 
Beta-Cyclodextrin 
(peak 2) 
+H 1135.38 1135.37 0.639 0.002 319.6 1.2 0.4% 12 Analytical Standard Sigma-Aldrich 
HexNAc-(Fuc)4-
(Hex)2 
+Na 1152.42 1152.40 0.646 0.002 316.1 0.9 0.3% 12 Derivative Signal  
Maltoheptaose +H 1153.39 1153.39 0.674 0.002 303.3 0.7 0.2% 14 Analytical Standard Sigma-Aldrich 
Beta-Cyclodextrin +Na 1157.36 1157.36 0.639 0.000 319.7 0.7 0.2% 11 Analytical Standard Sigma-Aldrich 
HexNAc-(Fuc)3-
(Hex)3 
+Na 1168.41 1168.41 0.626 0.003 326.3 1.5 0.4% 11 Derivative Signal  
Beta-Cyclodextrin +K 1173.33 1173.33 0.638 0.001 320.3 0.5 0.2% 12 Analytical Standard Sigma-Aldrich 
Maltoheptaose +Na 1175.37 1175.37 0.674 0.001 303.1 0.5 0.2% 14 Analytical Standard Sigma-Aldrich 
Maltoheptaose +K 1191.34 1191.34 0.673 0.001 303.4 0.5 0.2% 14 Analytical Standard Sigma-Aldrich 
(Hex)8  - H2O +H 1297.43 1297.42 0.611 0.001 333.8 0.8 0.2% 12 Derivative Signal  
Gamma-Cyclodextrin +H 1297.43 1297.43 0.633 0.001 322.6 0.7 0.2% 12 Analytical Standard Sigma-Aldrich 
Gamma-Cyclodextrin +Li 1303.44 1303.44 0.642 0.001 317.7 0.4 0.1% 12 Analytical Standard Sigma-Aldrich 
Gamma-Cyclodextrin +Na 1319.41 1319.42 0.633 0.001 322.1 0.5 0.2% 12 Analytical Standard Sigma-Aldrich 
Gamma-Cyclodextrin +K 1335.39 1335.39 0.628 0.001 324.8 0.5 0.2% 12 Analytical Standard Sigma-Aldrich 
(Hex)8 (peak 1) +Na 1337.42 1337.42 0.636 0.003 320.9 1.3 0.4% 7 Derivative Signal  
(Hex)8 (peak 2) +Na 1337.42 1337.42 0.602 0.001 338.8 0.7 0.2% 10 Derivative Signal  
HexNAc-(Hex)7 
(peak 1) 
+Na 1378.45 1378.45 0.612 0.003 333.4 1.7 0.5% 11 Derivative Signal  
HexNAc-(Hex)7 
(peak 2) 
+Na 1378.45 1378.45 0.593 0.001 343.7 0.8 0.2% 10 Derivative Signal  
Gamma-Cyclodextrin +Rb 1381.33 1381.33 0.623 0.001 327.3 0.6 0.2% 12 Analytical Standard Sigma-Aldrich 
Gamma-Cyclodextrin +Cs 1429.33 1429.33 0.603 0.001 338.2 0.6 0.2% 10 Analytical Standard Sigma-Aldrich 
(Hex)9 - H2O +H 1459.48 1459.48 0.577 0.002 353.3 1.2 0.4% 10 Derivative Signal  
(Hex)9 (peak 1) +Na 1499.48 1499.48 0.598 0.003 340.5 1.6 0.5% 10 Derivative Signal  
(Hex)9 (peak 2) +Na 1499.48 1499.48 0.579 0.002 351.9 1.5 0.4% 10 Derivative Signal  
HexNAc-(Hex)8 +H 1518.52 1518.52 0.586 0.003 347.8 1.5 0.4% 10 Derivative Signal  
HexNAc-(Hex)8 
(peak 1) 
+Na 1540.50 1540.50 0.575 0.003 354.2 1.7 0.5% 10 Derivative Signal  
HexNAc-(Hex)8 
(peak 2) 
+Na 1540.50 1540.50 0.579 0.003 351.6 1.5 0.4% 8 Derivative Signal  
(Hex)10  - H2O +H 1621.54 1621.54 0.531 0.001 383.4 0.9 0.2% 8 Derivative Signal  
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HexNAc-(Fuc)2-
(Hex)7  - H2O 
+H 1630.57 1630.58 0.556 0.001 366.1 0.8 0.2% 10 Derivative Signal  
(Hex)10 (peak 1) +H 1639.55 1639.55 0.558 0.002 365.1 1.4 0.4% 9 Derivative Signal  
(Hex)10 (peak 2) +H 1639.55 1639.55 0.522 0.001 390.3 0.8 0.2% 8 Derivative Signal  
(Hex)10 (peak 1) +Na 1661.53 1661.53 0.558 0.002 365.1 1.3 0.4% 10 Derivative Signal  
(Hex)10 (peak 2) +Na 1661.53 1661.53 0.545 0.002 373.8 1.1 0.3% 8 Derivative Signal  
(Hex)11  - H2O +H 1783.59 1783.60 0.537 0.002 379.1 1.5 0.4% 6 Derivative Signal  
(Hex)11 +Li 1807.61 1807.59 0.546 0.002 372.4 1.1 0.3% 8 Derivative Signal  
(Hex)11 +Na 1823.58 1823.60 0.529 0.002 384.6 1.4 0.4% 8 Derivative Signal  
(Hex)11 (peak 1) +K 1839.56 1839.53 0.554 0.002 367.4 1.6 0.4% 7 Derivative Signal  
(Hex)11 (peak 2) +K 1839.56 1839.53 0.550 0.002 369.7 1.4 0.4% 8 Derivative Signal  
(Hex)11 (peak 1) +Rb 1885.50 1885.48 0.556 0.002 365.7 1.3 0.4% 8 Derivative Signal  
(Hex)11 (peak 2) +Rb 1885.50 1885.48 0.546 0.002 372.5 1.5 0.4% 6 Derivative Signal  
(Hex)12  - H2O (peak 
1) 
+H 1945.64 1945.65 0.508 0.001 400.3 0.6 0.1% 8 Derivative Signal  
(Hex)12  - H2O (peak 
2) 
+H 1945.64 1945.65 0.481 0.001 422.9 1.3 0.3% 6 Derivative Signal  
(Hex)12  - H2O (peak 
1) 
+Na 1967.62 1967.63 0.520 0.001 390.6 0.9 0.2% 8 Derivative Signal  
(Hex)12  - H2O (peak 
2) 
+Na 1967.62 1967.63 0.496 0.002 410.0 1.4 0.4% 6 Derivative Signal  
(Hex)13 (peak 1) +Na 2147.69 2147.72 0.504 0.001 402.7 1.0 0.2% 6 Derivative Signal  
(Hex)13 (peak 2) +Na 2147.69 2147.72 0.494 0.001 411.6 1.1 0.3% 6 Derivative Signal  
 
  
194
  
 
Table C.3 Collision Cross-Section Database of Peptides. Adapted from Jody C. May, Cody R. 
Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. Kurulugama, A. 
Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, George C. Stafford, John C. 
Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen 
Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass 
Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/ 
doi/10.1021/ac4038448) Note that further permissions related to the material excerpted should 
be directed to the ACS. 
Analyte Z 
Exact 
m/z 
Meas-
ured 
m/z 
K0 
K0 
σ 
CCS 
CCS 
σ 
RSD 
(%) 
N 
Analyte 
Source 
Vendor 
Source 
Source 
Protein 
DGDK +H 434.19 434.19 1.064 0.004 195.8 0.7 0.3% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
YVR +H 437.25 437.25 1.006 0.002 207.0 0.4 0.2% 8 
Analytical 
Standard 
Waters ADH_YST 
DVCK +H 464.22 464.22 1.016 0.004 204.7 0.7 0.4% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
WIR +H 474.28 474.27 0.964 0.003 215.4 0.7 0.3% 8 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
GVFR +H 478.28 478.28 0.967 0.001 214.8 0.3 0.1% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
SDGRG +H 491.22 491.22 1.015 0.003 204.6 0.5 0.3% 11 
Analytical 
Standard 
Sigma-
Aldrich 
SYNTHET
IC 
GRGDS +H 491.22 491.22 1.008 0.001 205.9 0.2 0.1% 14 
Analytical 
Standard 
Sigma-
Aldrich 
SYNTHET
IC 
FGER +H 508.25 508.24 0.955 0.002 217.1 0.4 0.2% 8 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
VYAR +H 508.29 508.29 0.912 0.001 227.2 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
SDGRG +Na 513.20 513.20 1.018 0.002 203.5 0.5 0.2% 11 
Analytical 
Standard 
Sigma-
Aldrich 
SYNTHET
IC 
GRGDS +Na 513.20 513.20 0.996 0.002 208.2 0.3 0.2% 14 
Analytical 
Standard 
Sigma-
Aldrich 
SYNTHET
IC 
ADLAK +H 517.30 517.30 0.908 0.004 228.3 1.1 0.5% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
QENK +H 518.26 518.26 0.946 0.003 219.0 0.6 0.3% 6 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
MVIR +H 518.31 518.31 0.906 0.001 228.7 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
WMGK +H 521.25 521.26 0.941 0.002 220.1 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
SDGRG +K 529.18 529.17 1.009 0.004 205.4 0.8 0.4% 10 
Analytical 
Standard 
Sigma-
Aldrich 
SYNTHET
IC 
GRGDS +K 529.18 529.18 0.984 0.001 210.4 0.2 0.1% 14 
Analytical 
Standard 
Sigma-
Aldrich 
SYNTHET
IC 
FWGK +H 537.28 537.28 0.896 0.003 231.0 0.8 0.3% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
VASLR +H 545.34 545.34 0.890 0.001 232.5 0.3 0.1% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
QENK +H 549.31 549.31 0.889 0.001 232.8 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
NFNR +H 550.27 550.27 0.920 0.002 225.0 0.6 0.3% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
LEYK +H 552.30 552.30 0.863 0.003 239.6 0.9 0.4% 7 
Analytical 
Standard 
Waters ADH_YST 
FQNK +Na 559.27 559.27 0.848 0.005 243.9 1.4 0.6% 5 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
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FQNK +Na 569.31 569.31 0.945 0.002 218.9 0.6 0.3% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
EWTR +H 591.29 591.29 0.885 0.001 233.4 0.4 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
AMGYR +H 597.28 597.28 0.843 0.001 245.0 0.3 0.1% 7 
Analytical 
Standard 
Waters ADH_YST 
QISVR +H 602.36 602.36 0.855 0.001 241.4 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
LWSAK +H 604.35 604.34 0.865 0.001 238.6 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
AFDEK +H 609.29 609.29 0.867 0.001 238.3 0.3 0.1% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
FSSDR +H 611.28 611.28 0.870 0.001 237.3 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
FVVPR (peak 1) +H 617.38 617.37 0.810 0.002 254.7 0.7 0.3% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
FVVPR (peak2) +H 617.38 617.37 0.828 0.001 249.3 0.4 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
GQIVGR +H 629.37 629.37 0.840 0.001 245.5 0.3 0.1% 7 
Analytical 
Standard 
Waters ADH_YST 
VSLAEK +H 646.38 646.38 0.828 0.001 249.0 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
IETMR or 
CASIQK 
+H 649.33 649.33 0.815 0.001 252.8 0.4 0.2% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
AAGHDGK +H 655.32 655.32 0.828 0.002 249.0 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
NVATPR +H 657.37 657.37 0.811 0.001 254.0 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
ANIDVK +H 659.37 659.37 0.831 0.001 248.1 0.4 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
VSALYK (peak 1) +H 680.40 680.40 0.787 0.001 261.8 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
VSALYK (peak 2) +H 680.40 680.40 0.811 0.001 254.0 0.4 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
IHEYK +H 689.36 689.37 0.797 0.001 258.5 0.2 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
NIATSGK +H 690.38 690.38 0.801 0.001 257.2 0.3 0.1% 8 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
EELFR +H 693.36 693.35 0.810 0.001 254.1 0.3 0.1% 8 
Analytical 
Standard 
Waters ADH_YST 
DHLVGR +H 696.38 696.38 0.826 0.002 249.4 0.6 0.2% 8 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
TVMIGGK +H 705.40 705.40 0.785 0.001 262.2 0.4 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
GVLHAVK +H 723.45 723.45 0.762 0.001 269.9 0.4 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
SVYDSR +H 726.34 726.34 0.796 0.002 258.4 0.6 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
VEDVDR +H 732.35 732.35 0.801 0.001 256.6 0.5 0.2% 8 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
NVPLYK +H 733.42 733.42 0.756 0.001 272.2 0.4 0.1% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
QPDLFK +H 745.45 745.44 0.746 0.001 275.5 0.3 0.1% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
LNQLLR +H 756.47 756.47 0.746 0.001 275.6 0.4 0.1% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
TNGITPR (peak 
1) 
+H 758.42 758.41 0.733 0.001 280.4 0.3 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
TNGITPR (peak 
2) 
+H 758.42 758.41 0.762 0.001 269.8 0.5 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
TNGITPR (peak 
3) 
+H 758.42 758.41 0.795 0.001 258.4 0.4 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
HLADLSK +H 783.44 783.43 0.752 0.001 273.3 0.5 0.2% 6 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
LVTDLTK +H 789.47 789.47 0.743 0.001 276.6 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
YDLDFK +H 800.38 800.38 0.754 0.001 272.4 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
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TFAEALR +H 807.44 807.43 0.724 0.001 283.5 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
YVVDTSK +H 811.42 811.42 0.746 0.001 275.2 0.3 0.1% 7 
Analytical 
Standard 
Waters ADH_YST 
AADALLLK or 
DIVGAVLK 
+H 814.50 814.50 0.704 0.001 291.8 0.4 0.1% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST or 
ADH_YST 
AADALLLK or 
DIVGAVLK 
+H 814.50 814.50 0.739 0.001 277.8 0.3 0.1% 7 
Analytical 
Standard 
Waters 
ENOLASE
_YST or 
ADH_YST 
ATEEQLK +H 818.43 818.42 0.730 0.001 281.3 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
TIAQYAR +H 822.45 822.45 0.729 0.001 281.6 0.5 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
AWEVTVK +H 832.46 832.45 0.736 0.000 279.0 0.7 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
IGDYAGIK +H 836.45 836.45 0.718 0.001 285.9 0.3 0.1% 6 
Analytical 
Standard 
Waters ADH_YST 
VLVDLER +H 843.49 843.49 0.718 0.001 285.7 0.4 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
FAAYLER +H 869.45 869.45 0.694 0.001 295.5 0.4 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
YGNPWEK +H 893.42 893.41 0.722 0.001 283.8 0.6 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
DIPVPKPK +H 893.55 893.54 0.697 0.002 294.2 0.7 0.2% 7 
Analytical 
Standard 
Waters ADH_YST 
NLAENISR +H 916.48 916.48 0.703 0.001 291.7 0.6 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
APNDFNLK +H 918.47 918.46 0.683 0.001 300.0 0.6 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
AEFVEVTK +H 922.49 922.49 0.693 0.001 295.7 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
YLYEIAR +H 927.49 927.49 0.672 0.001 305.0 0.5 0.2% 7 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
VLGIDGGEGK +H 944.50 944.50 0.703 0.000 291.2 0.2 0.1% 7 
Analytical 
Standard 
Waters ADH_YST 
NNVVNTMR +H 947.47 947.47 0.681 0.001 300.7 0.6 0.2% 8 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
EALDFFAR +H 968.48 968.48 0.669 0.001 305.9 0.4 0.1% 7 
Analytical 
Standard 
Waters ADH_YST 
LVVSTQTALA +H 1002.58 1002.58 0.649 0.001 315.6 0.3 0.1% 6 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
ANELLINVK +H 1013.60 1013.60 0.626 0.001 326.8 0.3 0.1% 6 
Analytical 
Standard 
Waters ADH_YST 
VIFLENYR +H 1053.57 1053.57 0.643 0.001 318.3 0.4 0.1% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
EIWGVEPSR +H 1072.54 1072.54 0.639 0.001 320.2 0.6 0.2% 7 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
VAAAFPGDVDR 
(peak1) 
+H 1117.56 1117.56 0.626 0.001 326.7 0.5 0.2% 5 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
VAAAFPGDVDR 
(peak 2) 
+H 1117.56 1117.56 0.630 0.001 324.3 0.4 0.1% 6 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
GVIFYESHGK +H 1136.57 1136.57 0.614 0.001 332.9 0.5 0.2% 5 
Analytical 
Standard 
Waters ADH_YST 
IGSEVYHNLK +H 1159.61 1159.61 0.586 0.001 348.4 0.7 0.2% 5 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
LVNELTEFAK +H 1163.63 1163.63 0.593 0.000 344.4 0.2 0.1% 5 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
SISIVGSYVGNR +H 1251.67 1251.67 0.585 0.001 349.1 0.8 0.2% 6 
Analytical 
Standard 
Waters ADH_YST 
VFADYEEYVK +H 1262.59 1262.59 0.557 0.002 366.4 1.2 0.3% 6 
Analytical 
Standard 
Waters 
PHOSPH_
RAB 
VNQIGTLSESIK +H 1288.71 1288.71 0.569 0.001 358.7 0.5 0.1% 5 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
SIGGEVFIDFTK +H 1312.68 1312.68 0.534 0.001 382.3 0.9 0.2% 5 
Analytical 
Standard 
Waters ADH_YST 
TVMENFVAFVDK +H 1399.69 1399.69 0.522 0.003 390.2 1.9 0.5% 5 
Analytical 
Standard 
Waters 
ALBUMIN
_BOV 
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AVDDFLISLDGTA
NK 
+H 1578.80 1578.80 0.474 0.001 429.7 0.7 0.2% 6 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
TAGIQIVADDLTV
TNPK 
+H 1755.95 1755.95 0.452 0.000 450.6 0.5 0.1% 4 
Analytical 
Standard 
Waters 
ENOLASE
_YST 
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Table C.4 Collision Cross-Section Database of Lipids. Adapted from Jody C. May, Cody R. Goodwin, 
Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. Kurulugama, A. Mordehai, C. 
Klein, W. Barry, E. Darland, G. Overney, K. Imatani, George C. Stafford, John C. Fjeldsted, John A. 
McLean, “Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross 
Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer,” 
Analytical Chemistry 2014, 86 (4), 2107-2116. (https://pubs.acs.org/doi/10.1021/ac4038448) 
Note that further permissions related to the material excerpted should be directed to the ACS. 
Analyte Z 
Exact 
m/z 
Meas-
ured 
m/z 
K0 
K0 
σ 
CCS 
CCS 
σ 
RSD 
(%) 
N Analyte Source Vendor Source 
GlcCer 34:01 +Na 722.55 722.55 0.742 0.002 277.3 0.8 0.3% 15 Analytical Standard Avanti Polar Lipids 
GlcCer 34:00 +Na 724.57 724.56 0.730 0.002 281.7 0.7 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 36:02 +Na 748.57 748.56 0.727 0.002 282.6 0.6 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 36:01 +Na 750.59 750.58 0.717 0.001 286.7 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 37:01 +Na 764.60 764.59 0.717 0.002 286.8 0.9 0.3% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 36:01 h +Na 766.58 766.58 0.705 0.001 291.5 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 38:02 +Na 776.60 776.60 0.705 0.002 291.4 1.0 0.3% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 38:01 +Na 778.62 778.61 0.699 0.001 293.8 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 38:00 +Na 780.63 780.63 0.695 0.001 295.6 0.5 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 38:02 h +Na 792.60 792.59 0.692 0.002 296.6 0.8 0.3% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 38:01 h +Na 794.61 794.61 0.690 0.001 297.7 0.5 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 40:03 +Na 802.62 802.61 0.694 0.003 295.8 1.3 0.4% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 40:02 +Na 804.63 804.63 0.691 0.002 297.1 0.6 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 40:01 +Na 806.65 806.65 0.682 0.001 301.1 0.5 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 40:00 +Na 808.66 808.66 0.679 0.001 302.3 0.5 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 41:02 +Na 818.65 818.64 0.685 0.001 299.6 0.6 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 41:01 +Na 820.66 820.65 0.679 0.001 302.5 0.5 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 40:01 h +Na 822.64 822.64 0.677 0.001 303.4 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 40:00 h +Na 824.66 824.65 0.671 0.001 306.1 0.6 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 42:03 +Na 830.65 830.64 0.679 0.001 302.3 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 42:02 +Na 832.66 832.67 0.672 0.001 305.2 0.5 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 42:01 +Na 834.68 834.68 0.667 0.001 307.5 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 42:00 +Na 836.70 836.68 0.666 0.001 308.2 0.5 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 43:03 +Na 844.66 844.65 0.670 0.002 306.1 0.7 0.2% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 43:02 +Na 846.68 846.67 0.667 0.002 307.8 1.0 0.3% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 42:02 h +Na 848.66 848.66 0.664 0.001 309.0 0.4 0.1% 14 Analytical Standard Avanti Polar Lipids 
GlcCer 42:01 h +Na 850.67 850.68 0.656 0.001 312.7 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 44:03 +Na 858.68 858.67 0.660 0.001 310.7 0.7 0.2% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 44:02 +Na 860.70 860.69 0.651 0.001 315.3 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 43:02 h +Na 862.67 862.69 0.652 0.001 314.6 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 43:01 h +Na 864.69 864.68 0.654 0.001 313.7 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 44:04 h +Na 872.66 872.65 0.652 0.001 314.7 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 44:03 h +Na 874.67 874.67 0.653 0.001 314.0 0.6 0.2% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 44:02 h +Na 876.69 876.69 0.644 0.001 318.4 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
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GlcCer 44:01 h +Na 878.71 878.70 0.642 0.001 319.5 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 44:02 h +K 892.66 892.68 0.639 0.001 321.1 0.7 0.2% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 47:09 +K 904.61 904.60 0.648 0.001 316.4 0.6 0.2% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 46:02 h +Na 904.72 904.72 0.633 0.001 323.8 0.6 0.2% 12 Analytical Standard Avanti Polar Lipids 
GlcCer 47:10 h +K 918.59 918.59 0.643 0.001 318.6 0.5 0.2% 12 Analytical Standard Avanti Polar Lipids 
PC 31:02 +K 754.48 754.48 0.725 0.002 283.6 0.8 0.3% 8 Analytical Standard Avanti Polar Lipids 
PC 31:01 +K 756.49 756.50 0.718 0.002 286.5 0.7 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 32:03 +K 766.48 766.49 0.711 0.001 288.9 0.6 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 32:02 +K 768.49 768.50 0.711 0.001 289.2 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 33:04 +K 778.48 778.48 0.715 0.002 287.5 0.7 0.3% 10 Analytical Standard Avanti Polar Lipids 
PC 33:03 +K 780.49 780.50 0.708 0.001 290.1 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 33:02 +K 782.51 782.52 0.705 0.001 291.5 0.6 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 34:04 +K 792.49 792.50 0.711 0.002 289.0 1.0 0.3% 10 Analytical Standard Avanti Polar Lipids 
PC 34:03 +K 794.51 794.51 0.702 0.002 292.4 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PC 34:02 +K 796.53 796.53 0.705 0.001 291.3 0.6 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 36:07 +Na 798.50 798.51 0.702 0.002 292.5 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 35:06 +K 802.48 802.48 0.704 0.002 291.8 1.0 0.3% 10 Analytical Standard Avanti Polar Lipids 
PC 35:05 +K 804.49 804.50 0.699 0.001 293.8 0.6 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 35:04 +K 806.51 806.51 0.697 0.002 294.5 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 35:03 +K 808.53 808.53 0.693 0.001 296.1 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 35:02 +K 810.54 810.54 0.690 0.001 297.7 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 38:10 +Na 820.49 820.50 0.694 0.001 295.9 0.6 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 38:09 +Na 822.50 822.51 0.689 0.001 297.8 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 38:08 +Na 824.52 824.52 0.684 0.002 299.9 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 37:07 +K 828.49 828.50 0.692 0.001 296.6 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 37:06 +K 830.51 830.51 0.688 0.001 298.2 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 37:05 +K 832.53 832.53 0.686 0.001 299.0 0.6 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 40:15 +Na 838.44 838.45 0.699 0.002 293.5 1.0 0.3% 9 Analytical Standard Avanti Polar Lipids 
PC 40:14 +Na 840.46 840.46 0.700 0.001 293.3 0.6 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 40:13 +Na 842.47 842.47 0.692 0.002 296.6 0.8 0.3% 8 Analytical Standard Avanti Polar Lipids 
PC 40:12 +Na 844.49 844.49 0.683 0.001 300.6 0.6 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 40:11 +Na 846.50 846.50 0.682 0.002 300.7 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 40:10 +Na 848.52 848.52 0.680 0.001 301.5 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 40:10 +Na 850.54 850.53 0.679 0.002 302.2 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 39:07 +K 856.53 856.53 0.675 0.002 303.8 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 39:06 +K 858.54 858.54 0.676 0.001 303.4 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 39:05 +K 860.56 860.55 0.673 0.002 304.7 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 42:15 +Na 866.47 866.47 0.679 0.003 301.9 1.1 0.4% 10 Analytical Standard Avanti Polar Lipids 
PC 42:14 +Na 868.49 868.49 0.686 0.002 299.0 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PC 42:13 +Na 870.50 870.50 0.673 0.002 304.9 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 42:12 +Na 872.52 872.52 0.675 0.002 303.9 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
PC 43:17 +K 892.43 892.44 0.675 0.001 303.5 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PC 43:16 +K 894.45 894.44 0.674 0.002 304.1 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE O-18:03/0:00 +Na 498.26 498.26 0.941 0.003 220.5 0.6 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-20:05 +Na 522.26 522.26 0.956 0.004 216.8 0.9 0.4% 11 Analytical Standard Avanti Polar Lipids 
PE O-20:04 +Na 524.28 524.27 0.913 0.002 226.9 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-20:03 +Na 526.29 526.29 0.906 0.002 228.7 0.6 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-22:07 +Na 546.26 546.26 0.938 0.007 220.6 1.7 0.8% 11 Analytical Standard Avanti Polar Lipids 
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PE O-22:06 +Na 548.28 548.27 0.907 0.003 228.1 0.7 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE 21:03 +K 570.26 570.26 0.908 0.003 227.8 0.7 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE 21:02 +K 572.28 572.27 0.902 0.001 229.3 0.3 0.2% 8 Analytical Standard Avanti Polar Lipids 
PE O-26:05 +K 622.33 622.31 0.851 0.002 242.4 0.4 0.2% 8 Analytical Standard Avanti Polar Lipids 
PE 26:06 +K 634.29 634.27 0.854 0.003 241.7 1.0 0.4% 8 Analytical Standard Avanti Polar Lipids 
PE 26:05 +K 636.31 636.29 0.850 0.003 242.6 0.8 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE 26:04 +K 638.32 638.30 0.841 0.003 245.4 1.0 0.4% 8 Analytical Standard Avanti Polar Lipids 
PE 28:07 +K 660.31 660.29 0.843 0.003 244.4 0.8 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE 28:06 +K 662.32 662.30 0.829 0.002 248.7 0.7 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE 28:05 +K 664.34 664.32 0.821 0.002 250.9 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PE O-31:06 +K 690.39 690.37 0.799 0.002 257.8 0.5 0.2% 13 Analytical Standard Avanti Polar Lipids 
PE 32:01 +Na 712.49 712.49 0.751 0.002 274.1 0.7 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE O-34:04 +Na 720.49 720.49 0.746 0.002 275.9 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-34:03 +Na 722.51 722.51 0.740 0.003 278.0 0.9 0.3% 12 Analytical Standard Avanti Polar Lipids 
PE O-34:02 +Na 724.53 724.52 0.735 0.002 279.7 0.8 0.3% 12 Analytical Standard Avanti Polar Lipids 
PE 34:04 +Na 734.47 734.47 0.752 0.003 273.6 1.2 0.5% 8 Analytical Standard Avanti Polar Lipids 
PE O-O-36:04 +Na 734.55 734.55 0.736 0.003 279.3 1.2 0.4% 8 Analytical Standard Avanti Polar Lipids 
PE 34:03 +Na 736.49 736.49 0.745 0.003 276.1 1.0 0.4% 10 Analytical Standard Avanti Polar Lipids 
PE 34:02 +Na 738.50 738.51 0.739 0.001 278.3 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 34:01 +Na 740.52 740.52 0.731 0.002 281.3 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 33:00 +K 744.49 744.49 0.742 0.003 277.2 1.2 0.4% 11 Analytical Standard Avanti Polar Lipids 
PE O-36:05 +Na 746.51 746.51 0.736 0.002 279.2 0.7 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-36:04 +Na 748.53 748.52 0.730 0.002 281.6 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-36:03 +Na 750.54 750.54 0.720 0.003 285.4 1.1 0.4% 11 Analytical Standard Avanti Polar Lipids 
PE 35:02 +Na 752.52 752.52 0.731 0.001 281.3 0.3 0.1% 8 Analytical Standard Avanti Polar Lipids 
PE O-36:02 +Na 752.56 752.55 0.716 0.001 287.3 0.6 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 35:01 +Na 754.54 754.54 0.727 0.001 282.9 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 36:06 +Na 758.47 758.47 0.744 0.001 276.3 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 36:05 +Na 760.49 760.49 0.739 0.001 278.2 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 36:04 +Na 762.50 762.51 0.732 0.001 280.6 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 36:02 +Na 766.54 766.54 0.719 0.001 285.7 0.4 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 35:02 +K 768.49 768.49 0.728 0.002 282.5 0.7 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 36:01 +Na 768.55 768.55 0.712 0.001 288.5 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 35:01 +K 770.51 770.51 0.725 0.001 283.6 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE 35:00 +K 772.53 772.53 0.718 0.002 286.2 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-38:05 +Na 774.54 774.54 0.714 0.001 287.7 0.3 0.1% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-38:05 +K 776.54 776.53 0.720 0.003 285.6 1.0 0.4% 10 Analytical Standard Avanti Polar Lipids 
PE 37:03 +Na 778.54 778.54 0.718 0.002 286.2 0.7 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 37:02 +Na 780.55 780.55 0.713 0.001 288.2 0.4 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 38:08 +Na 782.47 782.46 0.729 0.002 281.9 0.7 0.2% 13 Analytical Standard Avanti Polar Lipids 
PE 37:01 +Na 782.57 782.56 0.703 0.002 292.2 0.9 0.3% 12 Analytical Standard Avanti Polar Lipids 
PE 38:07 +Na 784.49 784.49 0.724 0.001 283.7 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 38:06 +Na 786.50 786.50 0.721 0.001 285.0 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 38:05 +Na 788.52 788.52 0.715 0.001 287.2 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 38:04 +Na 790.54 790.54 0.708 0.001 290.0 0.5 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 37:04 +K 792.49 792.49 0.721 0.002 284.7 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 38:03 +Na 792.55 792.54 0.710 0.002 289.3 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 37:03 +K 794.51 794.51 0.717 0.001 286.5 0.4 0.2% 11 Analytical Standard Avanti Polar Lipids 
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PE 37:02 +K 796.53 796.52 0.709 0.001 289.8 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 37:01 +K 798.54 798.54 0.696 0.001 295.0 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 38:07 +K 800.46 800.48 0.716 0.001 287.0 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 39:06 +Na 800.52 800.52 0.717 0.002 286.4 0.7 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 37:00 +K 800.56 800.56 0.690 0.001 297.8 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE 38:06 +K 802.48 802.48 0.711 0.001 288.7 0.5 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE O-39:06 +K 802.52 802.52 0.706 0.001 290.9 0.5 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE O-O-40:06 +K 802.55 802.55 0.700 0.000 293.3 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 39:04 +Na 804.55 804.55 0.701 0.002 292.8 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 40:09 +Na 808.49 808.49 0.717 0.001 286.6 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE 40:08 +Na 810.50 810.50 0.710 0.001 289.2 0.3 0.1% 10 Analytical Standard Avanti Polar Lipids 
PE 40:07 +Na 812.52 812.52 0.706 0.001 290.8 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 40:05 +Na 816.55 816.55 0.696 0.002 294.8 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-42:11 +K 818.49 818.50 0.708 0.002 289.8 0.9 0.3% 12 Analytical Standard Avanti Polar Lipids 
PE O-O-42:10 +K 820.50 820.51 0.702 0.001 292.6 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 39:03 +K 822.54 822.54 0.700 0.002 293.4 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-44:14 +Na 824.50 824.48 0.712 0.002 288.2 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 39:02 +K 824.56 824.55 0.694 0.001 295.9 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-44:13 +Na 826.52 826.50 0.709 0.001 289.4 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE O-O-42:08 +K 826.55 826.56 0.691 0.002 297.0 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-44:12 +Na 828.53 828.51 0.707 0.002 290.4 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 40:06 +K 830.51 830.53 0.696 0.002 294.7 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 42:10 +Na 834.50 834.50 0.705 0.002 291.0 0.7 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 42:09 +Na 836.52 836.52 0.694 0.001 295.6 0.4 0.1% 12 Analytical Standard Avanti Polar Lipids 
PE 42:08 +Na 838.54 838.53 0.690 0.001 297.3 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-44:14 +K 842.49 842.49 0.704 0.002 291.4 0.7 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-44:13 +K 844.50 844.51 0.696 0.001 294.7 0.6 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE O-O-44:12 +K 846.52 846.52 0.691 0.001 297.0 0.6 0.2% 12 Analytical Standard Avanti Polar Lipids 
PE 42:10 +K 848.46 848.48 0.705 0.001 290.8 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-44:11 +K 848.54 848.53 0.691 0.002 297.1 0.9 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-46:15 +Na 850.52 850.50 0.701 0.002 292.7 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE 42:08 +K 852.49 852.51 0.693 0.002 296.1 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-45:14 +K 856.50 856.51 0.690 0.002 297.2 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 44:12 +Na 858.50 858.51 0.685 0.002 299.7 1.0 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE 44:11 +Na 860.52 860.51 0.683 0.002 300.3 1.0 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE O-O-46:16 +K 866.49 866.49 0.689 0.002 297.7 1.1 0.4% 12 Analytical Standard Avanti Polar Lipids 
PE O-O-46:15 +K 868.50 868.51 0.682 0.002 300.8 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-46:14 +K 870.52 870.52 0.677 0.001 302.9 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE O-45:12 +K 874.52 874.51 0.685 0.002 299.3 1.0 0.3% 7 Analytical Standard Avanti Polar Lipids 
PE 44:11 +K 876.49 876.50 0.685 0.001 299.3 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE O-47:16 +Na 878.51 878.51 0.684 0.002 299.7 0.9 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-47:16 +K 880.50 880.51 0.681 0.002 301.3 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-46:14 +K 884.50 884.51 0.684 0.003 299.8 1.4 0.5% 8 Analytical Standard Avanti Polar Lipids 
PE O-46:13 +K 886.52 886.52 0.670 0.002 306.0 1.1 0.4% 8 Analytical Standard Avanti Polar Lipids 
PE O-O-48:16 +K 894.52 894.52 0.672 0.001 305.1 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-47:14 +K 898.52 898.52 0.680 0.001 301.2 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE O-47:13 +K 900.53 900.53 0.684 0.003 299.9 1.2 0.4% 11 Analytical Standard Avanti Polar Lipids 
PE 46:11 +K 904.53 904.51 0.678 0.002 302.4 0.9 0.3% 8 Analytical Standard Avanti Polar Lipids 
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PE O-O-49:17 +K 906.52 906.52 0.672 0.002 304.9 0.9 0.3% 9 Analytical Standard Avanti Polar Lipids 
PE O-48:16 +K 908.50 908.49 0.675 0.002 303.5 0.9 0.3% 9 Analytical Standard Avanti Polar Lipids 
PE O-O-49:15 +K 910.52 910.52 0.672 0.001 304.9 0.6 0.2% 9 Analytical Standard Avanti Polar Lipids 
PE O-49:17 +K 920.50 920.50 0.670 0.002 306.1 1.0 0.3% 8 Analytical Standard Avanti Polar Lipids 
PE O-49:16 +K 922.52 922.52 0.682 0.002 300.6 1.1 0.4% 9 Analytical Standard Avanti Polar Lipids 
PE O-49:15 +K 924.53 924.53 0.673 0.003 304.7 1.2 0.4% 12 Analytical Standard Avanti Polar Lipids 
PE O-49:14 +K 926.55 926.55 0.665 0.002 308.1 1.0 0.3% 10 Analytical Standard Avanti Polar Lipids 
PE O-50:17 +K 934.52 934.51 0.658 0.002 311.2 1.0 0.3% 9 Analytical Standard Avanti Polar Lipids 
PE O-51:16 +K 950.55 950.54 0.659 0.002 311.0 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PE (1008.51) -- 1008.51 1008.51 0.637 0.002 321.2 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE O-O-62:19 +K 1084.69 1084.69 0.600 0.001 340.5 0.8 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE O-O-62:18 +K 1086.71 1086.71 0.598 0.001 341.8 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE O-O-64:19 +K 1112.72 1112.72 0.589 0.002 347.3 1.1 0.3% 10 Analytical Standard Avanti Polar Lipids 
PE O-O-66:21 +K 1136.72 1136.73 0.586 0.001 348.9 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 
36:05+36:04 
+Na 1500.00 1500.00 0.481 0.001 423.9 0.8 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 36:04 +Na 1502.02 1502.02 0.477 0.001 426.9 0.8 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 
36:05+38:05 
+Na 1526.02 1526.02 0.474 0.001 429.9 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 
36:05+38:04 
+Na 1528.04 1528.04 0.473 0.001 430.3 0.6 0.1% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 38:06 +Na 1550.02 1550.03 0.472 0.001 431.8 0.9 0.2% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 
38:06+38:05 
+Na 1552.04 1552.04 0.470 0.001 433.5 0.6 0.1% 10 Analytical Standard Avanti Polar Lipids 
PE Dimer 39:06 +Na 1578.05 1578.06 0.460 0.000 443.1 0.3 0.1% 8 Analytical Standard Avanti Polar Lipids 
PE Dimer 40:07 +Na 1602.05 1602.05 0.460 0.001 442.8 0.8 0.2% 8 Analytical Standard Avanti Polar Lipids 
PS O-O-36:03 +Na 780.55 780.55 0.707 0.002 290.6 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PS O-O-36:02 +Na 782.57 782.57 0.703 0.002 292.2 0.7 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS O-36:05 +Na 804.52 804.52 0.708 0.002 290.2 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 36:04 +Na 806.49 806.50 0.713 0.003 287.8 1.0 0.4% 13 Analytical Standard Avanti Polar Lipids 
PS 37:04 +Na 820.51 820.51 0.696 0.002 295.0 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 38:07 +Na 828.48 828.48 0.707 0.001 290.2 0.4 0.1% 11 Analytical Standard Avanti Polar Lipids 
PS 38:06 +Na 832.51 832.51 0.698 0.001 294.0 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 38:05 +Na 834.53 834.53 0.698 0.002 294.2 0.8 0.3% 12 Analytical Standard Avanti Polar Lipids 
PS 37:02 +K 840.52 840.51 0.700 0.002 293.0 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 39:07 +Na 842.49 842.50 0.700 0.002 293.1 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 39:06 +Na 846.53 846.52 0.689 0.002 297.7 1.0 0.3% 9 Analytical Standard Avanti Polar Lipids 
PS 39:05 +Na 848.54 848.54 0.677 0.002 303.3 0.9 0.3% 11 Analytical Standard Avanti Polar Lipids 
PE 38:04 +K 850.50 850.50 0.683 0.002 300.5 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS O-O-41:10 +K 852.49 852.49 0.692 0.002 296.6 0.6 0.2% 7 Analytical Standard Avanti Polar Lipids 
PS 40:08 +Na 854.49 854.49 0.699 0.002 293.6 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 40:07 +Na 856.51 856.51 0.694 0.001 295.6 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 40:06 +Na 860.54 860.54 0.684 0.002 299.9 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 40:05 +Na 862.56 862.56 0.679 0.002 302.2 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 41:07 +Na 870.53 870.52 0.686 0.002 299.2 0.9 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS O-O-44:13 +Na 872.52 872.51 0.687 0.002 298.4 1.0 0.3% 8 Analytical Standard Avanti Polar Lipids 
PS 41:06 +Na 872.54 872.54 0.676 0.002 303.3 1.1 0.4% 11 Analytical Standard Avanti Polar Lipids 
PS 42:12 +Na 874.46 874.46 0.698 0.003 293.7 1.1 0.4% 10 Analytical Standard Avanti Polar Lipids 
PS 42:11 +Na 876.48 876.48 0.697 0.002 294.2 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 42:10 +Na 878.49 878.49 0.690 0.001 297.1 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
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PS 42:09 +Na 880.51 880.51 0.679 0.002 302.0 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 42:08 +Na 882.53 882.53 0.681 0.002 301.3 0.9 0.3% 12 Analytical Standard Avanti Polar Lipids 
PS 42:07 +Na 884.54 884.54 0.673 0.001 304.7 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 42:05 +Na 888.57 888.57 0.668 0.001 307.0 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 43:09 +Na 894.53 894.52 0.676 0.002 303.2 1.0 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 43:08 +Na 896.54 896.53 0.672 0.001 305.2 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 44:13 +Na 900.48 900.48 0.695 0.002 294.9 0.8 0.3% 8 Analytical Standard Avanti Polar Lipids 
PS 44:12 +Na 902.49 902.50 0.684 0.001 299.7 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 44:11 +Na 904.51 904.51 0.679 0.001 302.1 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 44:10 +Na 906.53 906.52 0.675 0.001 303.5 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 44:09 +Na 908.54 908.54 0.675 0.002 303.7 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 44:08 +Na 910.56 910.56 0.668 0.001 306.8 0.5 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 45:15 +K 912.52 912.51 0.683 0.002 300.2 0.9 0.3% 8 Analytical Standard Avanti Polar Lipids 
PS 44:07 +Na 912.57 912.58 0.657 0.002 311.8 1.0 0.3% 13 Analytical Standard Avanti Polar Lipids 
PS 45:14 +K 914.47 914.47 0.677 0.002 302.6 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 43:07 +K 914.53 914.53 0.675 0.002 303.6 0.7 0.2% 8 Analytical Standard Avanti Polar Lipids 
PS 44:05 +Na 916.60 916.62 0.658 0.002 311.5 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS O-45:12 +K 918.51 918.51 0.674 0.001 304.0 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 44:09 +K 924.52 924.52 0.667 0.002 307.0 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 46:12 +Na 930.53 930.53 0.662 0.002 309.5 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 46:11 +Na 932.54 932.54 0.666 0.002 307.7 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 46:10 +Na 934.56 934.56 0.663 0.002 309.2 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 45:10 +K 936.52 936.52 0.654 0.002 313.2 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 45:09 +K 938.53 938.53 0.659 0.002 310.6 1.1 0.4% 12 Analytical Standard Avanti Polar Lipids 
PS 46:08 +Na 938.59 938.60 0.654 0.002 313.2 0.8 0.2% 8 Analytical Standard Avanti Polar Lipids 
PS O-47:14 +K 942.51 942.51 0.670 0.002 305.9 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
PS O-47:13 +K 944.52 944.52 0.665 0.002 308.1 1.0 0.3% 12 Analytical Standard Avanti Polar Lipids 
PS O-47:12 +K 946.54 946.53 0.662 0.002 309.2 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 46:10 +K 950.53 950.52 0.669 0.002 306.3 1.0 0.3% 12 Analytical Standard Avanti Polar Lipids 
PS 48:15 +Na 952.51 952.52 0.666 0.002 307.8 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 48:14 +Na 954.53 954.53 0.657 0.002 312.0 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 49:18 +Na 960.48 960.47 0.665 0.001 307.7 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PS 47:12 +K 960.52 960.52 0.665 0.002 307.8 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
PS 47:11 +K 962.53 962.53 0.659 0.000 311.0 0.2 0.1% 9 Analytical Standard Avanti Polar Lipids 
PS 49:16 +Na 964.51 964.50 0.661 0.001 309.6 0.7 0.2% 7 Analytical Standard Avanti Polar Lipids 
PS O-50:16 +Na 964.55 964.54 0.655 0.001 312.4 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
PS 49:15 +Na 966.53 966.52 0.656 0.000 312.3 1.2 0.4% 12 Analytical Standard Avanti Polar Lipids 
PS 49:14 +Na 968.54 968.54 0.651 0.002 314.6 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 48:14 +K 970.50 970.50 0.658 0.001 311.0 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 48:13 +K 972.52 972.52 0.654 0.002 313.0 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 48:12 +K 974.53 974.53 0.653 0.002 313.6 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 51:16 +Na 992.54 992.54 0.645 0.002 317.3 0.8 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 51:15 +Na 994.56 994.56 0.634 0.001 322.8 0.8 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 52:19 +Na 1000.51 1000.51 0.646 0.002 316.7 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
PS 52:18 +Na 1002.53 1002.53 0.641 0.001 319.1 0.7 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 52:17 +Na 1004.54 1004.54 0.637 0.001 321.4 0.6 0.2% 10 Analytical Standard Avanti Polar Lipids 
PS 52:16 +Na 1006.56 1006.57 0.635 0.001 322.2 0.4 0.1% 7 Analytical Standard Avanti Polar Lipids 
PS O-51:10 +K 1006.63 1006.63 0.635 0.002 322.4 0.8 0.3% 9 Analytical Standard Avanti Polar Lipids 
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PS 51:13 +K 1014.56 1014.55 0.626 0.002 326.8 1.0 0.3% 8 Analytical Standard Avanti Polar Lipids 
PS 51:12 +K 1016.58 1016.56 0.637 0.001 321.1 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
PS 53:17 +Na 1018.56 1018.56 0.633 0.001 323.3 0.5 0.2% 7 Analytical Standard Avanti Polar Lipids 
PS 55:18 +Na 1044.57 1044.57 0.621 0.002 329.3 0.9 0.3% 7 Analytical Standard Avanti Polar Lipids 
SM 34:01 +Na 725.56 725.56 0.722 0.001 285.1 0.4 0.1% 10 Analytical Standard Avanti Polar Lipids 
SM O-36:03 +Na 735.58 735.57 0.708 0.001 290.4 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
SM 35:01 +Na 739.57 739.57 0.711 0.002 289.1 0.8 0.3% 11 Analytical Standard Avanti Polar Lipids 
SM 36:02 +Na 751.57 751.57 0.707 0.001 290.9 0.2 0.1% 11 Analytical Standard Avanti Polar Lipids 
SM 36:01 +Na 753.59 753.59 0.703 0.001 292.4 0.2 0.1% 11 Analytical Standard Avanti Polar Lipids 
SM 37:01 +Na 767.60 767.60 0.697 0.001 294.8 0.6 0.2% 11 Analytical Standard Avanti Polar Lipids 
SM O-38:00 +Na 769.66 769.66 0.676 0.002 303.9 1.0 0.3% 11 Analytical Standard Avanti Polar Lipids 
SM 771.07 -- 771.67 771.67 0.672 0.002 305.6 0.9 0.3% 10 Analytical Standard Avanti Polar Lipids 
SM 38:01 +Na 781.62 781.62 0.688 0.001 298.5 0.4 0.1% 10 Analytical Standard Avanti Polar Lipids 
SM 39:01 +Na 795.64 795.63 0.681 0.002 301.6 0.7 0.2% 11 Analytical Standard Avanti Polar Lipids 
SM O-40:00 +Na 797.69 797.69 0.670 0.002 306.7 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
SM 40:03 +Na 805.62 805.62 0.685 0.002 299.9 0.9 0.3% 11 Analytical Standard Avanti Polar Lipids 
SM 40:02 +Na 807.64 807.63 0.681 0.001 301.7 0.3 0.1% 11 Analytical Standard Avanti Polar Lipids 
SM 40:01 +Na 809.65 809.65 0.676 0.001 303.9 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
SM 40:00 +Na 811.67 811.66 0.672 0.001 305.7 0.5 0.1% 10 Analytical Standard Avanti Polar Lipids 
SM O-42:04 +Na 817.66 817.65 0.659 0.001 311.3 0.5 0.2% 9 Analytical Standard Avanti Polar Lipids 
SM 41:02 +Na 821.65 821.65 0.675 0.001 303.9 0.5 0.2% 11 Analytical Standard Avanti Polar Lipids 
SM 41:01 +Na 823.67 823.66 0.670 0.001 306.3 0.3 0.1% 9 Analytical Standard Avanti Polar Lipids 
SM 42:03 +Na 833.65 833.65 0.672 0.001 305.6 0.4 0.1% 11 Analytical Standard Avanti Polar Lipids 
SM 42:02 +Na 835.67 835.67 0.666 0.001 308.2 0.2 0.1% 10 Analytical Standard Avanti Polar Lipids 
SM 42:01 +Na 837.68 837.68 0.663 0.001 309.3 0.3 0.1% 9 Analytical Standard Avanti Polar Lipids 
SM 43:03 +Na 847.67 847.66 0.663 0.001 309.6 0.3 0.1% 10 Analytical Standard Avanti Polar Lipids 
SM 43:02 +Na 849.68 849.68 0.659 0.001 311.5 0.3 0.1% 8 Analytical Standard Avanti Polar Lipids 
SM 43:01 +Na 851.70 851.69 0.657 0.001 312.5 0.4 0.1% 9 Analytical Standard Avanti Polar Lipids 
SM O-43:01 +K 853.69 853.68 0.645 0.001 318.0 0.7 0.2% 9 Analytical Standard Avanti Polar Lipids 
SM 44:03 +Na 861.68 861.68 0.657 0.001 312.0 0.5 0.2% 8 Analytical Standard Avanti Polar Lipids 
SM 44:02 +Na 863.70 863.70 0.654 0.001 313.5 0.4 0.1% 10 Analytical Standard Avanti Polar Lipids 
SM 44:01 +Na 865.71 865.71 0.651 0.001 315.1 0.3 0.1% 9 Analytical Standard Avanti Polar Lipids 
SM dimer 35:01 +Na 1456.16 1456.17 0.459 0.001 444.2 0.8 0.2% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 
36:01+36:02 
+Na 1482.17 1482.18 0.457 0.000 445.6 0.3 0.1% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 36:01 +Na 1484.19 1484.20 0.465 0.000 438.1 0.1 0.0% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 37:01 +Na 1512.22 1512.23 0.458 0.000 444.8 0.3 0.1% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 
38:01+38:02 
+Na 1538.23 1538.25 0.469 0.000 433.9 0.3 0.1% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 38:01 +Na 1540.25 1540.26 0.464 0.000 439.4 0.1 0.0% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 
38:01+39:02 
+Na 1552.25 1552.26 0.441 0.001 461.7 0.8 0.2% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 
38:01+39:01 
+Na 1554.27 1554.28 0.452 0.000 450.2 0.3 0.1% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 39:02 +Na 1564.25 1564.27 0.464 0.001 438.5 0.6 0.1% 4 Analytical Standard Avanti Polar Lipids 
SM dimer 39:01 + 
39:02 
+Na 1566.27 1566.28 0.451 0.000 451.5 0.2 0.1% 4 Analytical Standard Avanti Polar Lipids 
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Table C.5 CCS Values Measured in Both Helium and Nitrogen Drift Gas. Adapted from Jody C. 
May, Cody R. Goodwin, Nichole M. Lareau, Katrina L. Leaptrot, Caleb B. Morris, Ruwan T. 
Kurulugama, A. Mordehai, C. Klein, W. Barry, E. Darland, G. Overney, K. Imatani, George C. 
Stafford, John C. Fjeldsted, John A. McLean, “Conformational Ordering of Biomolecules in the Gas 
Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion 
Mobility-Mass Spectrometer,” Analytical Chemistry 2014, 86 (4), 2107-2116. 
(https://pubs.acs.org/doi/10.1021/ac4038448) Note that further permissions related to the 
material excerpted should be directed to the ACS. 
Analyte 
Exact 
m/z 
Nitrogen 
CCS 
(This Work) 
[Å2] 
Helium CCS 
(Literature) 
[Å2] 
Difference 
in CCS 
[Å2] 
Absolute 
Difference 
[%] 
Literature 
Reference 
for Helium 
CCS 
Values 
Quaternary Ammonium Salts (N=8) 
Tetramethylammonium TAA1 74.1 107.4* 48.5 58.9 76% 1 
Tetraethylammonium TAA2 130.3 123.3 65.9 57.4 61% 1 
Tetrapropylammonium TAA3 186.4 144.1 88.9 55.2 47% 1 
Tetrabutylammonium TAA4 242.5 166.6 111.2 55.4 40% 1 
Tetrapentylammonium TAA5 298.6 190.1 133.5 56.6 35% 1 
Tetrahexylammonium TAA6 354.7 213.5 154.9 58.6 32% 1 
Tetraheptylammonium TAA7 410.8 236.4 174.5 61.9 30% 1 
Tetraoctylammonium TAA8 466.5 256.6 194.3 62.3 28% 1 
Carbohydrates (N=24) 
Lactose + Na 342.30 178.1 121.1 57.0 38% 2 
Maltotetraose + Na 689.21 235.3 159.0 76.3 39% 2 
Lacto-N-fucopentaose I + Li 860.32 269.6 203.1 66.5 28% 2 
Lacto-N-fucopentaose I + Na 876.30 276.1 204.4 71.7 30% 2 
Lacto-N-fucopentaose II + Na 876.30 271.1 201.3 69.8 30% 2 
Lacto-N-fucopentaose I + K 892.27 274.7 205.0 69.7 29% 2 
Lacto-N-fucopentaose II + K 892.27 267.2 202.6 64.6 28% 2 
Lacto-N-fucopentaose I + Rb 938.22 275.2 198.4 76.8 32% 2 
Lacto-N-fucopentaose II + Rb 938.22 278.4 197.5 80.9 34% 2 
Lacto-N-fucopentaose I + Cs 986.21 275.6 204.0 71.6 30% 2 
α-cyclodextrin + Na 995.31 285.5 200.7 84.8 35% 2 
Lacto-N-difucohexaose I + Li 1006.38 301.4 225.9 75.5 29% 6 
Maltohexaose + Na 1013.32 286.4 206.0 80.4 33% 2 
Lacto-N-difucohexaose I + Na 1022.35 290.6 225.6 65.0 25% 2 
Lacto-N-difucohexaose I + Na 1022.35 304.2 225.6 78.6 30% 2 
Lacto-N-difucohexaose II + Na 1022.35 291.2 220.6 70.6 28% 2 
Lacto-N-difucohexaose II + Na 1022.35 306.3 220.6 85.7 33% 2 
Lacto-N-difucohexaose I + K 1038.33 303.5 229.8 73.8 28% 6 
Lacto-N-difucohexaose II + K 1038.33 305.8 225.3 80.5 30% 6 
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Lacto-N-difucohexaose I + Rb 1084.28 303.2 230.0 73.2 27% 6 
Lacto-N-difucohexaose I + Cs 1132.27 301.2 232.3 68.9 26% 6 
β-cyclodextrin + Na 1157.36 319.7 231.4 88.3 32% 2 
Maltoheptaose + Na 1175.37 303.1 236.4 66.7 25% 6 
Maltoheptaose + K 1191.34 303.4 236.7 66.7 25% 6 
Tryptic Peptides (N=38) 
YVR + H 437.3 207.0 140.2 66.8 38% 3 
GVFR + H 478.3 214.8 146.8 68.1 38% 3 
SDGRG + H 491.2 204.6 130.0 74.6 45% 4 
GRGDS + H 491.2 205.9 132.0 73.9 44% 4 
VYAR + H 508.3 217.1 157.1 60.1 32% 3 
ADLAK + H 517.3 228.3 159.3 69.0 36% 3 
WMGK + H 521.3 220.1 152.9 67.2 36% 3 
FWGK + H 537.3 231.0 160.5 70.5 36% 3 
VASLR + H 545.3 232.5 163.7 68.8 35% 3 
AFDEK + H 609.3 238.3 168.4 69.9 34% 3 
GQIVGR + H 629.4 245.5 173.6 71.9 34% 3 
IETMR + H 649.3 252.8 181.3 71.5 33% 3 
AAGHDGK + H 655.3 249.0 170.2 78.8 38% 3 
ANIDVK + H 659.4 248.1 176.8 71.3 34% 3 
GVLHAVK + H 723.5 269.9 199.2 70.7 30% 3 
SVYDSR + H 726.3 258.4 184.2 74.3 34% 3 
NVPLYK + H 733.4 272.2 195.3 76.9 33% 3 
IATAIEK + H 745.4 275.5 202.9 72.6 30% 3 
LNQLLR + H 756.5 275.6 205.0 70.6 29% 3 
HLADLSK + H 783.4 273.3 201.8 71.6 30% 3 
LVTDLTK + H 789.5 276.6 205.8 70.8 29% 3 
YDLDFK + H 800.4 272.4 201.0 71.4 30% 3 
TFAEALR + H 807.4 283.5 210.0 73.5 30% 3 
AADALLLK + H 814.5 291.8 223.9 68.0 26% 3 
DIVGAVLK + H 814.5 277.8 206.1 71.7 30% 3 
ATEEQLK + H 818.4 281.3 206.4 74.9 31% 3 
IGDYAGIK + H 836.5 285.9 210.4 75.5 30% 3 
DIPVPKPK + H 893.5 294.2 219.2 75.0 29% 3 
AEFVEVTK + H 922.5 295.7 223.4 72.3 28% 3 
YLYEIAR + H 927.5 305.0 228.0 76.9 29% 3 
EALDFFAR + H 968.5 305.9 231.1 74.9 28% 3 
LVVSTQTALA + H 1002.6 315.6 239.3 76.3 28% 3 
ANELLINVK + H 1013.6 326.8 249.7 77.1 27% 3 
GVIFYESHGK + H 1136.6 332.9 254.9 78.0 27% 3 
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IGSEVYHNLK + H 1159.6 348.4 269.7 78.7 25% 3 
LVNELTEFAK + H 1163.6 344.4 267.5 76.9 25% 3 
SISIVGSYVGNR + H 1251.7 349.1 267.8 81.3 26% 3 
VNQIGTLSESIK + H 1288.7 358.7 278.8 80.0 25% 3 
Lipids (N=49) 
PE 34:02 + Na 738.5 278.3 213.5 64.8 26% 2 
PE 34:01 + Na 740.5 281.3 214.7 66.6 27% 2 
SM (36:01) + Na 753.6 292.4 221.3 71.1 28% 2 
PC 32:01 + Na
 †
 754.5 283.6 217.6 66.0 26% 5 
PC 32:00 + Na 756.6 286.5 217.4 69.1 27% 5 
PE 36:04 + Na 762.5 280.6 214.4 66.2 27% 2 
PE 36:02 + Na 766.5 285.7 220.9 64.8 26% 2 
PE 35:02 + K
 †
 768.6 282.5 221.7 60.8 24% 2 
SM O-(38:00) + Na
 †
 769.6 303.9 222.7 81.2 31% 2 
PC 34:02 + Na 780.6 290.1 218.9 71.2 28% 2 
SM (38:01)  + Na 781.6 298.5 231.3 67.2 25% 2 
PC 34:01 + Na 782.6 291.5 221.7 69.8 27% 2 
PE 38:05  + Na 788.5 287.2 220.6 66.6 26% 2 
PE 38:04  + Na 790.5 290.0 228.1 61.9 24% 2 
SM O-(40:00) + Na
 †
 797.6 306.7 227.9 78.8 29% 5 
PC 34:01 + K 798.5 292.5 222.0 70.5 27% 5 
PC 36:04 + Na 804.6 293.8 221.3 72.5 28% 5 
PC 36:03 + Na
 †
 806.6 294.5 220.6 73.9 29% 5 
GlcCer 40:01 + Na 806.6 301.1 232.9 68.2 26% 2 
PC 36:02 + Na 808.6 296.1 226.7 69.4 27% 2 
GlcCer 40:00 + Na
 †
 808.6 302.3 236.6 65.7 24% 2 
SM (40:01) + Na
 †
 809.7 303.9 225.4 78.5 30% 5 
PC 36:01 + Na 810.6 297.7 228.1 69.6 26% 2 
GlcCer 41:01 + Na
 †
 820.6 302.5 236.2 66.3 25% 2 
PC 36:03 + K 822.5 297.8 222.9 74.9 29% 5 
GlcCer 40:01 h + Na 822.6 303.4 234.6 68.8 26% 2 
PC 36:02 + K 824.6 299.9 226.2 73.7 28% 2 
GlcCer 40:00 h + Na
 †
 824.6 306.1 237.9 68.2 25% 2 
PC 38:05 + Na 830.6 298.2 222.2 76.0 29% 2 
PC 38:04 + Na 832.6 299.0 228.5 70.5 27% 2 
GlcCer 42:02 + Na 832.7 305.2 238.8 66.4 24% 2 
PS 38:05 + Na
 †
 834.5 294.2 225.5 68.7 26% 2 
GlcCer 42:01 + Na 834.7 307.5 239.3 68.2 25% 2 
SM (42:02) + Na 835.7 308.2 239.4 68.8 25% 2 
GlcCer 42:00 + Na
 †
 836.7 308.2 240.2 68.0 25% 2 
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SM (42:01) + Na 837.7 309.3 239.3 70.0 26% 2 
PS 37:02 + K
 †
 840.6 293.0 222.6 70.4 27% 2 
PC 38:06 + K 844.5 300.6 224.6 76.0 29% 5 
GlcCer 43:02 + Na
 †
 846.6 307.8 238.8 69.0 25% 2 
PC 38:04 + K 848.6 301.5 230.0 71.5 27% 5 
GlcCer 42:02 h + Na 848.7 309.0 240.3 68.7 25% 2 
GlcCer 42:01 h + Na
 †
 850.6 312.7 242.8 69.9 25% 5 
SM O-(43:01) + K
 †
 853.7 318.0 241.2 76.8 27% 5 
GlcCer 44:02 + Na 860.7 315.3 245.9 69.4 25% 5 
GlcCer 43:02 h + Na
 †
 862.7 314.6 244.3 70.3 25% 5 
GlcCer 43:01 h + Na
 †
 864.6 313.7 245.2 68.5 25% 2 
GlcCer 44:02 h + Na 876.7 318.4 246.7 71.7 25% 5 
PS 42:09 + Na 880.5 302.0 238.0 64.0 24% 2 
PS 42:08 + Na 882.5 301.3 230.8 70.5 26% 2 
* TAA1 nitrogen CCS value obtained from Reference 1. 
† Denotes lipid identifications which are different than originally reported in literature, due to the higher mass accuracy 
measurements obtained in this study. 
 
References: 
1. I. Campuzano, M.F. Bush, C.V. Robinson, C. Beaumont, K. Richardson, H. Kim, H.I. Kim, Analytical Chemistry 2012, 
84(2), 1026-33. 
2. L.S. Fenn, M. Kliman, A. Mahsut, S. Zhao, J.A. McLean, Analytical and Bioanalytical Chemistry 2009, 394, 235-244. 
3. S.J. Valentine, A.E. Counterman, D.E. Clemmer, Journal of the American Society for Mass Spectrometry 1999, 10, 
1188-1211. 
4. M.F. Bush, Z. Hall, K. Giles, J. Hoyes, C.V. Robinson, B.T. Ruotolo, Analytical Chemistry 2010, 82(22), 9557-9565. 
5. W.B. Ridenour, M. Kliman, J.A. McLean, R.M. Caprioli, Analytical Chemistry 2010, 82(5), 1881-1889.  
6. Unpublished values measured in helium on a uniform field IM-MS instrument (Vanderbilt drift tube).  For 
instrumentation details, see: S. Sundarapandian, J.C. May, J.A. McLean, Analytical Chemistry 2010, 82, 3247-3254. 
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C.4 Carbohydrate Nomenclature 
Lacto-N-fucopentaose I  Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc 
Lacto-N-fucopentaose II  Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4Glc 
Lacto-N-difucohexaose I  Fucα1-2Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4Glc 
Lacto-N-difucohexaose II  Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4[Fucα1-
3]Glc 
α-cyclodextrin    cyclomaltohexaose 
β-cyclodextrin    cyclomaltoheptaose 
 
Hex   – Hexose (Hexose assignments in the database are based on exact mass 
measurement. The exact type of hexose is uncertain) 
Fuc   – Fucose (All pentose identifications are assigned as fucose in the database 
as this is the only pentose present in the samples) 
HexNAc  – N-acetylated hexosamine (the exact type of hexose is uncertain). 
Gal   – Galactose 
Glc   – Glucose 
GlcNAc  – N-acetylglucosamine 
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C.5 Lipid Nomenclature 
Glycerophospholipids: 
Ex. PC x:y 
PC, PE, PS = abbreviated names for phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine respectively 
  x = total number of carbons in fatty acid chains 
  y = total number of double bonds in fatty acid chains 
Sphingolipids: 
Ex. SM x:y 
SM, GlcCer = abbreviated names for sphingomyelin and cerebroside respectively 
   x = total number of carbons in the amide linked fatty acid of the ceramide 
plus eighteen carbons from the sphingosine backbone 
   y = total number of double bonds, one trans double bond in the 
sphingosine backbone plus the number of double bonds in the amide 
         linked fatty acid of the ceramide 
 
Hydroxylation on Cerebrosides: 
Ex. GlcCer x:y h 
h = denotes hydroxylation on the number two carbon (from the carbonyl) 
of the amide linked fatty acid 
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Alkyl Ether Linkage 
 
 Ex. PS O-x:y 
     x = total number of carbons in fatty acid chains 
     y = total number of double bonds in fatty acid chains 
        O = alkyl ether substituent 
  O-O = alkyl ether substituent occurs on both chains 
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 APPENDIX D 
 
SUPPLEMENTAL INFORMATION FOR CHAPTER 5 
 
D.1     Equations used to calculate the various analytical figures-of-merit in this work 
Single-peak resolving power (Rp) is calculated in this work as 
 
      𝑅𝑝 =  
𝐶𝐶𝑆
∆𝐶𝐶𝑆
      (D.1) 
 
Here, CCS is the collision cross section, and ΔCCS is the full width at half maximum (FWHM) 
in CCS for the peak. 
 
 
Two-peak resolution (Rpp) is calculated in this work as 
 
𝑅𝑝𝑝 = 1.18 ∗
(𝑡2−𝑡1)
(∆𝑡2+∆𝑡1)
     (D.2) 
 
Here, t1 is the centroid drift time of the first analyte peak, t2 is the centroid drift time of the 
second analyte peak, Δt1 is the FWHM for the first analyte peak, and Δt2 is the FWHM for the 
second analyte peak. 
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Peak capacity is calculated in this work as 
 
  𝑃𝑒𝑎𝑘 𝐶𝑎𝑝𝑎𝑐𝑖𝑡𝑦 =  
𝐶𝐶𝑆2−𝐶𝐶𝑆1
1
2
∗(∆𝐶𝐶𝑆1+∆𝐶𝐶𝑆2)
     (D.3) 
 
Here, CCS1 is the collision cross section for the most compact structure in a given mass range, 
CCS2 is the collision cross section for the most loosely packed structure, ΔCCS1 is the FWHM 
of the peak for the most compact CCS, and ΔCCS2 is the FWHM of the peak for the most 
loosely packed CCS. In this work, the mass range selected is a ca. 100 Da wide mass window 
that contains four small mass analytes from the different chemical classes investigated (c.f., 
the insets in Figure 5.4 of the main text).  
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Figure D.1 The effect of the operational pressure of the two front funnel regions (HPF and TF) on 
the measured CCS of HFAP ions. Mass (in Da) is projected on the x-axis, whereas the y-axis 
represents the change in CCS relative to high pressure operational conditions (denoted with the 
asterisk in each legend). Error bars represent five replicate measurements. Red and blue shading 
in the legends indicate high or low relative pressure conditions for HPF and TF. Lower HPF and TF 
operational pressures had minimal effect on the CCS in N2, but increased CCS in Ar and CO2 and 
decreased the measured CCS in He. These results are interpreted as a DT gas intrusion effect 
caused when operating at the higher pressures. Adapted from Caleb B. Morris, Jody C. May, 
Katrina L. Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross 
Section Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases 
for Drift Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass 
Spectrometry 2019 (in press). 
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Figure D.2 The effect of the ion injection voltage (trap exit voltage) on the ion intensity (relative 
peak areas) of HFAP ions. The y-axis is the percent change in peak area relative to the vendor-
recommended setting of 10 V at each trap funnel exit voltage bias (x-axis, in volts). All error bars 
are based on five replicate measurements. The highest ion abundances were observed at around 
10 V.  Data for voltages above 35V in helium was not obtained due to electrical breakdown issues. 
Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, “Evaluating 
Separation Selectivity and Collision Cross Section Measurement Reproducibility in Helium, 
Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spectrometry,” 
Journal of the American Society for Mass Spectrometry 2019 (in press).  
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Figure D.3 The effect of the ion injection voltage (trap funnel exit bias, in volts) on the single-peak 
resolving power (Rp) for all HFAP ions.  The y-axis is the change in Rp as compared to the vendor 
default setting of 10 V. All error bars are based on five replicate measurements. Increasing the ion 
injection voltage modestly increased (~15%) the resolving power in N2 and Ar, however CO2 
exhibited a maximum resolving power at 10 to 15 V, whereas He saw no Rp difference outside of 
error. Data for voltages above 35V in helium was not obtained due to electrical breakdown issues. 
Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, “Evaluating 
Separation Selectivity and Collision Cross Section Measurement Reproducibility in Helium, 
Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spectrometry,” 
Journal of the American Society for Mass Spectrometry 2019 (in press).  
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Figure D.4 The effect of the ion injection voltage (trap exit voltage) on the measured CCS for HFAP 
ions. The y-axis is the change in CCS relative to the vendor-recommended setting of 10 V at each 
trap funnel exit voltage bias (x-axis, in volts). All error bars are based on five replicate 
measurements. Increasing the ion injection voltage decreases the CCS for all but helium, which 
saw no difference outside of error. Data for voltages above 35V in helium was not obtained due 
to electrical breakdown issues. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, 
and John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section Measurement 
Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion 
Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 2019 (in 
press). 
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Figure D.5 Histogram of the empirical relative standard deviations (RSD) in CCS observed in each 
drift gas, based on five measurements for each analyte. The average %RSD observed for N2, Ar, 
and CO2 was ~0.2%, whereas in He, the RSD was ~0.6% on average, but deviations >1% were also 
observed. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, 
“Evaluating Separation Selectivity and Collision Cross Section Measurement Reproducibility in 
Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass 
Spectrometry,” Journal of the American Society for Mass Spectrometry 2019 (in press). 
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Figure D.6 Tuning mixture (HFAP) CCS measurements obtained in nitrogen, for this work and 
compared to previously published values.1,2 Measurements in tan (Stow et al., gridded1) were 
obtained on a gridded reference drift tube instrument, while the measurements in brown (Stow 
et al., interlab1) represent the averaged DTCCSN2 values reported in a recent interlaboratory study 
Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, “Evaluating 
Separation Selectivity and Collision Cross Section Measurement Reproducibility in Helium, 
Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spectrometry,” 
Journal of the American Society for Mass Spectrometry 2019 (in press). 
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Figure D.7 Polyalanine values compared to previously published values2,3 for helium (left column) 
and nitrogen (right column) drift gases. Each row represents a different charge state family. The 
values reported from this work were calculated using a drift tube effective length that was 
determined from comparison of tune mix values in nitrogen to values gathered on a gridded 
instrument also operated in nitrogen1. Adapted from Caleb B. Morris, Jody C. May, Katrina L. 
Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section 
Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift 
Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 
2019 (in press). 
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Figure D.8 TAA values compared to previously published values2-7 for helium (left column) and 
nitrogen (right column) drift gases. The effective length used in this work was the same as used 
to for the measurements in Figure D.7. Adapted from Caleb B. Morris, Jody C. May, Katrina L. 
Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section 
Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift 
Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 
2019 (in press).  
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Figure D.9 CCS values (in square angstroms) plotted as a function of drift gas polarizability (in 
cubic angstroms) for multiple charge states of poly-DL-alanine, with linear fits for each analyte 
ion. The linear fits within each charge state exhibit similar slopes, whereas the slopes increase as 
the charge state increases, indicating a stronger contribution to the drift gas polarizability. 
Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, “Evaluating 
Separation Selectivity and Collision Cross Section Measurement Reproducibility in Helium, 
Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spectrometry,” 
Journal of the American Society for Mass Spectrometry 2019 (in press). 
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Table D.1 Gas-specific instrument parameters which yield CCS measurements exhibiting high 
reproducibility and correspondence to literature. The header titles correspond to the names of 
the tabs and instrument controls found in the vendor acquisition software. For all gases, data is 
acquired at each drift field for 30 seconds. Adapted from Caleb B. Morris, Jody C. May, Katrina L. 
Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section 
Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift 
Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 
2019 (in press). 
 
  Source IM Trap 
  
Gas 
Temp. 
(°C) 
Drying 
Gas 
(L/min) 
Nebulizer 
(psig) 
Sheath Gas 
Temp. (°C) 
Sheath Gas 
Flow (L/min) 
Trap Fill 
Time (μs) 
Trap Release 
Time (μs) 
Helium 
325 13 20 275 12 40000 100 
Nitrogen 
Argon 
Carbon Dioxide 
    
  IM-FrontFunnel IM-DriftTube Pressure 
  
Trap 
Funnel 
Delta 
(V) 
Trap 
Funnel 
RF (Vpp) 
Trap 
Funnel 
Exit (V) 
Drift Tube 
Entrance 
Voltage (V) 
Drift Tube 
Exit Voltage 
(V) 
High 
Pressure 
Funnel 
(Torr) 
Trap 
Funnel 
(Torr) 
Drift 
Tube 
(Torr) 
Helium 
180 150 10 
874, 974, 
1074, 1174, 
1274, 1374, 
1474 
224 
4.35 3.72 
3.95 
Nitrogen 1074, 1174, 
1274, 1374, 
1474, 1574, 
1674 
4.80 
3.80 
Argon 3.74 
Carbon Dioxide 4.30 3.72 
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Table D.2 CCS measurements for all analyte ions investigated in this work. CCS values are reported 
as an average of five replicate measurements made on multiple days. Analytes are reported in 
this table if they were consistently observed across all drift gases and days and had a %RSD of 
0.7% or less in helium and 0.5% or less in other drift gases. The values reported here were 
calculated from an effective length of 78.06 cm determined for this instrument by comparison of 
HFAP DTCCSN2 values to measurements obtained on a specially-modified reference instrument.1 
Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, “Evaluating 
Separation Selectivity and Collision Cross Section Measurement Reproducibility in Helium, 
Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass Spectrometry,” 
Journal of the American Society for Mass Spectrometry 2019 (in press). 
 
Name 
Ion Exact 
Mass 
Charge 
State 
Adduct 
He N2 Ar CO2 
CCS %RSD CCS %RSD CCS %RSD CCS %RSD 
HFAP 322 322.0487 1 +H 96.30 1.38 153.78 0.11 148.00 0.20 203.74 0.21 
HFAP 622 622.0295 1 +H 135.27 0.77 203.15 0.09 194.29 0.21 259.98 0.13 
HFAP 922 922.0103 1 +H 171.74 0.81 243.93 0.08 234.31 0.16 294.68 0.11 
HFAP 1222 1221.9911 1 +H 204.10 0.76 282.46 0.09 271.81 0.11 332.82 0.11 
HFAP 1522 1521.9720 1 +H 234.01 0.70 317.37 0.07 305.92 0.11 367.98 0.12 
HFAP 1822 1821.9529 1 +H 262.79 0.73 351.00 0.09 338.52 0.09 402.55 0.16 
HFAP 2122 2121.9337 1 +H 290.34 0.72 382.72 0.14 369.96 0.13 435.67 0.13 
HFAP 2422 2421.9145 1 +H 316.49 0.73 412.40 0.21 399.70 0.12 467.25 0.14 
HFAP 2722 2721.8954 1 +H 341.79 0.73 440.42 0.31 428.90 0.15 498.08 0.11 
D-(+)-Maltose 365.1060 1 +Na 99.54 1.34 179.72 0.09 167.24 0.23 246.97 0.10 
D-(+)-Maltose 381.0799 1 +K 103.12 0.83 181.89 0.11 170.03 0.21 251.92 0.36 
 Maltotriose 527.1588 1 +Na 132.14 0.77 211.11 0.12 199.90 0.20 278.33 0.21 
 Maltotriose 543.1327 1 +K 132.47 0.70 212.07 0.08 200.66 0.22 280.84 0.25 
Maltotetraose 689.2116 1 +Na 147.88 0.67 231.29 0.13 220.17 0.27 301.80 0.31 
Maltopentaose 851.2644 1 +Na 171.04 0.58 257.24 0.15 246.32 0.30 330.98 0.29 
Maltopentaose 867.2384 1 +K 171.50 0.74 258.17 0.28 247.33 0.25 333.73 0.49 
Maltohexaose 1013.3173 1 +Na 189.94 0.70 281.45 0.17 270.63 0.29 359.44 0.24 
Maltoheptaose 1175.3701 1 +Na 206.45 0.66 299.65 0.15 288.22 0.29 377.75 0.32 
PAla 6 445.2411 1 +H 123.68 0.70 194.02 0.15 186.07 0.23 250.40 0.42 
PAla 7 516.2782 1 +H 137.76 0.61 210.05 0.16 201.61 0.15 266.97 0.27 
PAla 8 587.3153 1 +H 152.45 0.39 226.70 0.10 217.87 0.17 283.87 0.21 
PAla 9 658.3524 1 +H 164.28 0.66 240.58 0.14 231.75 0.16 298.05 0.06 
PAla 10 729.3895 1 +H 175.32 0.29 252.98 0.05 243.80 0.27 310.86 0.12 
PAla 11 800.4266 1 +H 186.58 0.47 266.43 0.09 256.93 0.14 325.31 0.21 
PAla 12 871.4637 1 +H 197.46 0.42 279.19 0.10 269.64 0.19 339.30 0.21 
PAla 13 942.5008 1 +H 207.83 0.42 291.49 0.07 281.80 0.20 352.52 0.26 
PAla 14 1013.5380 1 +H 217.38 0.35 302.56 0.13 292.99 0.18 365.12 0.18 
PAla 15 1084.5751 1 +H 227.72 0.46 314.62 0.08 304.72 0.12 377.70 0.30 
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PAla 14 1014.5457 2 +H 224.89 0.96 331.65 0.13 320.03 0.49 419.08 0.32 
PAla 15 1085.5829 2 +H 235.31 0.71 344.05 0.31 332.61 0.67 429.48 0.17 
PAla 16 1156.6200 2 +H 246.53 0.73 356.30 0.23 343.25 0.45 442.25 0.17 
PAla 17 1227.6571 2 +H 257.17 0.94 368.24 0.24 354.66 0.21 452.93 0.13 
PAla 18 1298.6942 2 +H 268.00 0.70 380.74 0.21 366.49 0.33 464.61 0.25 
PAla 19 1369.7313 2 +H 278.02 0.65 391.89 0.14 377.18 0.26 476.48 0.16 
PAla 20 1440.7685 2 +H 287.80 0.81 404.15 0.27 388.87 0.23 487.54 0.16 
PAla 21 1511.8056 2 +H 298.57 0.65 415.35 0.24 400.82 0.83 498.36 0.19 
PAla 22 1582.8427 2 +H 308.06 0.67 425.66 0.20 409.75 0.33 509.95 0.28 
PAla 23 1653.8798 2 +H 317.95 0.88 437.18 0.21 420.10 0.54 521.70 0.17 
PAla 24 1724.9169 2 +H 326.39 0.65 448.33 0.24 432.49 0.62 531.52 0.18 
PAla 26 1866.9911 2 +H 349.89 1.20 470.87 0.40 454.44 0.33 555.51 0.28 
PAla 25 1796.9618 3 +H 399.94 0.76 560.74 0.07 539.10 0.34 672.22 0.34 
PAla 26 1867.9990 3 +H 412.11 0.63 576.82 0.31 554.01 0.27 687.38 0.40 
PAla 27 1939.0361 3 +H 424.61 0.67 592.10 0.15 567.88 0.31 702.88 0.67 
PAla 28 2010.0732 3 +H 437.84 0.54 606.82 0.10 582.61 0.38 721.15 0.37 
PAla 29 2081.1103 3 +H 449.98 0.79 620.94 0.21 598.68 0.34 732.70 0.14 
PAla 30 2152.1474 3 +H 462.05 0.68 636.26 0.14 610.94 0.31 749.72 0.46 
PAla 32 2294.2216 3 +H 484.79 0.57 663.67 0.15 637.58 0.25 774.74 0.34 
PAla 33 2365.2587 3 +H 496.05 0.71 676.23 0.15 650.47 0.70 787.85 0.30 
PAla 34 2436.2958 3 +H 506.59 0.66 689.67 0.24 665.06 0.54 804.93 0.49 
PAla 37 2649.4072 3 +H 539.58 0.62 729.03 0.14 700.89 0.42 845.26 0.44 
TAA 7 410.4726 1 + 169.38 1.80 234.48 0.07 225.76 0.33 284.26 0.17 
TAA 8 466.5351 1 + 187.00 1.25 254.81 0.05 245.32 0.29 305.61 0.17 
TAA 10 578.6603 1 + 217.24 1.42 290.58 0.09 280.59 0.24 344.70 0.16 
TAA 12 690.7855 1 + 240.42 1.39 316.77 0.16 307.00 0.24 373.60 0.15 
TAA 16 915.0359 1 + 273.51 1.32 353.81 0.15 343.15 0.23 412.76 0.21 
TAA 18 1027.1611 1 + 290.49 1.48 372.90 0.25 362.38 0.26 433.63 0.19 
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Table D.3 CCS measurements for analytes that were not observed across all drift gases and days 
but still had a %RSD of 0.7% or less in helium and 0.5% or less in other drift gases. Relative 
standard deviations are based on three to five runs. Adapted from Caleb B. Morris, Jody C. May, 
Katrina L. Leaptrot, and John A. McLean, “Evaluating Separation Selectivity and Collision Cross 
Section Measurement Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases 
for Drift Tube Ion Mobility-Mass Spectrometry,” Journal of the American Society for Mass 
Spectrometry 2019 (in press). 
 
Name 
Ion Exact 
Mass 
Charge 
State 
Adduct 
He N2 Ar CO2 
CCS %RSD CCS %RSD CCS %RSD CCS %RSD 
α-D-Glucose 203.05 1 +Na - - 147.15 0.11 - - - - 
PAla 5 374.20 1 +H - - 179.77 0.16 172.05 0.43 238.16 0.69 
PAla 13 471.75 2 +H 212.79 0.70 318.71 0.11 304.81 0.29 406.59 0.70 
PAla 25 897.98 2 +H 335.15 0.76 456.95 0.33 440.81 0.53 542.60 0.52 
PAla 27 969.01 2 +H 356.01 1.33 479.65 0.82 466.32 1.38 561.03 0.88 
PAla 29 1040.05 2 +H 379.87 0.74 505.68 0.33 489.84 1.58 - - 
PAla 30 1075.57 2 +H 389.40 0.92 518.75 0.72 - - - - 
PAla 24 575.31 3 +H 385.00 0.73 543.79 0.21 523.53 0.40 656.03 0.21 
PAla 31 741.06 3 +H 471.40 0.77 646.84 0.21 623.48 0.30 758.37 0.33 
PAla 35 835.78 3 +H 517.05 0.68 699.31 0.35 671.81 0.46 813.57 0.19 
PAla 36 859.46 3 +H 526.31 0.77 712.14 0.18 692.38 0.76 829.33 0.52 
PAla 38 906.81 3 +H 547.16 0.82 735.72 0.33 716.79 1.75 849.94 0.69 
PAla 39 930.49 3 +H 559.58 0.58 749.15 0.46 728.90 1.44 - - 
PAla 40 954.17 3 +H 572.00 0.63 760.07 0.43 - - 882.56 1.20 
PAla 41 977.85 3 +H 580.28 0.53 775.36 0.21 755.62 2.03 892.86 0.66 
TAA 2 130.16 1 + - - 124.64 0.14 120.34 0.68 176.85 0.66 
TAA 3 186.22 1 + 87.47 1.06 145.44 0.07 140.41 0.25 196.31 0.24 
TAA 4 242.28 1 + 109.60 0.33 166.52 0.09 161.00 0.25 216.48 0.21 
TAA 5 298.35 1 + 130.81 2.45 189.59 0.09 183.17 0.33 238.53 0.26 
TAA 6 354.41 1 + 149.68 0.93 212.05 0.11 204.54 0.30 261.02 0.19 
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Table D.4 Chemical standards used in this work, their vendor sources, product numbers, and CAS 
numbers. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and John A. McLean, 
“Evaluating Separation Selectivity and Collision Cross Section Measurement Reproducibility in 
Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion Mobility-Mass 
Spectrometry,” Journal of the American Society for Mass Spectrometry 2019 (in press). 
 
Analyte Source Product# CAS# 
HFAPs 
(ESI Tuning Mixture) 
Agilent Technologies 
G1969-
85000 
(321 Da) 957-13-1 
(621 Da) 186817-57-2 
(921 Da) 58943-98-9 
(1221 Da) 186406-47-3 
(1521 Da) 16059-16-8 
(1821 Da) 186406-48-4 
(2121 Da) 3830-74-8 
(2421 Da) 186406-49-5 
(2721 Da) 186043-67-4 
D-(+)-Maltose Sigma-Aldrich 63419 6363-53-7 
Isomaltotriose Sigma-Aldrich (Supelco) 4-7884 3371-50-4 
Maltotetraose Sigma-Aldrich (Supelco) 4-7877 34612-38-9 
Maltopentaose Sigma-Aldrich (Supelco) 4-7876 34620-76-3 
Maltohexaose Sigma-Aldrich (Supelco) 4-7873 34620-77-4 
Maltoheptaose Sigma-Aldrich M7753 34620-78-5 
Poly-DL-Alanine Sigma-Aldrich P9003 25281-63-4 
TAA 7 
(Tetraheptylammonium Bromide) 
Sigma-Aldrich 87301 4368-51-8 
TAA 8 
(Tetraoctylammonium Bromide) 
Acros Organics 352100050 14866-33-2 
TAA 10 
(Tetradecylammonium Bromide) 
Sigma-Aldrich 87578 14937-42-9 
TAA 12 
(Tetradodecylammonium Bromide) 
Sigma-Aldrich 87249 14866-34-3 
TAA 16 
(Tetrahexadecylammonium Bromide) 
Sigma-Aldrich 367524 139653-55-7 
TAA 18 
(Tetraoctadecylammonium Bromide) 
Alfa Aesar 20582 63462-99-7 
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Table D.5 Slope, intercept, and regression coefficient values corresponding to the linear fits in 
Figure 5.6 of the main text. Adapted from Caleb B. Morris, Jody C. May, Katrina L. Leaptrot, and 
John A. McLean, “Evaluating Separation Selectivity and Collision Cross Section Measurement 
Reproducibility in Helium, Nitrogen, Argon, and Carbon Dioxide Drift Gases for Drift Tube Ion 
Mobility-Mass Spectrometry,” Journal of the American Society for Mass Spectrometry 2019 (in 
press). 
 
 
Slope 
(Å-1) 
Intercept 
(Å2) R2  
HFAP m/z 322 (+1) 39.389 85.779 0.996 
HFAP m/z 922 (+1) 45.290 161.512 0.998 
Maltose (+1) 54.075 84.732 0.993 
Maltohexaose (+1) 62.163 173.122 0.996 
PAla 6 (+1) 46.544 112.071 0.998 
PAla 13 (+1) 53.261 195.594 0.999 
PAla 14 (+2) 71.291 206.624 0.998 
TAA 7 (+1) 42.235 158.816 0.998 
TAA 16 (+1) 51.246 260.976 0.998 
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